| 1 |
Shakoor N, Adeel M, Ahmad MA, Zain M, Waheed U, Javaid RA, Haider FU, Azeem I, Zhou P, Li Y, Jilani G, Xu M, Rinklebe J, Rui Y. Reimagining safe lithium applications in the living environment and its impacts on human, animal, and plant system. Environ Sci Ecotechnol 2023;15:100252. [PMID: 36891261 DOI: 10.1016/j.ese.2023.100252] [Reference Citation Analysis]
|
| 2 |
Chirio-Espitalier M, Harscoët YA, Duval M, Jupille J, Moret L, Grall-Bronnec M. The experience of caregivers providing therapeutic patient education for people living with bipolar disorder: a qualitative study. BMC Psychiatry 2023;23:196. [PMID: 36964544 DOI: 10.1186/s12888-023-04623-0] [Reference Citation Analysis]
|
| 3 |
Engin AB, Engin A, Engin ED, Memis L. Does lithium attenuate the liver damage due to oxidative stress and liver glycogen depletion in experimental common bile duct obstruction? Toxicol Appl Pharmacol 2023;:116489. [PMID: 36963521 DOI: 10.1016/j.taap.2023.116489] [Reference Citation Analysis]
|
| 4 |
Okasha TA, Abdel Maksoud M, Moneum DMA, Hegazy Ali D. Management challenges and choices in patients with bipolar disorder: An Egyptian observational study. Int J Soc Psychiatry 2023;69:370-7. [PMID: 35506634 DOI: 10.1177/00207640221092707] [Reference Citation Analysis]
|
| 5 |
Fancy F, Rodrigues NB, Di Vincenzo JD, Chau EH, Sethi R, Husain MI, Gill H, Tabassum A, Mckenzie A, Phan L, McIntyre RS, Rosenblat JD. Real-world effectiveness of repeated ketamine infusions for treatment-resistant bipolar depression. Bipolar Disord 2023;25:99-109. [PMID: 36516343 DOI: 10.1111/bdi.13284] [Reference Citation Analysis]
|
| 6 |
Jeong JH, Bahk WM, Woo YS, Yoon BH, Lee JG, Kim W, Sohn I, Park SY, Shim SH, Seo JS, Choo IH, Yang CM, Jung MH, Jon DI, Kim MD. Korean Medication Algorithm Project for Bipolar Disorder 2022: Comparisons with Other Treatment Guidelines. Clin Psychopharmacol Neurosci 2023;21:32-48. [PMID: 36700310 DOI: 10.9758/cpn.2023.21.1.32] [Reference Citation Analysis]
|
| 7 |
Zhang L, Li Q, Du Y, Gao Y, Bai T, Ji GJ, Tian Y, Wang K. Effect of high-definition transcranial direct current stimulation on improving depression and modulating functional activity in emotion-related cortical-subcortical regions in bipolar depression. J Affect Disord 2023;323:570-80. [PMID: 36503046 DOI: 10.1016/j.jad.2022.12.007] [Reference Citation Analysis]
|
| 8 |
Platania GA, Savia Guerrera C, Sarti P, Varrasi S, Pirrone C, Popovic D, Ventimiglia A, De Vivo S, Cantarella RA, Tascedda F, Drago F, Di Nuovo S, Colliva C, Caraci F, Castellano S, Blom JMC. Predictors of functional outcome in patients with major depression and bipolar disorder: A dynamic network approach to identify distinct patterns of interacting symptoms. PLoS One 2023;18:e0276822. [PMID: 36791083 DOI: 10.1371/journal.pone.0276822] [Reference Citation Analysis]
|
| 9 |
Musetti L, Tundo A, Cambiali E, Del Grande C, De Filippis R, Franceschini C, Proietti L, Betrò S, Marazziti D, Dell'Osso L. Which patients with bipolar depression receive antidepressant augmentation? Results from an observational multicenter study. CNS Spectr 2022;27:731-9. [PMID: 34505564 DOI: 10.1017/S109285292100078X] [Reference Citation Analysis]
|
| 10 |
Holmes SE, Asch RH, Davis MT, DellaGioia N, Pashankar N, Gallezot JD, Nabulsi N, Matuskey D, Sanacora G, Carson RE, Blumberg HP, Esterlis I. Differences in Quantification of the Metabotropic Glutamate Receptor 5 Across Bipolar Disorder and Major Depressive Disorder. Biol Psychiatry 2022:S0006-3223(22)01713-9. [PMID: 36764853 DOI: 10.1016/j.biopsych.2022.10.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Lee Y, Lee D, Jung H, Cho Y, Baek JH, Hong KS. Heterogeneous early illness courses of Korean patients with bipolar disorders: replication of the staging model. BMC Psychiatry 2022;22:684. [PMID: 36333702 DOI: 10.1186/s12888-022-04318-y] [Reference Citation Analysis]
|
| 12 |
Chatterton ML, Lee YY, Berk L, Mohebbi M, Berk M, Suppes T, Lauder S, Mihalopoulos C. Cost-Utility and Cost-effectiveness of MoodSwings 2.0, an Internet-Based Self-management Program for Bipolar Disorder: Economic Evaluation Alongside a Randomized Controlled Trial. JMIR Ment Health 2022;9:e36496. [PMID: 36318243 DOI: 10.2196/36496] [Reference Citation Analysis]
|
| 13 |
Jidong DE, Husain IM, Ike TJ, Husain N, Taru MY, Nwoga CN, Francis C, Jack DB, Mwankon SB, Xue S, Pwajok JY, Nyam PN, Murshed M. Bipolar disorders in Nigeria: A mixed-methods study of patients, family caregivers, clinicians, and the community members’ perspectives.. [DOI: 10.21203/rs.3.rs-1927978/v1] [Reference Citation Analysis]
|
| 14 |
Veyej N, Moosa MYH. Prescribing patterns of long-acting injectable antipsychotics in a community setting in South Africa. S Afr J Psychiatr 2022;28:1809. [PMID: 35812829 DOI: 10.4102/sajpsychiatry.v28i0.1809] [Reference Citation Analysis]
|
| 15 |
Chen Y, Chen J, Zhuang X, Chen X, Zeng J, Wang R, Miao J. Risk factors of elevated blood ammonia level in epilepsy patients treated with lamotrigine. Medicine (Baltimore) 2022;101:e29780. [PMID: 35776999 DOI: 10.1097/MD.0000000000029780] [Reference Citation Analysis]
|
| 16 |
Perros P, Hegedus L. Enhanced Well-Being Associated with Thyrotoxicosis: A Neglected Effect of Thyroid Hormones? Int J Endocrinol Metab 2022;20. [DOI: 10.5812/ijem-127230] [Reference Citation Analysis]
|
| 17 |
Chatterton ML, Lee YY, Berk L, Mohebbi M, Berk M, Suppes T, Lauder S, Mihalopoulos C. Cost-utility and cost-effectiveness analyses of an internet-based self-management program for bipolar disorder: Randomised controlled trial (Preprint).. [DOI: 10.2196/preprints.36496] [Reference Citation Analysis]
|
| 18 |
Edinoff AN, Sathivadivel N, Mcneil SE, Ly AI, Kweon J, Kelkar N, Cornett EM, Kaye AM, Kaye AD. Antipsychotic Use in Pregnancy: Patient Mental Health Challenges, Teratogenicity, Pregnancy Complications, and Postnatal Risks. Neurology International 2022;14:62-74. [DOI: 10.3390/neurolint14010005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 19 |
Kim W, Bahk W, Woo YS, Jeong J, Seo JS, Choo IH, Yang C, Lee JG, Shim S, Jung MH, Jon D, Park S, Sohn I, Kim M, Yoon B. Korean Medication Algorithm Project for Bipolar Disorder 2022: Overview. J Korean Neuropsychiatr Assoc 2022;61:98. [DOI: 10.4306/jknpa.2022.61.2.98] [Reference Citation Analysis]
|
| 20 |
Hudak R, Gannon JM. Bipolar Disorder. Handbook of Psychiatric Disorders in Adults in the Primary Care Setting 2022. [DOI: 10.1007/978-3-030-98709-1_3] [Reference Citation Analysis]
|
| 21 |
Vrublevska J, Renemane L. Neuropsychopharmacotherapy: Guidelines. NeuroPsychopharmacotherapy 2022. [DOI: 10.1007/978-3-030-62059-2_16] [Reference Citation Analysis]
|
| 22 |
Wang X, Luo H, Zhang Y, Mao M, Lu Y, Zhang Z, Jiang C, Luo Q. Effect of online aerobic exercise training in patients with bipolar depression: Protocol of a randomized clinical trial. Front Psychiatry 2022;13:1011978. [PMID: 36458119 DOI: 10.3389/fpsyt.2022.1011978] [Reference Citation Analysis]
|
| 23 |
Yang C, Bahk W, Woo YS, Jeong J, Seo JS, Choo IH, Kim W, Lee JG, Jung MH, Jon D, Park S, Sohn I, Kim M, Yoon B, Shim S. Korean Medication Algorithm Project for Bipolar Disorder 2022: Children and Adolescents. J Korean Neuropsychiatr Assoc 2022;61:224. [DOI: 10.4306/jknpa.2022.61.3.224] [Reference Citation Analysis]
|
| 24 |
Lewitzka U, Haußmann R. Lithium - ein Update. InFo Neurologie 2022;24:44-53. [DOI: 10.1007/s15005-021-2201-4] [Reference Citation Analysis]
|
| 25 |
Mak ADP, Neggers SFW, Leung ONW, Chu WCW, Ho JYM, Chou IWY, Chan SSM, Lam LCW, Lee S. Antidepressant efficacy of low-frequency repetitive transcranial magnetic stimulation in antidepressant-nonresponding bipolar depression: a single-blind randomized sham-controlled trial. Int J Bipolar Disord 2021;9:40. [PMID: 34877622 DOI: 10.1186/s40345-021-00245-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 26 |
Marjani M, Dolab N, Kamkar MZ, Amiriani T, Yuzugulen J, Marjani A. Gender and Body Mass Index-Related Serum Level of Adipokines and Metabolic Syndrome Components in Bipolar Patients who received Lithium and Valproic Acid. Metab Syndr Relat Disord 2021;:1-9. [PMID: 34874780 DOI: 10.1089/met.2021.0078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 27 |
Kim JY, Park HH, Yong TS, Jeon SH. Lithium chloride inhibits the migration and invasion of osteosarcoma cells by blocking nuclear translocation of phospho-Erk. Biochem Biophys Res Commun 2021;581:74-80. [PMID: 34656851 DOI: 10.1016/j.bbrc.2021.10.025] [Reference Citation Analysis]
|
| 28 |
Yatham LN, Chakrabarty T, Bond DJ, Schaffer A, Beaulieu S, Parikh SV, McIntyre RS, Milev RV, Alda M, Vazquez G, Ravindran AV, Frey BN, Sharma V, Goldstein BI, Rej S, O'Donovan C, Tourjman V, Kozicky JM, Kauer-Sant'Anna M, Malhi G, Suppes T, Vieta E, Kapczinski F, Kanba S, Lam RW, Kennedy SH, Calabrese J, Berk M, Post R. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations. Bipolar Disord 2021;23:767-88. [PMID: 34599629 DOI: 10.1111/bdi.13135] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 29 |
Schubert KO, Thalamuthu A, Amare AT, Frank J, Streit F, Adl M, Akula N, Akiyama K, Ardau R, Arias B, Aubry JM, Backlund L, Bhattacharjee AK, Bellivier F, Benabarre A, Bengesser S, Biernacka JM, Birner A, Marie-Claire C, Cearns M, Cervantes P, Chen HC, Chillotti C, Cichon S, Clark SR, Cruceanu C, Czerski PM, Dalkner N, Dayer A, Degenhardt F, Del Zompo M, DePaulo JR, Étain B, Falkai P, Forstner AJ, Frisen L, Frye MA, Fullerton JM, Gard S, Garnham JS, Goes FS, Grigoroiu-Serbanescu M, Grof P, Hashimoto R, Hauser J, Heilbronner U, Herms S, Hoffmann P, Hou L, Hsu YH, Jamain S, Jiménez E, Kahn JP, Kassem L, Kuo PH, Kato T, Kelsoe J, Kittel-Schneider S, Ferensztajn-Rochowiak E, König B, Kusumi I, Laje G, Landén M, Lavebratt C, Leboyer M, Leckband SG, Maj M, Manchia M, Martinsson L, McCarthy MJ, McElroy S, Colom F, Mitjans M, Mondimore FM, Monteleone P, Nievergelt CM, Nöthen MM, Novák T, O'Donovan C, Ozaki N, Ösby U, Papiol S, Pfennig A, Pisanu C, Potash JB, Reif A, Reininghaus E, Rouleau GA, Rybakowski JK, Schalling M, Schofield PR, Schweizer BW, Severino G, Shekhtman T, Shilling PD, Shimoda K, Simhandl C, Slaney CM, Squassina A, Stamm T, Stopkova P, Tekola-Ayele F, Tortorella A, Turecki G, Veeh J, Vieta E, Witt SH, Roberts G, Zandi PP, Alda M, Bauer M, McMahon FJ, Mitchell PB, Schulze TG, Rietschel M, Baune BT; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium. Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients. Transl Psychiatry 2021;11:606. [PMID: 34845190 DOI: 10.1038/s41398-021-01702-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 30 |
Cañada Y, Sabater A, Sierra P, Balanzá-Martínez V, Berk M, Dodd S, Navalón P, Livianos L, García-Blanco A. The effect of concomitant benzodiazepine use on neurocognition in stable, long-term patients with bipolar disorder. Aust N Z J Psychiatry 2021;55:1005-16. [PMID: 33153268 DOI: 10.1177/0004867420969819] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 31 |
Le Clerc S, Lombardi L, Baune BT, Amare AT, Schubert KO, Hou L, Clark SR, Papiol S, Cearns M, Heilbronner U, Degenhardt F, Tekola-Ayele F, Hsu YH, Shekhtman T, Adli M, Akula N, Akiyama K, Ardau R, Arias B, Aubry JM, Backlund L, Bhattacharjee AK, Bellivier F, Benabarre A, Bengesser S, Biernacka JM, Birner A, Brichant-Petitjean C, Cervantes P, Chen HC, Chillotti C, Cichon S, Cruceanu C, Czerski PM, Dalkner N, Dayer A, Del Zompo M, DePaulo JR, Étain B, Jamain S, Falkai P, Forstner AJ, Frisen L, Frye MA, Fullerton JM, Gard S, Garnham JS, Goes FS, Grigoroiu-Serbanescu M, Grof P, Hashimoto R, Hauser J, Herms S, Hoffmann P, Jiménez E, Kahn JP, Kassem L, Kuo PH, Kato T, Kelsoe JR, Kittel-Schneider S, Ferensztajn-Rochowiak E, König B, Kusumi I, Laje G, Landén M, Lavebratt C, Leckband SG, Tortorella A, Manchia M, Martinsson L, McCarthy MJ, McElroy SL, Colom F, Millischer V, Mitjans M, Mondimore FM, Monteleone P, Nievergelt CM, Nöthen MM, Novák T, O'Donovan C, Ozaki N, Ösby U, Pfennig A, Potash JB, Reif A, Reininghaus E, Rouleau GA, Rybakowski JK, Schalling M, Schofield PR, Schweizer BW, Severino G, Shilling PD, Shimoda K, Simhandl C, Slaney CM, Pisanu C, Squassina A, Stamm T, Stopkova P, Maj M, Turecki G, Vieta E, Veeh J, Witt SH, Wright A, Zandi PP, Mitchell PB, Bauer M, Alda M, Rietschel M, McMahon FJ, Schulze TG, Spadoni JL, Boukouaci W, Richard JR, Le Corvoisier P, Barrau C, Zagury JF, Leboyer M, Tamouza R. HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders. Sci Rep 2021;11:17823. [PMID: 34497278 DOI: 10.1038/s41598-021-97140-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 32 |
Ashrafi A, Tabatabaee M, Sharifi V. Development and Evaluation of Acceptability and Feasibility of a Web-Based Intervention for Patients With Bipolar Disorder in Iran: Implementation Study. JMIR Form Res 2021;5:e23360. [PMID: 34402794 DOI: 10.2196/23360] [Reference Citation Analysis]
|
| 33 |
Hozer F, Sarrazin S, Laidi C, Favre P, Pauling M, Cannon D, McDonald C, Emsell L, Mangin JF, Duchesnay E, Bellani M, Brambilla P, Wessa M, Linke J, Polosan M, Versace A, Phillips ML, Delavest M, Bellivier F, Hamdani N, d'Albis MA, Leboyer M, Houenou J. Lithium prevents grey matter atrophy in patients with bipolar disorder: an international multicenter study. Psychol Med 2021;51:1201-10. [PMID: 31983348 DOI: 10.1017/S0033291719004112] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 34 |
Tundo A, Musetti L, Del Grande C, de Filippis R, Proietti L, Cambiali E, Franceschini C, Dell'Osso L. Is short-term antidepressant treatment effective and safe in bipolar depression? Results from an observational multicenter study. Hum Psychopharmacol 2021;36:e2773. [PMID: 33351233 DOI: 10.1002/hup.2773] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 35 |
Bond DJ, Silveira LE, Torres IJ, Lam RW, Yatham LN. Weight gain as a risk factor for progressive neurochemical abnormalities in first episode mania patients: a longitudinal magnetic resonance spectroscopy study. Psychol Med 2021;:1-9. [PMID: 33706825 DOI: 10.1017/S0033291721000544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 36 |
Queissner R, Lenger M, Birner A, Dalkner N, Fellendorf F, Bengesser S, Platzer M, Hamm C, Maget A, Reininghaus B, Ratzenhofer M, Schuller J, Mangge H, Kapfhammer HP, Reininghaus EZ. The association between anti-inflammatory effects of long-term lithium treatment and illness course in Bipolar Disorder. J Affect Disord 2021;281:228-34. [PMID: 33338840 DOI: 10.1016/j.jad.2020.11.063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 37 |
Keramatian K, Su W, Saraf G, Chakrabarty T, Yatham LN. Preservation of Gray Matter Volume in Early Stage of Bipolar Disorder: A Case for Early Intervention: Préservation du volume de matière grise au stade précoce du trouble bipolaire: un cas pour intervention précoce. Can J Psychiatry 2021;66:139-46. [PMID: 32419481 DOI: 10.1177/0706743720927827] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 38 |
Saunders H, Osuch E, Anderson K, Martin J, Kunnilathu A, John-Baptiste A. Factors associated with initiation of community-based therapy for emerging adults with mood and anxiety disorders. Early Interv Psychiatry 2021;15:123-32. [PMID: 31975541 DOI: 10.1111/eip.12920] [Reference Citation Analysis]
|
| 39 |
Pal M, Ray R, Maji P, Panja A. Remote Patient Monitoring during pandemic caused by COVID-19 using Semantic Web Technologies. J Phys : Conf Ser 2021;1797:012023. [DOI: 10.1088/1742-6596/1797/1/012023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 40 |
Ahmed GK, Elbeh K, Khalifa H, Samaan MR. Impact of duration of untreated illness in bipolar I disorder (manic episodes) on clinical outcome, socioecnomic burden in Egyptian population. Psychiatry Res 2021;296:113659. [PMID: 33360586 DOI: 10.1016/j.psychres.2020.113659] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 41 |
Tortella G, Sampaio-Junior B, Moreno ML, Moffa AH, da Silva AF, Lafer B, Lotufo PA, Gattaz W, Borrione L, Machado-Vieira R, Goerigk S, Benseñor IM, Brunoni AR. Cognitive outcomes of the bipolar depression electrical treatment trial (BETTER): a randomized, double-blind, sham-controlled study. Eur Arch Psychiatry Clin Neurosci 2021;271:93-100. [PMID: 32221654 DOI: 10.1007/s00406-020-01121-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 42 |
González-pinto A, Balanzá-martínez V, Benaberre Hernández A, Gutiérrez-rojas L, Montes JM, Perrino CDD, Pérez Sola V, Montejo González ÁL, Giménez Palomo A, Crespo JM. Expert consensus on information sheet proposals for patients under treatment with lithium. Revista de Psiquiatría y Salud Mental (English Edition) 2021;14:27-39. [DOI: 10.1016/j.rpsmen.2021.03.003] [Reference Citation Analysis]
|
| 43 |
Sunder P, Chia MF, Filia K, Macneil C, Hasty M, Davey C, McGorry P, Berk M, Cotton S, Ratheesh A. Does guideline-concordant care predict naturalistic outcomes in youth with early stage bipolar I disorder? J Affect Disord 2021;278:23-32. [PMID: 32949870 DOI: 10.1016/j.jad.2020.09.037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 44 |
Mcgirr A, Vöhringer PA, Nassir Ghaemi S, Lam RW, Yatham LN. Safety and Efficacy of Adjunctive Second-Generation Antidepressant Therapy With A Mood Stabiliser or an Atypical Antipsychotic in Acute Bipolar Depression: Randomised Systematic Review and Meta-Analysis of A Placebo-Controlled Trials. FOC 2021;19:129-137. [DOI: 10.1176/appi.focus.19102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 45 |
Rosenblat JD. Novel therapeutic drug targets for bipolar disorder. Neurobiology of Bipolar Disorder 2021. [DOI: 10.1016/b978-0-12-819182-8.00037-5] [Reference Citation Analysis]
|
| 46 |
Zeng Y, Chen Y, Li J, Su Y. Brain-derived Neurotrophic Factor: a Key Gene Risk Factor and Potential Therapy Target in Bipolar Disorder. E3S Web Conf 2021;271:03069. [DOI: 10.1051/e3sconf/202127103069] [Reference Citation Analysis]
|
| 47 |
Tondo L, Baldessarini RJ. Suicide in psychiatric disorders: rates, risk factors, and therapeutics. Ketamine for Treatment-Resistant Depression 2021. [DOI: 10.1016/b978-0-12-821033-8.00004-6] [Reference Citation Analysis]
|
| 48 |
Hanyu S, Sugita N, Matsuda M, Murai T, Fujiwara H. Lithium intoxication–induced dysgeusia accompanied by glossalgia in a patient receiving lithium carbonate: a case report. J Med Case Reports 2020;14:149. [DOI: 10.1186/s13256-020-02495-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 49 |
Kidnapillai S, Bortolasci CC, Udawela M, Panizzutti B, Spolding B, Connor T, Sanigorski A, Dean OM, Crowley T, Jamain S, Gray L, Scarr E, Leboyer M, Dean B, Berk M, Walder K. The use of a gene expression signature and connectivity map to repurpose drugs for bipolar disorder. World J Biol Psychiatry 2020;21:775-83. [PMID: 29956574 DOI: 10.1080/15622975.2018.1492734] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 50 |
Patrick RE, Heintz HL, Skurla MD, Forester BP. A Comprehensive Review of the Evaluation, Diagnosis, and Treatment of Older Adult Bipolar Disorder. Curr Treat Options Psych 2020;7:508-530. [DOI: 10.1007/s40501-020-00232-w] [Reference Citation Analysis]
|
| 51 |
Fisher A, Manicavasagar V, Sharpe L, Laidsaar‐powell R, Juraskova I. Identifying and Addressing Barriers to Treatment Decision‐making in Bipolar II Disorder: Clinicians’ Perspective. Australian Psychologist 2018;53:40-51. [DOI: 10.1111/ap.12264] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 52 |
Orsolini L, Pompili S, Volpe U. The ‘collateral side’ of mood stabilizers: safety and evidence-based strategies for managing side effects. Expert Opinion on Drug Safety 2020;19:1461-95. [DOI: 10.1080/14740338.2020.1820984] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 53 |
Barroilhet SA, Ghaemi SN. When and how to use lithium. Acta Psychiatr Scand 2020;142:161-72. [PMID: 32526812 DOI: 10.1111/acps.13202] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 54 |
Dai Prà M. Uno studio di caso di paziente con Disabilità Intellettiva e disturbo Bipolare in contesto residenziale: comportamenti aggressivi, furto, Qualità della Vita e terapia farmacologica. Un intervento Comportamentale e Cognitivo. RIVISTA SPERIMENTALE DI FRENIATRIA 2020. [DOI: 10.3280/rsf2020-002007] [Reference Citation Analysis]
|
| 55 |
Ashrafi A, Tabatabaee M, Sharifi V. Development and Evaluation of Acceptability and Feasibility of a Web-Based Intervention for Patients With Bipolar Disorder in Iran: Implementation Study (Preprint).. [DOI: 10.2196/preprints.23360] [Reference Citation Analysis]
|
| 56 |
Jon DI, Woo YS, Seo JS, Lee JG, Jeong JH, Kim W, Shin YC, Min KJ, Yoon BH, Bahk WM. The Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP): Changes in preferred treatment strategies and medications over 16 years and five editions. Bipolar Disord 2020;22:461-71. [PMID: 32202033 DOI: 10.1111/bdi.12902] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 57 |
Wang D, Osser DN. The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An update on bipolar depression. Bipolar Disord 2020;22:472-89. [PMID: 31650675 DOI: 10.1111/bdi.12860] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 58 |
Uguz F. Pharmacological prevention of mood episodes in women with bipolar disorder during the perinatal period: A systematic review of current literature. Asian J Psychiatr 2020;52:102145. [PMID: 32516746 DOI: 10.1016/j.ajp.2020.102145] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 59 |
Dolab N, Kamkar MZ, Amiriani T, Yuzugulen J, Marjani M, Marjani A. The association between leptin and adiponectin, and metabolic syndrome components and serum levels of lipid peroxidation in bipolar disorder patients treated with lithium and valproic acid. Heliyon 2020;6:e04553. [PMID: 32760840 DOI: 10.1016/j.heliyon.2020.e04553] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 60 |
Salsaa M, Pereira B, Liu J, Yu W, Jadhav S, Hüttemann M, Greenberg ML. Valproate inhibits mitochondrial bioenergetics and increases glycolysis in Saccharomyces cerevisiae. Sci Rep 2020;10:11785. [PMID: 32678210 DOI: 10.1038/s41598-020-68725-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 61 |
Landry S, Provencher MD. Évaluation qualitative de l’implantation de groupes psychoéducatifs pour le trouble bipolaire à Québec. smq 2020;45:31-52. [DOI: 10.7202/1070240ar] [Reference Citation Analysis]
|
| 62 |
Dimick MK, Omrin D, MacIntosh BJ, Mitchell RHB, Riegert D, Levitt A, Schaffer A, Belo S, Iazzetta J, Detzler G, Choi M, Choi S, Orser BA, Goldstein BI. Nitrous oxide as a putative novel dual-mechanism treatment for bipolar depression: Proof-of-concept study design and methodology. Contemp Clin Trials Commun 2020;19:100600. [PMID: 32637725 DOI: 10.1016/j.conctc.2020.100600] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 63 |
Chen PH, Kao YH, Chang CK, Lin YK, Lin YF, Chen YJ. Clinical Risk Factors for Therapeutic Lithium-Associated Electrocardiographic Changes in Patients With Bipolar Disorder. J Clin Psychopharmacol 2020;40:46-53. [PMID: 31834090 DOI: 10.1097/JCP.0000000000001164] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 64 |
Sun L, Yagoda S, Yao B, Graham C, von Moltke L. Combination of Olanzapine and Samidorphan Has No Clinically Significant Effect on the Pharmacokinetics of Lithium or Valproate. Clin Drug Investig 2020;40:55-64. [PMID: 31584140 DOI: 10.1007/s40261-019-00860-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 65 |
Jonathan GK, Dopke CA, Michaels T, Bank A, Martin CR, Adhikari K, Krakauer RL, Ryan C, Mcbride A, Babington P, Frauenhofer E, Silver J, Capra C, Simon M, Begale M, Mohr DC, Goulding EH. A Smartphone-Based Self-management Intervention for Bipolar Disorder (LiveWell): User-Centered Development Approach (Preprint).. [DOI: 10.2196/preprints.20424] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 66 |
Wang S, Zhang Z, Yao L, Ding N, Jiang L, Wu Y. Bright light therapy in the treatment of patients with bipolar disorder: A systematic review and meta-analysis. PLoS One 2020;15:e0232798. [PMID: 32437356 DOI: 10.1371/journal.pone.0232798] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 67 |
Patel K, Stummer L, Patel K. Stiff-person syndrome in a patient with comorbid bipolar and panic disorders: A case report and literature review. Ment Health Clin 2020;10:95-9. [PMID: 32420007 DOI: 10.9740/mhc.2020.05.095] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 68 |
Szota AM, Radajewska I, Grudzka P, Araszkiewicz A. Lamotrigine, quetiapine and aripiprazole-induced neuroleptic malignant syndrome in a patient with renal failure caused by lithium: a case report. BMC Psychiatry 2020;20:179. [PMID: 32306929 DOI: 10.1186/s12888-020-02597-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 69 |
Yaramala SR, McElroy SL, Geske J, Winham S, Gao K, Reilly-Harrington NA, Ketter TA, Deckersbach T, Kinrys G, Kamali M, Sylvia LG, McInnis MG, Friedman ES, Thase ME, Kocsis JH, Tohen M, Calabrese JR, Bowden CL, Shelton RC, Nierenberg AA, Bobo WV. The impact of binge eating behavior on lithium- and quetiapine-associated changes in body weight, body mass index, and waist circumference during 6 months of treatment: Findings from the bipolar CHOICE study. J Affect Disord 2020;266:772-81. [PMID: 30241956 DOI: 10.1016/j.jad.2018.09.025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 70 |
Morcos N, Bess JD, Casher MI. The Inpatient with Mania. Manual of Inpatient Psychiatry 2020. [DOI: 10.1017/9781108656672.005] [Reference Citation Analysis]
|
| 71 |
Sharma V, Sharma P, Sharma S. Managing bipolar disorder during pregnancy and the postpartum period: a critical review of current practice. Expert Rev Neurother 2020;20:373-83. [PMID: 32172610 DOI: 10.1080/14737175.2020.1743684] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 72 |
Hanley GE, Miller T, Mintzes B. A Cohort Study of Psychotropic Prescription Drug Use in Pregnancy in British Columbia, Canada from 1997 to 2010. J Womens Health (Larchmt) 2020;29:1339-49. [PMID: 32176573 DOI: 10.1089/jwh.2019.8199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 73 |
Morana P, Mucci F, Baroni S, Della Vecchia A, Piccinni A, Morana B, Marazziti D. Effectiveness of clozapine, oxcarbazepine and rivastigmine combination in a bipolar disorder patient with initial cerebral atrophy. Clin Case Rep 2020;8:254-7. [PMID: 32128167 DOI: 10.1002/ccr3.2462] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 74 |
Matsuo K, Harada K, Fujita Y, Okamoto Y, Ota M, Narita H, Mwangi B, Gutierrez CA, Okada G, Takamura M, Yamagata H, Kusumi I, Kunugi H, Inoue T, Soares JC, Yamawaki S, Watanabe Y. Distinctive Neuroanatomical Substrates for Depression in Bipolar Disorder versus Major Depressive Disorder. Cereb Cortex 2019;29:202-14. [PMID: 29202177 DOI: 10.1093/cercor/bhx319] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 75 |
Soltmann B, Pfennig A, Bauer M. Methodik des Leitlinien-Updates Bipolare Störungen und Ausblick auf künftige Aktualisierungen. Nervenarzt 2020;91:222-226. [DOI: 10.1007/s00115-020-00880-6] [Reference Citation Analysis]
|
| 76 |
Sharma S, Dang S. Neuropsychological Disorders and their Nanocarriers. Curr Pharm Des 2020;26:2247-56. [PMID: 32091327 DOI: 10.2174/1381612826666200224111241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 77 |
Medić B, Stojanović M, Stimec BV, Divac N, Vujović KS, Stojanović R, Čolović M, Krstić D, Prostran M. Lithium - Pharmacological and Toxicological Aspects: The Current State of the Art. CMC 2020;27:337-51. [DOI: 10.2174/0929867325666180904124733] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 78 |
Stampone E, Bencivenga D, Barone C, Aulitto A, Verace F, Della Ragione F, Borriello A. High Dosage Lithium Treatment Induces DNA Damage and p57Kip2 Decrease. Int J Mol Sci 2020;21:E1169. [PMID: 32050593 DOI: 10.3390/ijms21031169] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 79 |
Torres IJ, Qian H, Basivireddy J, Chakrabarty T, Wong H, Lam RW, Yatham LN. Three-year longitudinal cognitive functioning in patients recently diagnosed with bipolar disorder. Acta Psychiatr Scand 2020;141:98-109. [PMID: 31840225 DOI: 10.1111/acps.13141] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 80 |
Cremaschi L, Ketter TA, Arici C, Miller S, Hooshmand F, Dell'Osso B. Antipsychotic use in Northern Italian inter-episode bipolar disorder patients: considering both second- and first-generation agents. Int Clin Psychopharmacol 2020;35:49-58. [PMID: 31453901 DOI: 10.1097/YIC.0000000000000283] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 81 |
Tavares DF, Dos Santos CGR, Valiengo LDCL, Klein I, Borrione L, Forte PM, Brunoni AR, Moreno RA. Efficacy, Safety, and Tolerability of Theta-Burst Stimulation in Mixed Depression: Design, Rationale, and Objectives of a Randomized, Double-Blinded, Sham-Controlled Trial. Front Psychiatry 2020;11:435. [PMID: 32499730 DOI: 10.3389/fpsyt.2020.00435] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 82 |
Dell'Osso B, Cremaschi L, Arici C, Altamura AC, Hooshmand F, Do D, Shah S, Gershon A, Holsinger A, Yeon Park D, Miller S, Wang PW, Ketter TA. Differential core pharmacotherapy in bipolar I versus bipolar II disorder and European versus American patients not in a syndromal episode. Int Clin Psychopharmacol 2020;35:8-18. [PMID: 31609786 DOI: 10.1097/YIC.0000000000000282] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 83 |
Ramirez-Mahaluf JP, Rozas-Serri E, Ivanovic-Zuvic F, Risco L, Vöhringer PA. Effectiveness of Sleep Deprivation in Treating Acute Bipolar Depression as Augmentation Strategy: A Systematic Review and Meta-Analysis. Front Psychiatry 2020;11:70. [PMID: 32161557 DOI: 10.3389/fpsyt.2020.00070] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 84 |
Zhou J, Ma X, Li C, Liao A, Yang Z, Ren H, Tang J, Li J, Li Z, He Y, Chen X. Frequency-Specific Changes in the Fractional Amplitude of the Low-Frequency Fluctuations in the Default Mode Network in Medication-Free Patients With Bipolar II Depression: A Longitudinal Functional MRI Study. Front Psychiatry 2020;11:574819. [PMID: 33488415 DOI: 10.3389/fpsyt.2020.574819] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 85 |
Vrublevska J, Renemane L. Neuropsychopharmacotherapy: Guidelines. NeuroPsychopharmacotherapy 2020. [DOI: 10.1007/978-3-319-56015-1_16-1] [Reference Citation Analysis]
|
| 86 |
Aga VM, Shad MU, Zhu H, Salzman C. Psychopharmacologic treatment. Handbook of Mental Health and Aging 2020. [DOI: 10.1016/b978-0-12-800136-3.00023-5] [Reference Citation Analysis]
|
| 87 |
Forrest LF, Smith M, Quevedo J, Frey BN. Bipolar Disorder in Women: Menstrual Cycle, Perinatal Period, and Menopause Transition. Women's Mental Health 2020. [DOI: 10.1007/978-3-030-29081-8_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 88 |
Frontoni S, Picconi F. Impact of Drugs on Diabetes Risk and Glycemic Control. Endocrinology 2020. [DOI: 10.1007/978-3-030-36694-0_19] [Reference Citation Analysis]
|
| 89 |
Patrinos GP, Andritsou A, Chalikiopoulou K, Mendrinou E, Tsermpini E. Pharmacogenomics in Clinical Care: Implications for Public Health. Applied Genomics and Public Health 2020. [DOI: 10.1016/b978-0-12-813695-9.00006-6] [Reference Citation Analysis]
|
| 90 |
D. Rosenblat J, Mcintyre RS. Pharmacological Treatment of Major Depressive Disorder. Major Depressive Disorder 2020. [DOI: 10.1016/b978-0-323-58131-8.00008-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 91 |
González-Pinto A, Balanzá-Martínez V, Benabarre Hernández A, Gutiérrez-Rojas L, Montes JM, de Dios Perrino C, Pérez Sola V, Montejo González ÁL, Giménez Palomo A, Crespo JM. Expert consensus on information sheet proposals for patients under treatment with lithium. Rev Psiquiatr Salud Ment (Engl Ed) 2021;14:27-39. [PMID: 31882351 DOI: 10.1016/j.rpsm.2019.11.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 92 |
Singh S, Kumar S, Mahal P, Vishwakarma A, Deep R. Self-reported medication adherence and its correlates in a lithium-maintained cohort with bipolar disorder at a tertiary care centre in India. Asian J Psychiatr 2019;46:34-40. [PMID: 31590007 DOI: 10.1016/j.ajp.2019.09.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 93 |
Maripuu M, Norrback K, Adolfsson R. Quality of life for patients diagnosed with bipolar disorder: Lifestyle and treatment. Neurology, Psychiatry and Brain Research 2019;34:34-40. [DOI: 10.1016/j.npbr.2019.09.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 94 |
Rakofsky J, Rapaport M. Mood Disorders. Continuum (Minneap Minn) 2018;24:804-27. [PMID: 29851879 DOI: 10.1212/CON.0000000000000604] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 95 |
Tournier M, Neumann A, Pambrun E, Weill A, Chaffiol JP, Alla F, Bégaud B, Maura G, Verdoux H. Conventional mood stabilizers and/or second-generation antipsychotic drugs in bipolar disorders: A population-based comparison of risk of treatment failure. J Affect Disord 2019;257:412-20. [PMID: 31306992 DOI: 10.1016/j.jad.2019.07.054] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 96 |
Mandal S, Mamidipalli SS, Mukherjee B, Hara SKH. Perspectives, attitude, and practice of lithium prescription among psychiatrists in India. Indian J Psychiatry 2019;61:451-6. [PMID: 31579157 DOI: 10.4103/psychiatry.IndianJPsychiatry_451_18] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 97 |
Tundo A, de Filippis R, De Crescenzo F. Pramipexole in the treatment of unipolar and bipolar depression. A systematic review and meta-analysis. Acta Psychiatr Scand 2019;140:116-25. [PMID: 31111467 DOI: 10.1111/acps.13055] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 98 |
Sharma V, Doobay M. Lamotrigine-induced obsessive-compulsive disorder in patients with bipolar disorder. CNS Spectr 2019;24:390-4. [PMID: 30086812 DOI: 10.1017/S1092852918001049] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 99 |
Almeida OP, Dols A, Sajatovic M. Bipolar Disorder. Seminars in Old Age Psychiatry 2019. [DOI: 10.1017/9781108593946.011] [Reference Citation Analysis]
|
| 100 |
Salvi V, Cerveri G, Aguglia A, Calò S, Corbo M, Martinotti G, Serafini G, Signorelli MS, Aguglia E, Amore M, Biggio G, DI Sciascio G, Mencacci C. Off-Label Use of Second-generation Antipsychotics in Bipolar Disorder: A Survey of Italian Psychiatrists. J Psychiatr Pract 2019;25:318-27. [PMID: 31291215 DOI: 10.1097/PRA.0000000000000405] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 101 |
Gitlin MJ. Antidepressants in Bipolar Depression: An Enduring Controversy. FOC 2019;17:278-283. [DOI: 10.1176/appi.focus.17306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 102 |
Kittel-Schneider S, Hilscher M, Scholz CJ, Weber H, Grünewald L, Schwarz R, Chiocchetti AG, Reif A. Lithium-induced gene expression alterations in two peripheral cell models of bipolar disorder. World J Biol Psychiatry 2019;20:462-75. [PMID: 29067888 DOI: 10.1080/15622975.2017.1396357] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 103 |
Stern S, Linker S, Vadodaria KC, Marchetto MC, Gage FH. Prediction of Response to Drug Therapy in Psychiatric Disorders. FOC 2019;17:294-307. [DOI: 10.1176/appi.focus.17304] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 104 |
Keleş Altun İ, Kılıç N, Yıldızoğlu E, Atagün Mİ. Lityuma Bağlı Yan Etkiler ve Nörotoksisite: Lityum Nörotoksisitesi Demir Birikimiyle İlgili Olabilir mi? Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry 2019;11:141-153. [DOI: 10.18863/pgy.384067] [Reference Citation Analysis]
|
| 105 |
Vinigiri K, Kammari BR, Rao p N, Kotu GM. Base‐Promoted Isomerization of cis ‐Lactam to trans ‐Lactam of Asenapine and Optimization of Crystallization Process of Asenapine Maleate Salt: An Antipsychotic Drug. ChemistrySelect 2019;4:7051-7057. [DOI: 10.1002/slct.201900658] [Reference Citation Analysis]
|
| 106 |
Kanba S, Murasaki M, Koyama T, Takeuchi M, Shimizu Y, Arita E, Kuroishi K, Takeuchi M, Kamei S. Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression. BMC Psychiatry 2019;19:198. [PMID: 31242884 DOI: 10.1186/s12888-019-2181-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 107 |
Kerner B, Crisanti AS, DeShaw JL, Ho JG, Jordan K, Krall RL, Kuntz MJ, Mazurie AJ, Nestsiarovich A, Perkins DJ, Schroeter QL, Smith AN, Tohen M, Volesky E, Zhu Y, Lambert CG. Preferences of Information Dissemination on Treatment for Bipolar Disorder: Patient-Centered Focus Group Study. JMIR Ment Health 2019;6:e12848. [PMID: 31237566 DOI: 10.2196/12848] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 108 |
Mannapperuma U, Galappatthy P, Jayakody RL, Mendis J, de Silva VA, Hanwella R. Safety monitoring of treatment in bipolar disorder in a tertiary care setting in Sri Lanka and recommendations for improved monitoring in resource limited settings. BMC Psychiatry 2019;19:194. [PMID: 31234824 DOI: 10.1186/s12888-019-2183-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 109 |
Keating LE, Becker S, McCabe K, Whattam J, Garrick L, Frey BN, Sassi RB, McKinnon MC. Impact of a structured, group-based running programme on clinical, cognitive and social function in youth and adults with complex mood disorders: a 12-week pilot study. BMJ Open Sport Exerc Med 2019;5:e000521. [PMID: 31191972 DOI: 10.1136/bmjsem-2019-000521] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 110 |
Jeong JH, Bahk WM, Woo YS, Lee JG, Kim MD, Sohn I, Shim SH, Jon DI, Seo JS, Kim W, Song HR, Min KJ, Yoon BH. Korean Medication Algorithm for Bipolar Disorder 2018: Comparisons with Other Treatment Guidelines. Clin Psychopharmacol Neurosci 2019;17:155-69. [PMID: 30905116 DOI: 10.9758/cpn.2019.17.2.155] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 111 |
Marazziti D, Mucci F, Falaschi V, Dell'Osso L. Asenapine for the treatment of bipolar disorder. Expert Opin Pharmacother 2019;20:1321-30. [PMID: 31132287 DOI: 10.1080/14656566.2019.1617849] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 112 |
Kuo CJ, Chen PH. Author's reply. Br J Psychiatry 2019;214:305-6. [PMID: 31012410 DOI: 10.1192/bjp.2019.64] [Reference Citation Analysis]
|
| 113 |
Fotso Soh J, Klil-Drori S, Rej S. Using Lithium in Older Age Bipolar Disorder: Special Considerations. Drugs Aging 2019;36:147-54. [PMID: 30613911 DOI: 10.1007/s40266-018-0628-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 114 |
Ashton MM, Berk M, Ng CH, Hopwood M, Kavanagh B, Williams LJ, Sarris J, Dean OM. Nutraceuticals and nutritional supplements for the treatment of bipolar disorder: protocol for a systematic review. BMJ Open 2019;9:e025640. [PMID: 30948585 DOI: 10.1136/bmjopen-2018-025640] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 115 |
Fontaine BN, Puttaert CM, Stewart TL, Struthers AM, Bapuji SB. Bridging the Gap Between Hospital and Community-Based Mental Health Services. Occupational Therapy in Mental Health 2019;35:157-178. [DOI: 10.1080/0164212x.2018.1539367] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 116 |
Duan J, Lai J, Wang D, Zhou W, Huang M, Hu S, Xu Y, Lu J. Topiramate precipitating a manic episode in a bipolar patient comorbid with binge eating disorder: A case report. Medicine (Baltimore) 2019;98:e15287. [PMID: 31027088 DOI: 10.1097/MD.0000000000015287] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 117 |
Szcześniak P, Staszewska-Krajewska O, Mlynarski J. Asymmetric total synthesis of (+)-asenapine. Org Biomol Chem 2019;17:3225-31. [PMID: 30840011 DOI: 10.1039/c9ob00178f] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 118 |
Stern S, Linker S, Vadodaria KC, Marchetto MC, Gage FH. Prediction of response to drug therapy in psychiatric disorders. Open Biol. 2018;8. [PMID: 29794033 DOI: 10.1098/rsob.180031] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 119 |
Berkol TD, Balcioglu YH, Kirlioglu SS, Ozarslan Z, Islam S, Ozyildirim I. Clinical characteristics of antidepressant use and related manic switch in bipolar disorder. Neurosciences (Riyadh) 2019;24:45-52. [PMID: 30842399 DOI: 10.17712/nsj.2019.1.20180008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 120 |
Jacob L, Schmitz B, Bohlken J, Kostev K. Trends in valproate use in patients in Germany between 2009 and 2017. Epilepsy Behav 2019;92:26-30. [PMID: 30599459 DOI: 10.1016/j.yebeh.2018.12.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 121 |
Bahji A, Hawken ER, Sepehry AA, Cabrera CA, Vazquez G. ECT beyond unipolar major depression: systematic review and meta-analysis of electroconvulsive therapy in bipolar depression. Acta Psychiatr Scand 2019;139:214-26. [PMID: 30506992 DOI: 10.1111/acps.12994] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 122 |
Watts D, Pfaffenseller B, Wollenhaupt-aguiar B, Paul Géa L, Cardoso TDA, Kapczinski F. Agmatine as a potential therapeutic intervention in bipolar depression: the preclinical landscape. Expert Opinion on Therapeutic Targets 2019;23:327-39. [DOI: 10.1080/14728222.2019.1581764] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 123 |
Tundo A, Musetti L, de Filippis R, Grande CD, Falaschi V, Proietti L, Dell'Osso L. Is there a relationship between depression with anxious distress DSM-5 specifier and bipolarity? A multicenter cohort study on patients with unipolar, bipolar I and II disorders. J Affect Disord 2019;245:819-26. [PMID: 30699865 DOI: 10.1016/j.jad.2018.11.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 124 |
Chakrabarty T, Torres IJ, Bond DJ, Yatham LN. Inflammatory cytokines and cognitive functioning in early-stage bipolar I disorder. J Affect Disord 2019;245:679-85. [PMID: 30447566 DOI: 10.1016/j.jad.2018.11.018] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 125 |
Baldessarini RJ, Tondo L, Vázquez GH. Pharmacological treatment of adult bipolar disorder. Mol Psychiatry 2019;24:198-217. [PMID: 29679069 DOI: 10.1038/s41380-018-0044-2] [Cited by in Crossref: 91] [Cited by in F6Publishing: 110] [Article Influence: 22.8] [Reference Citation Analysis]
|
| 126 |
Chen R, Zhu X, Capitão LP, Zhang H, Luo J, Wang X, Xi Y, Song X, Feng Y, Cao L, Malhi GS. Psychoeducation for psychiatric inpatients following remission of a manic episode in bipolar I disorder: A randomized controlled trial. Bipolar Disord 2019;21:76-85. [PMID: 29578271 DOI: 10.1111/bdi.12642] [Cited by in Crossref: 19] [Cited by in F6Publishing: 32] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 127 |
Pikard JL, Oliver D, Saraceno J, Groll D. Lithium: contributor to movement disorder sensitivity after anoxic brain injury? SAGE Open Med Case Rep 2019;7:2050313X18823101. [PMID: 30675359 DOI: 10.1177/2050313X18823101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 128 |
Yatham LN. Management Commentary. In: Parker G, editor. Bipolar II Disorder. Cambridge University Press; 2018. pp. 281-4. [DOI: 10.1017/9781108333252.036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 129 |
Tavella G, Boyce P. Perinatal Nuances in Managing Bipolar II Disorder. Bipolar II Disorder 2019. [DOI: 10.1017/9781108333252.015] [Reference Citation Analysis]
|
| 130 |
Frangou S. Management Commentary. Bipolar II Disorder 2019. [DOI: 10.1017/9781108333252.024] [Reference Citation Analysis]
|
| 131 |
Ossani GP, Uceda AM, Acosta JM, Lago NR, Repetto MG, Martino DJ, Toblli JE. Role of Oxidative Stress in Lithium-Induced Nephropathy. Biol Trace Elem Res 2019;191:412-8. [PMID: 30600502 DOI: 10.1007/s12011-018-1617-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 132 |
Testerink AE, van Lankeren JE, Daggenvoorde TH, Poslawsky IE, Goossens PJJ. Caregivers experiences of nursing care for relatives hospitalized during manic episode: A phenomenological study. Perspect Psychiatr Care 2019;55:23-9. [PMID: 29566256 DOI: 10.1111/ppc.12275] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 133 |
Sanches M, Quevedo J, Soares JC. Treatment Resistance in Bipolar Disorders. Treatment Resistance in Psychiatry 2019. [DOI: 10.1007/978-981-10-4358-1_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 134 |
Maron E, Lan C, Nutt D. Genetic Factors Underlying Treatment Resistance in Psychiatry. Treatment Resistance in Psychiatry 2019. [DOI: 10.1007/978-981-10-4358-1_3] [Reference Citation Analysis]
|
| 135 |
Literaturverzeichnis zu Voderholzer/Hohagen (Hrsg.): Therapie psychischer Erkrankungen, 14. Auflage. Therapie psychischer Erkrankungen 2019. [DOI: 10.1016/b978-3-437-24911-2.16001-8] [Reference Citation Analysis]
|
| 136 |
Boswell J, Lowe H, Adorati K, Ray SD, Rust C. Lithium. Side Effects of Drugs Annual 2019. [DOI: 10.1016/bs.seda.2019.07.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 137 |
Frontoni S, Picconi F. Impact of Drugs on Diabetes Risk and Glycemic Control. Endocrinology 2019. [DOI: 10.1007/978-3-319-27316-7_19-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 138 |
Jeong JH, Kang MJ, Kwon MY, Lee SM, Lee KY. The Effectiveness on Prevention of Rehospitalization with Long-Term Psychosocial Interventions for Patients with Major Psychiatric Disorders. Korean J Schizophr Res 2019;22:66. [DOI: 10.16946/kjsr.2019.22.2.66] [Reference Citation Analysis]
|
| 139 |
Patel JJ, Smith DW, Heafner J, Ng C, Grossberg GT. Pharmacological Interventions in Older Adults. Primary Care Mental Health in Older People 2019. [DOI: 10.1007/978-3-030-10814-4_9] [Reference Citation Analysis]
|
| 140 |
Galli F, Gambini O. Psychopharmacology of headache and its psychiatric comorbidities. Psychopharmacology of Neurologic Disease 2019. [DOI: 10.1016/b978-0-444-64012-3.00020-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 141 |
Tomar Bozkurt H, Erbasan V, Eğilmez Ü, Şen B, Aydın M, Altınbaş K. Lityuma Tedavi Yanıtının Klinik, Biyolojik ve Genetik Yordayıcıları. Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry 2018;10:395-416. [DOI: 10.18863/pgy.347570] [Reference Citation Analysis]
|
| 142 |
Couffignal C, Bertrand J, Sportiche S, Jarroir M, El Balkhi S, Djebrani-Oussedik N, Poupon J, Declèves X, Mentré F, Bellivier F. Population pharmacokinetic modeling of sustained release lithium in the serum, erythrocytes and urine of patients with bipolar disorder. Eur J Clin Pharmacol 2019;75:519-28. [PMID: 30554270 DOI: 10.1007/s00228-018-2605-3] [Reference Citation Analysis]
|
| 143 |
Pisanu C, Heilbronner U, Squassina A. The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine. Mol Diagn Ther 2018;22:409-20. [PMID: 29790107 DOI: 10.1007/s40291-018-0335-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 144 |
Huang CY, Yang SY, Mojtabai R, Lin SK, He YL, Chong MY, Ungvari G, Tan CH, Xiang YT, Sartorius N, Shinfuku N, Chen LY. Trends of Polypharmacy and Prescription Patterns of Antidepressants in Asia. J Clin Psychopharmacol 2018;38:598-603. [PMID: 30273199 DOI: 10.1097/JCP.0000000000000954] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 145 |
Ostacher M, Ng-Mak D, Patel P, Ntais D, Schlueter M, Loebel A. Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis. World J Biol Psychiatry 2018;19:586-601. [PMID: 28264635 DOI: 10.1080/15622975.2017.1285050] [Cited by in Crossref: 29] [Cited by in F6Publishing: 185] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 146 |
Nederlof M, Kupka RW, Braam AM, Egberts A, Heerdink ER. Evaluation of clarity of presentation and applicability of monitoring instructions for patients using lithium in clinical practice guidelines for treatment of bipolar disorder. Bipolar Disord 2018;20:708-20. [PMID: 30105767 DOI: 10.1111/bdi.12681] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 147 |
Soeiro-de-Souza MG, Otaduy MCG, Machado-Vieira R, Moreno RA, Nery FG, Leite C, Lafer B. Lithium-associated anterior cingulate neurometabolic profile in euthymic Bipolar I disorder: A (1)H-MRS study. J Affect Disord 2018;241:192-9. [PMID: 30130684 DOI: 10.1016/j.jad.2018.08.039] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 148 |
Li DJ, Lin CH, Wu HC. Factors predicting re-hospitalization for inpatients with bipolar mania--A naturalistic cohort. Psychiatry Res 2018;270:749-54. [PMID: 30551320 DOI: 10.1016/j.psychres.2018.10.073] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 149 |
Gitlin MJ. Antidepressants in bipolar depression: an enduring controversy. Int J Bipolar Disord 2018;6:25. [PMID: 30506151 DOI: 10.1186/s40345-018-0133-9] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 150 |
Jawad I, Watson S, Haddad PM, Talbot PS, McAllister-Williams RH. Medication nonadherence in bipolar disorder: a narrative review. Ther Adv Psychopharmacol 2018;8:349-63. [PMID: 30524703 DOI: 10.1177/2045125318804364] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 14.4] [Reference Citation Analysis]
|
| 151 |
Woo YS, Bahk WM, Lee JG, Jeong JH, Kim MD, Sohn I, Shim SH, Jon DI, Seo JS, Min KJ, Kim W, Song HR, Yoon BH. Korean Medication Algorithm Project for Bipolar Disorder 2018 (KMAP-BP 2018): Fourth Revision. Clin Psychopharmacol Neurosci 2018;16:434-48. [PMID: 30466216 DOI: 10.9758/cpn.2018.16.4.434] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 152 |
Kerner B, Crisanti AS, Deshaw JL, Ho JG, Jordan K, Krall RL, Kuntz MJ, Mazurie AJ, Nestsiarovich A, Perkins DJ, Schroeter QL, Smith AN, Tohen M, Volesky E, Zhu Y, Lambert CG. Preferences of Information Dissemination on Treatment for Bipolar Disorder: Patient-Centered Focus Group Study (Preprint).. [DOI: 10.2196/preprints.12848] [Reference Citation Analysis]
|
| 153 |
DiSciullo AA, English CD, Horn WT. Modafinil Induced Psychosis in a Patient with Bipolar 1 Depression. Case Rep Psychiatry 2018;2018:3732958. [PMID: 30416836 DOI: 10.1155/2018/3732958] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 154 |
Medici CR, Kai LM, Kristensen SB, Kirkedal C, Munk-Jørgensen P, Straszek S. Typical Versus Atypical Antipsychotics for Acute Mania. Am J Ther 2020;27:e243-8. [PMID: 30418230 DOI: 10.1097/MJT.0000000000000871] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 155 |
Fisher A, Sharpe L, Costa D, Anderson J, Manicavasagar V, Juraskova I. Phase II Randomised Controlled Trial of a patient decision-aid website to improve treatment decision-making for young adults with bipolar II disorder: A feasibility study protocol. Contemp Clin Trials Commun 2018;12:137-44. [PMID: 30456328 DOI: 10.1016/j.conctc.2018.11.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 156 |
Sharma V. Weaning and Mixed Mania-A Case Report. J Hum Lact 2018;34:745-8. [PMID: 29928823 DOI: 10.1177/0890334418777695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 157 |
Dehning J, Grunze H, Walpoth-Niederwanger M, Kemmler G, Hausmann A. The use of (newer) antipsychotics in bipolar inpatients over a 17-year observation period. Int Clin Psychopharmacol 2018;33:297-303. [PMID: 30095482 DOI: 10.1097/YIC.0000000000000233] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 158 |
Eiring Ø, Brurberg KG, Nytrøen K, Nylenna M. Rapid methods including network meta-analysis to produce evidence in clinical decision support: a decision analysis. Syst Rev 2018;7:168. [PMID: 30342549 DOI: 10.1186/s13643-018-0829-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 159 |
Bareis N, Lu J, Kirkwood CK, Kornstein SG, Wu E, Mezuk B. Identifying clinical net benefit of psychotropic medication use with latent variable techniques: Evidence from Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Affect Disord 2018;238:147-55. [PMID: 29883936 DOI: 10.1016/j.jad.2018.05.063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 160 |
Veznedaroglu B, Dilbaz N, Uzun O, Isik E. TARC: Turkish aripiprazole consensus report- Aripiprazole use and switching from other antipsychotics to aripiprazole- consensus recommendations by a Turkish multidisciplinary panel. Ther Adv Psychopharmacol 2018;8:271-85. [PMID: 30210778 DOI: 10.1177/2045125318772712] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 161 |
Hodgkin D, Stewart MT, Merrick EL, Pogue YZ, Reilly-Harrington NA, Sylvia LG, Deckersbach T, Nierenberg AA. Prevalence and predictors of physician recommendations for medication adjustment in bipolar disorder treatment. J Affect Disord 2018;238:666-73. [PMID: 29966931 DOI: 10.1016/j.jad.2018.06.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 162 |
LaChance LR, Ramsey D. Antidepressant foods: An evidence-based nutrient profiling system for depression. World J Psychiatr 2018; 8(3): 97-104 [PMID: 30254980 DOI: 10.5498/wjp.v8.i3.97] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 43] [Article Influence: 8.6] [Reference Citation Analysis]
|
| 163 |
Pinto JV, Passos IC, Librenza-Garcia D, Marcon G, Schneider MA, Conte JH, da Silva JPA, Lima LP, Quincozes-Santos A, Kauer-Sant Anna M, Kapczinski F. Neuron-glia Interaction as a Possible Pathophysiological Mechanism of Bipolar Disorder. Curr Neuropharmacol 2018;16:519-32. [PMID: 28847296 DOI: 10.2174/1570159X15666170828170921] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 8.2] [Reference Citation Analysis]
|
| 164 |
Thomas RK, White PJ, Dursun S. Treating electroconvulsive therapy-induced mania with more electroconvulsive therapy: Evidence for electroconvulsive therapy as the ultra-mood stabilizer. SAGE Open Med Case Rep 2018;6:2050313X18799236. [PMID: 30214809 DOI: 10.1177/2050313X18799236] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 165 |
Stacey D, Schubert KO, Clark SR, Amare AT, Milanesi E, Maj C, Leckband SG, Shekhtman T, Kelsoe JR, Gurwitz D, Baune BT. A gene co-expression module implicating the mitochondrial electron transport chain is associated with long-term response to lithium treatment in bipolar affective disorder. Transl Psychiatry 2018;8:183. [PMID: 30185780 DOI: 10.1038/s41398-018-0237-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 166 |
Houser J, Graham A. Rechallenge of lamotrigine after development of rash. Mental Health Clinician 2018;8:247-249. [DOI: 10.9740/mhc.2018.09.247] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 167 |
Seripa D, Lozupone M, Miscio G, Stella E, La Montagna M, Gravina C, Urbano M, di Mauro L, Daniele A, Greco A, Logroscino G, Panza F, Bellomo A. CYP2D6 genotypes in revolving door patients with bipolar disorders: A case series. Medicine (Baltimore) 2018;97:e11998. [PMID: 30212929 DOI: 10.1097/MD.0000000000011998] [Cited by in Crossref: 7] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 168 |
Bareis N, Sando TA, Mezuk B, Cohen SA. Association Between Psychotropic Medication Polypharmacy and an Objective Measure of Balance Impairment Among Middle-Aged Adults: Results from the US National Health and Nutrition Examination Survey. CNS Drugs 2018;32:863-71. [PMID: 30014315 DOI: 10.1007/s40263-018-0542-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 169 |
Bjoerke-Bertheussen J, Schoeyen H, Andreassen OA, Malt UF, Oedegaard KJ, Morken G, Sundet K, Vaaler AE, Auestad B, Kessler U. Right unilateral electroconvulsive therapy does not cause more cognitive impairment than pharmacologic treatment in treatment-resistant bipolar depression: A 6-month randomized controlled trial follow-up study. Bipolar Disord 2018;20:531-8. [PMID: 29267990 DOI: 10.1111/bdi.12594] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 170 |
Grootens KP, Meijer A, Hartong EG, Doornbos B, Bakker PR, Al Hadithy A, Hoogerheide KN, Overmeire F, Marijnissen RM, Ruhe HG. Weight changes associated with antiepileptic mood stabilizers in the treatment of bipolar disorder. Eur J Clin Pharmacol 2018;74:1485-9. [PMID: 30083876 DOI: 10.1007/s00228-018-2517-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 171 |
Myczkowski ML, Fernandes A, Moreno M, Valiengo L, Lafer B, Moreno RA, Padberg F, Gattaz W, Brunoni AR. Cognitive outcomes of TMS treatment in bipolar depression: Safety data from a randomized controlled trial. J Affect Disord 2018;235:20-6. [PMID: 29631203 DOI: 10.1016/j.jad.2018.04.022] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 172 |
de Filippis R, Aloi M, Bruni A, Gaetano R, Segura-Garcia C, De Fazio P. Bipolar disorder and obsessive compulsive disorder: The comorbidity does not further impair the neurocognitive profile. J Affect Disord 2018;235:1-6. [PMID: 29627704 DOI: 10.1016/j.jad.2018.03.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 173 |
Jaracz J, Rudnicka ET, Bierejszyk M, Witczyk K, Raczyńska A, Nowak W, Pisarczyk A, Woźniak K, Czernaś W, Moniakowski A, Jaracz K. The pattern of pharmacological treatment of bipolar patients discharged from psychiatric units in Poland. Pharmacological Reports 2018;70:694-8. [DOI: 10.1016/j.pharep.2018.02.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 174 |
Nunes CS, Maes M, Roomruangwong C, Moraes JB, Bonifacio KL, Vargas HO, Barbosa DS, Anderson G, de Melo LGP, Drozdstoj S, Moreira E, Carvalho AF, Nunes SOV. Lowered quality of life in mood disorders is associated with increased neuro-oxidative stress and basal thyroid-stimulating hormone levels and use of anticonvulsant mood stabilizers. J Eval Clin Pract 2018;24:869-78. [PMID: 29665163 DOI: 10.1111/jep.12918] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 175 |
Fotso Soh J, Torres-Platas SG, Beaulieu S, Mantere O, Platt R, Mucsi I, Saury S, Renaud S, Levinson A, Andreazza AC, Mulsant BH, Müller D, Schaffer A, Dols A, Cervantes P, Low NC, Herrmann N, Christensen BM, Trepiccione F, Rajji T, Rej S. Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trial. BMC Psychiatry 2018;18:227. [PMID: 30012135 DOI: 10.1186/s12888-018-1793-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 176 |
Fisher A, Sharpe L, Anderson J, Manicavasagar V, Juraskova I. Development and pilot of a decision-aid for patients with bipolar II disorder and their families making decisions about treatment options to prevent relapse. PLoS One 2018;13:e0200490. [PMID: 29990368 DOI: 10.1371/journal.pone.0200490] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 177 |
Bastos JR, Perico KM, Marciano Vieira ÉL, Teixeira AL, Machado FS, de Miranda AS, Moreira FA. Inhibition of the dopamine transporter as an animal model of bipolar disorder mania: Locomotor response, neuroimmunological profile and pharmacological modulation. J Psychiatr Res 2018;102:142-9. [PMID: 29656188 DOI: 10.1016/j.jpsychires.2018.04.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 178 |
Keating LE, Becker S, McCabe K, Whattam J, Garrick L, Sassi RB, Frey BN, McKinnon MC. Effects of a 12-week running programme in youth and adults with complex mood disorders. BMJ Open Sport Exerc Med 2018;4:e000314. [PMID: 29955373 DOI: 10.1136/bmjsem-2017-000314] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 179 |
Machado-Vieira R. Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator. J Affect Disord 2018;233:92-9. [PMID: 29310970 DOI: 10.1016/j.jad.2017.12.026] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 8.2] [Reference Citation Analysis]
|
| 180 |
McIntyre RS, Young AH, Haddad PM. Rethinking the spectrum of mood disorders: implications for diagnosis and management - Proceedings of a symposium presented at the 30th Annual European College of Neuropsychopharmacology Congress, 4 September 2017, Paris, France. Ther Adv Psychopharmacol 2018;8:1-16. [PMID: 29977518 DOI: 10.1177/2045125318762911] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 181 |
Li DJ, Lin CH, Chen FC. Factors affecting time to remission for inpatients with bipolar mania - A naturalistic Taiwanese study. J Affect Disord 2018;232:73-8. [PMID: 29477587 DOI: 10.1016/j.jad.2018.02.032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 182 |
Porcu M, Urbano MR, Verri WA Jr, Barbosa DS, Baracat M, Vargas HO, Machado RCBR, Pescim RR, Nunes SOV. Effects of adjunctive N-acetylcysteine on depressive symptoms: Modulation by baseline high-sensitivity C-reactive protein. Psychiatry Res 2018;263:268-74. [PMID: 29605103 DOI: 10.1016/j.psychres.2018.02.056] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 183 |
Morton E, Murray G, Michalak EE, Lam RW, Beaulieu S, Sharma V, Cervantes P, Parikh SV, Yatham LN. Quality of life in bipolar disorder: towards a dynamic understanding. Psychol Med 2018;48:1111-8. [PMID: 28918761 DOI: 10.1017/S0033291717002495] [Cited by in Crossref: 16] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 184 |
Caldieraro MA, Dufour S, Sylvia LG, Gao K, Ketter TA, Bobo WV, Walsh S, Janos J, Tohen M, Reilly-Harrington NA, McElroy SL, Shelton RC, Bowden CL, Deckersbach T, Nierenberg AA. Treatment outcomes of acute bipolar depressive episode with psychosis. Depress Anxiety 2018;35:402-10. [PMID: 29329498 DOI: 10.1002/da.22716] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 185 |
Brown EE, Gerretsen P, Pollock B, Graff-Guerrero A. Psychiatric benefits of lithium in water supplies may be due to protection from the neurotoxicity of lead exposure. Med Hypotheses 2018;115:94-102. [PMID: 29685207 DOI: 10.1016/j.mehy.2018.04.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 186 |
Wang SM, Han C, Lee SJ, Patkar AA, Masand PS, Pae CU. Five potential therapeutic agents as antidepressants: a brief review and future directions. Expert Rev Neurother 2015;15:1015-29. [PMID: 26312645 DOI: 10.1586/14737175.2015.1071192] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 187 |
Nikolova VL, Pattanaseri K, Hidalgo-Mazzei D, Taylor D, Young AH. Is lithium monitoring NICE? Lithium monitoring in a UK secondary care setting. J Psychopharmacol 2018;32:408-15. [PMID: 29552933 DOI: 10.1177/0269881118760663] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 188 |
Medeiros GC, Lafer B, Kapczinski F, Miranda-Scippa Â, Almeida KM. Bipolar disorder and tobacco smoking: Categorical and dimensional clinical correlates in subjects from the Brazilian bipolar research network. Compr Psychiatry 2018;82:14-21. [PMID: 29367058 DOI: 10.1016/j.comppsych.2017.12.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 189 |
Becking K, Haarman BCM, Grosse L, Nolen WA, Claes S, Arolt V, Schoevers RA, Drexhage HA. The circulating levels of CD4+ t helper cells are higher in bipolar disorder as compared to major depressive disorder. J Neuroimmunol 2018;319:28-36. [PMID: 29685287 DOI: 10.1016/j.jneuroim.2018.03.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 190 |
Thomson M, Sharma V. Weighing the Risks: the Management of Bipolar Disorder During Pregnancy. Curr Psychiatry Rep 2018;20:20. [PMID: 29549608 DOI: 10.1007/s11920-018-0882-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 191 |
Parmentier T, Sienaert P. The use of triiodothyronine (T3) in the treatment of bipolar depression: A review of the literature. J Affect Disord 2018;229:410-4. [PMID: 29331701 DOI: 10.1016/j.jad.2017.12.071] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 192 |
O'Donnell S, Syoufi M, Jones W, Bennett K, Pelletier L. Use of medication and psychological counselling among Canadians with mood and/or anxiety disorders. Health Promot Chronic Dis Prev Can 2017;37:160-71. [PMID: 28493660 DOI: 10.24095/hpcdp.37.5.04] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 193 |
de Leon J, Spina E. Possible Pharmacodynamic and Pharmacokinetic Drug-Drug Interactions That Are Likely to Be Clinically Relevant and/or Frequent in Bipolar Disorder. Curr Psychiatry Rep 2018;20:17. [PMID: 29527636 DOI: 10.1007/s11920-018-0881-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 194 |
Hoffmann A, Sportelli V, Ziller M, Spengler D. From the Psychiatrist's Couch to Induced Pluripotent Stem Cells: Bipolar Disease in a Dish. Int J Mol Sci 2018;19:E770. [PMID: 29517996 DOI: 10.3390/ijms19030770] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 195 |
Perugi G, Medda P, Toni C, Mariani MG, Socci C, Mauri M. The Role of Electroconvulsive Therapy (ECT) in Bipolar Disorder: Effectiveness in 522 Patients with Bipolar Depression, Mixed-state, Mania and Catatonic Features. Curr Neuropharmacol 2017;15:359-71. [PMID: 28503107 DOI: 10.2174/1570159X14666161017233642] [Cited by in Crossref: 80] [Cited by in F6Publishing: 81] [Article Influence: 16.0] [Reference Citation Analysis]
|
| 196 |
da Costa SC, Machado-vieira R, Soares JC. Novel Therapeutics in Bipolar Disorder. Curr Treat Options Psych 2018;5:162-181. [DOI: 10.1007/s40501-018-0140-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 197 |
Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, McIntosh D, Lam RW, Vazquez G, Kapczinski F, McIntyre RS, Kozicky J, Kanba S, Lafer B, Suppes T, Calabrese JR, Vieta E, Malhi G, Post RM, Berk M. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord 2018;20:97-170. [PMID: 29536616 DOI: 10.1111/bdi.12609] [Cited by in Crossref: 804] [Cited by in F6Publishing: 799] [Article Influence: 160.8] [Reference Citation Analysis]
|
| 198 |
Graham RK, Tavella G, Parker GB. Is there consensus across international evidence-based guidelines for the psychotropic drug management of bipolar disorder during the perinatal period? J Affect Disord 2018;228:216-21. [PMID: 29274567 DOI: 10.1016/j.jad.2017.12.022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 199 |
Shvartzman Y, Krivoy A, Valevski A, Gur S, Weizman A, Hochman E. Adjunctive antidepressants in bipolar depression: A cohort study of six- and twelve-months rehospitalization rates. Eur Neuropsychopharmacol 2018;28:353-60. [PMID: 29449055 DOI: 10.1016/j.euroneuro.2018.01.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 200 |
Dean OM, Gliddon E, Van Rheenen TE, Giorlando F, Davidson SK, Kaur M, Ngo TT, Williams LJ. An update on adjunctive treatment options for bipolar disorder. Bipolar Disord 2018;20:87-96. [PMID: 29369487 DOI: 10.1111/bdi.12601] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 201 |
Morton E, Michalak EE, Hole R, Buzwell S, Murray G. 'Taking back the reins' - A qualitative study of the meaning and experience of self-management in bipolar disorder. J Affect Disord 2018;228:160-5. [PMID: 29248822 DOI: 10.1016/j.jad.2017.12.018] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 202 |
Ignácio ZM, Calixto AV, da Silva RH, Quevedo J, Réus GZ. The use of quetiapine in the treatment of major depressive disorder: Evidence from clinical and experimental studies. Neuroscience & Biobehavioral Reviews 2018;86:36-50. [DOI: 10.1016/j.neubiorev.2017.12.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 203 |
Girardi P, Brugnoli R, Manfredi G, Sani G. Lithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release Formulations. Drugs R D 2016;16:293-302. [PMID: 27770296 DOI: 10.1007/s40268-016-0139-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 204 |
Kessing LV, Bauer M, Nolen WA, Severus E, Goodwin GM, Geddes J. Effectiveness of maintenance therapy of lithium vs other mood stabilizers in monotherapy and in combinations: a systematic review of evidence from observational studies. Bipolar Disord 2018. [PMID: 29441712 DOI: 10.1111/bdi.12623] [Cited by in Crossref: 68] [Cited by in F6Publishing: 70] [Article Influence: 13.6] [Reference Citation Analysis]
|
| 205 |
Kessing LV, Andersen PK, Vinberg M. Risk of recurrence after a single manic or mixed episode - a systematic review and meta-analysis. Bipolar Disord 2018;20:9-17. [PMID: 29239075 DOI: 10.1111/bdi.12593] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 206 |
Sampaio-Junior B, Tortella G, Borrione L, Moffa AH, Machado-Vieira R, Cretaz E, Fernandes da Silva A, Fraguas R, Aparício LV, Klein I, Lafer B, Goerigk S, Benseñor IM, Lotufo PA, Gattaz WF, Brunoni AR. Efficacy and Safety of Transcranial Direct Current Stimulation as an Add-on Treatment for Bipolar Depression: A Randomized Clinical Trial. JAMA Psychiatry 2018;75:158-66. [PMID: 29282470 DOI: 10.1001/jamapsychiatry.2017.4040] [Cited by in Crossref: 86] [Cited by in F6Publishing: 84] [Article Influence: 17.2] [Reference Citation Analysis]
|
| 207 |
Etain B, Scott J, Cochet B, Bellivier F, Boudebesse C, Drancourt N, Lauer S, Dusser I, Yon L, Fouques D, Richard JR, Lajnef M, Leboyer M, Henry C. A study of the real-world effectiveness of group psychoeducation for bipolar disorders: Is change in illness perception a key mediator of benefit? J Affect Disord 2018;227:713-20. [PMID: 29179141 DOI: 10.1016/j.jad.2017.11.072] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 208 |
Calabrese JR, Sanchez R, Jin N, Amatniek J, Cox K, Johnson B, Perry P, Hertel P, Such P, McQuade RD, Nyilas M, Carson WH. Symptoms and functioning with aripiprazole once-monthly injection as maintenance treatment for bipolar I disorder. J Affect Disord 2018;227:649-56. [PMID: 29174738 DOI: 10.1016/j.jad.2017.10.035] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 209 |
Wilson L, Crowe M, Scott A, Lacey C. Psychoeducation for bipolar disorder: A discourse analysis. Int J Ment Health Nurs 2018;27:349-57. [PMID: 28299858 DOI: 10.1111/inm.12328] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 210 |
Zhou TH, Dang WM, Ma YT, Hu CQ, Wang N, Zhang GY, Wang G, Shi C, Zhang H, Guo B, Zhou SZ, Feng L, Geng SX, Tong YZ, Tang GW, He ZK, Zhen L, Yu X. Clinical efficacy, onset time and safety of bright light therapy in acute bipolar depression as an adjunctive therapy: A randomized controlled trial. J Affect Disord 2018;227:90-6. [PMID: 29053981 DOI: 10.1016/j.jad.2017.09.038] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 211 |
Earley W, Durgam S, Lu K, Ruth A, Németh G, Laszlovszky I, Yatham LN. Clinically relevant response and remission outcomes in cariprazine-treated patients with bipolar I disorder. J Affect Disord 2018;226:239-44. [PMID: 29017067 DOI: 10.1016/j.jad.2017.09.040] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 212 |
Chen VC, Yang YH, Lee CP, Wong J, Ponton L, Lee Y, McIntyre RS, Huang KY, Wu SI. Risks of road injuries in patients with bipolar disorder and associations with drug treatments: A population-based matched cohort study. J Affect Disord 2018;226:124-31. [PMID: 28972929 DOI: 10.1016/j.jad.2017.09.029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 213 |
Vázquez GH, Tondo L, Undurraga J, Zaratiegui R, Selle V, Baldessarini RJ. Pharmacological treatment of bipolar depression. Adv psychiatr treat 2014;20:193-201. [DOI: 10.1192/apt.bp.113.011460] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 214 |
Selek S, Soares JC. Neurobiology and Evidence-Based Review on Novel Therapeutic Strategy for Treatment-Resistant Depression (TRD). Understanding Depression 2018. [DOI: 10.1007/978-981-10-6577-4_19] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 215 |
Chung IW, Kim I, Youn T, Jeong SH, Jung HY, Kim YS. Antipsychotic-Induced Oculogyric Crisis and Paroxysmal Perceptual Alteration. Korean J Schizophr Res 2018;21:9. [DOI: 10.16946/kjsr.2018.21.1.9] [Reference Citation Analysis]
|
| 216 |
Frontoni S, Picconi F. Impact of Drugs on Diabetes Risk and Glycemic Control. Endocrinology 2018. [DOI: 10.1007/978-3-319-27316-7_19-1] [Reference Citation Analysis]
|
| 217 |
Sajatovic M, Ross R, Legacy SN, Correll CU, Kane JM, DiBiasi F, Fitzgerald H, Byerly M. Identifying patients and clinical scenarios for use of long-acting injectable antipsychotics - expert consensus survey part 1. Neuropsychiatr Dis Treat 2018;14:1463-74. [PMID: 29922062 DOI: 10.2147/NDT.S167394] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 218 |
Langosch J, Krienke U. Manie und bipolare Störungen. Therapie-Handbuch 2018. [DOI: 10.1016/b978-3-437-24950-1.00099-8] [Reference Citation Analysis]
|
| 219 |
Sun YR, Herrmann N, Scott CJM, Black SE, Khan MM, Lanctôt KL. Global grey matter volume in adult bipolar patients with and without lithium treatment: A meta-analysis. J Affect Disord 2018;225:599-606. [PMID: 28886501 DOI: 10.1016/j.jad.2017.08.078] [Cited by in Crossref: 29] [Cited by in F6Publishing: 49] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 220 |
Cheng T, Saperson K. Late-Life Bipolar Disorders. Geriatric Psychiatry 2018. [DOI: 10.1007/978-3-319-67555-8_11] [Reference Citation Analysis]
|
| 221 |
Pavlova B, Perroud N, Cordera P, Uher R, Alda M, Dayer A, Aubry JM. Anxiety disorders and childhood maltreatment as predictors of outcome in bipolar disorder. J Affect Disord 2018;225:337-41. [PMID: 28843916 DOI: 10.1016/j.jad.2017.08.048] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 222 |
Murasaki M, Koyama T, Kanba S, Takeuchi M, Shimizu Y, Arita E, Kuroishi K, Takeuchi M, Kamei S. Multi-center, randomized, double-blind, placebo-controlled study of quetiapine extended-release formulation in Japanese patients with bipolar depression. Psychopharmacology (Berl) 2018;235:2859-69. [PMID: 30069587 DOI: 10.1007/s00213-018-4977-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 223 |
Amare AT, Schubert KO, Hou L, Clark SR, Papiol S, Heilbronner U, Degenhardt F, Tekola-Ayele F, Hsu YH, Shekhtman T, Adli M, Akula N, Akiyama K, Ardau R, Arias B, Aubry JM, Backlund L, Bhattacharjee AK, Bellivier F, Benabarre A, Bengesser S, Biernacka JM, Birner A, Brichant-Petitjean C, Cervantes P, Chen HC, Chillotti C, Cichon S, Cruceanu C, Czerski PM, Dalkner N, Dayer A, Del Zompo M, DePaulo JR, Étain B, Falkai P, Forstner AJ, Frisen L, Frye MA, Fullerton JM, Gard S, Garnham JS, Goes FS, Grigoroiu-Serbanescu M, Grof P, Hashimoto R, Hauser J, Herms S, Hoffmann P, Hofmann A, Jamain S, Jiménez E, Kahn JP, Kassem L, Kuo PH, Kato T, Kelsoe J, Kittel-Schneider S, Kliwicki S, König B, Kusumi I, Laje G, Landén M, Lavebratt C, Leboyer M, Leckband SG, Tortorella A, Manchia M, Martinsson L, McCarthy MJ, McElroy S, Colom F, Mitjans M, Mondimore FM, Monteleone P, Nievergelt CM, Nöthen MM, Novák T, O'Donovan C, Ozaki N, Ösby U, Pfennig A, Potash JB, Reif A, Reininghaus E, Rouleau GA, Rybakowski JK, Schalling M, Schofield PR, Schweizer BW, Severino G, Shilling PD, Shimoda K, Simhandl C, Slaney CM, Squassina A, Stamm T, Stopkova P, Maj M, Turecki G, Vieta E, Volkert J, Witt S, Wright A, Zandi PP, Mitchell PB, Bauer M, Alda M, Rietschel M, McMahon FJ, Schulze TG, Baune BT; International Consortium on Lithium Genetics (ConLi+Gen). Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study. JAMA Psychiatry 2018;75:65-74. [PMID: 29121268 DOI: 10.1001/jamapsychiatry.2017.3433] [Cited by in Crossref: 26] [Cited by in F6Publishing: 54] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 224 |
Ketter TA, Sachs GS, Durgam S, Lu K, Starace A, Laszlovszky I, Németh G. The safety and tolerability of cariprazine in patients with manic or mixed episodes associated with bipolar I disorder: A 16-week open-label study. J Affect Disord 2018;225:350-6. [PMID: 28843918 DOI: 10.1016/j.jad.2017.08.040] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 225 |
Frontoni S, Picconi F. Impact of Drugs on Diabetes Risk and Glycemic Control. Endocrinology 2018. [DOI: 10.1007/978-3-319-44433-8_19] [Reference Citation Analysis]
|
| 226 |
Greene M, Paladini L, Lemmer T, Piedade A, Touya M, Clark O. Systematic literature review on patterns of pharmacological treatment and adherence among patients with bipolar disorder type I in the USA. Neuropsychiatr Dis Treat 2018;14:1545-59. [PMID: 29950839 DOI: 10.2147/NDT.S166730] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 227 |
Sajatovic M, Ross R, Legacy SN, Byerly M, Kane JM, DiBiasi F, Fitzgerald H, Correll CU. Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder - expert consensus survey part 2. Neuropsychiatr Dis Treat 2018;14:1475-92. [PMID: 29922063 DOI: 10.2147/NDT.S167485] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 228 |
Hategan A, Bourgeois JA, Cheng T, Young J. Late-Life Depressive Disorders, Bipolar Disorders, and Psychotic Disorders. Geriatric Psychiatry Study Guide 2018. [DOI: 10.1007/978-3-319-77128-1_5] [Reference Citation Analysis]
|
| 229 |
Engel-Yeger B, Gonda X, Canepa G, Pompili M, Rihmer Z, Amore M, Serafini G. Sensory profiles as potential mediators of the association between hypomania and hopelessness in 488 major affective outpatients. J Affect Disord 2018;225:466-73. [PMID: 28863299 DOI: 10.1016/j.jad.2017.08.036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 230 |
Chautant F, Rouch L. Traitement des troubles bipolaires. Pharmacie Clinique et Thérapeutique 2018. [DOI: 10.1016/b978-2-294-75077-9.00039-6] [Reference Citation Analysis]
|
| 231 |
Ng-Mak D, Poon JL, Roberts L, Kleinman L, Revicki DA, Rajagopalan K. Patient preferences for important attributes of bipolar depression treatments: a discrete choice experiment. Patient Prefer Adherence 2018;12:35-44. [PMID: 29343947 DOI: 10.2147/PPA.S151561] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 232 |
Alda M, Manchia M. Personalized management of bipolar disorder. Neurosci Lett 2018;669:3-9. [PMID: 29208408 DOI: 10.1016/j.neulet.2017.12.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 233 |
Liu B, Zhang Y, Fang H, Liu J, Liu T, Li L. Efficacy and safety of long-term antidepressant treatment for bipolar disorders - A meta-analysis of randomized controlled trials. J Affect Disord 2017;223:41-8. [PMID: 28715727 DOI: 10.1016/j.jad.2017.07.023] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 234 |
Rej S, Herrmann N, Shulman K, Fischer HD, Fung K, Gruneir A. Current psychotropic medication prescribing patterns in late-life bipolar disorder. Int J Geriatr Psychiatry 2017;32:1459-65. [PMID: 27911003 DOI: 10.1002/gps.4635] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 235 |
Brouillette J, Nattel S. A Practical Approach to Avoiding Cardiovascular Adverse Effects of Psychoactive Medications. Canadian Journal of Cardiology 2017;33:1577-86. [DOI: 10.1016/j.cjca.2017.09.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 236 |
Tavares DF, Myczkowski ML, Alberto RL, Valiengo L, Rios RM, Gordon P, de Sampaio-Junior B, Klein I, Mansur CG, Marcolin MA, Lafer B, Moreno RA, Gattaz W, Daskalakis ZJ, Brunoni AR. Treatment of Bipolar Depression with Deep TMS: Results from a Double-Blind, Randomized, Parallel Group, Sham-Controlled Clinical Trial. Neuropsychopharmacology 2017;42:2593-601. [PMID: 28145409 DOI: 10.1038/npp.2017.26] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 237 |
Collins N, Sager J. Acute Laryngeal Dystonia Associated With Asenapine Use: A Case Report. J Clin Psychopharmacol 2017;37:738-9. [PMID: 29040152 DOI: 10.1097/JCP.0000000000000802] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 238 |
Thomson M, Sharma V. Between a rock-a-bye and a hard place: mood disorders during the peripartum period. CNS Spectr 2017;22:49-64. [PMID: 29350128 DOI: 10.1017/S1092852917000852] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 239 |
Vaz G, Crockford D. The Diagnosis and Treatment of Comorbid Bipolar and Substance Use Disorders. Canadian Journal of Addiction 2017;8:13-16. [DOI: 10.1097/cxa.0000000000000005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 240 |
Iyer A, Palaniappan P. Biological dysrhythm in remitted bipolar I disorder. Asian J Psychiatr 2017;30:218-24. [PMID: 28559123 DOI: 10.1016/j.ajp.2017.05.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 241 |
Rosenblat JD, Mcintyre RS. Pharmacological Approaches to Minimizing Cardiometabolic Side Effects of Mood Stabilizing Medications. Curr Treat Options Psych 2017;4:319-32. [DOI: 10.1007/s40501-017-0131-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 242 |
Rybakowski JK. Recent advances in the understanding and management of bipolar disorder in adults. F1000Res 2017;6:2033. [PMID: 29188027 DOI: 10.12688/f1000research.12329.1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 243 |
Shim IH, Woo YS, Kim MD, Bahk WM. Antidepressants and Mood Stabilizers: Novel Research Avenues and Clinical Insights for Bipolar Depression. Int J Mol Sci 2017;18:E2406. [PMID: 29137178 DOI: 10.3390/ijms18112406] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 244 |
Amare AT, Schubert KO, Hou L, Clark SR, Papiol S, Heilbronner U, Degenhardt F, Tekola-ayele F, Hsu Y, Shekhtman T, Adli M, Akula N, Akiyama K, Ardau R, Arias B, Aubry J, Backlund L, Bhattacharjee AK, Bellivier F, Benabarre A, Bengesser S, Biernacka JM, Birner A, Brichant-petitjean C, Cervantes P, y H, Chillotti C, Cichon S, Cruceanu C, Czerski PM, Dalkner N, Dayer A, Zompo MD, Depaulo JR, Étain B, Falkai P, Forstner AJ, Frisen L, Frye MA, Fullerton JM, Gard S, Garnham JS, Goes FS, Grigoroiu-serbanescu M, Grof P, Hashimoto R, Hauser J, Herms S, Hoffmann P, Hofmann A, Jamain S, Jiménez E, Kahn J, Kassem L, Kuo P, Kato T, Kelsoe J, Kittel-schneider S, Kliwicki S, König B, Kusumi I, Laje G, Landén M, Lavebratt C, Leboyer M, Leckband SG, Tortorella A, Manchia M, Martinsson L, Mccarthy MJ, Mcelroy S, Colom F, Mitjans M, Mondimore FM, Monteleone P, Nievergelt CM, Nöthen MM, Novák T, O’donovan C, Ozaki N, Ösby U, Pfennig A, Potash JB, Reif A, Reininghaus E, Rouleau GA, Rybakowski JK, Schalling M, Schofield PR, Schweizer BW, Severino G, Shilling PD, Shimoda K, Simhandl C, Slaney CM, Squassina A, Stamm T, Stopkova P, Maj M, Turecki G, Vieta E, Volkert J, Witt SH, Wright A, Zandi PP, Mitchell PB, Bauer M, Alda M, Rietschel M, Mcmahon FJ, Schulze TG, Baune BT. High genetic loading of schizophrenia predicts poor response to lithium in patients with bipolar disorder: A polygenic score and cross-trait genetic analysis.. [DOI: 10.1101/209270] [Reference Citation Analysis]
|
| 245 |
Jakobsson E, Argüello-Miranda O, Chiu SW, Fazal Z, Kruczek J, Nunez-Corrales S, Pandit S, Pritchet L. Towards a Unified Understanding of Lithium Action in Basic Biology and its Significance for Applied Biology. J Membr Biol 2017;250:587-604. [PMID: 29127487 DOI: 10.1007/s00232-017-9998-2] [Cited by in Crossref: 64] [Cited by in F6Publishing: 52] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 246 |
Suppes T, Eberhard J, Lemming O, Young AH, McIntyre RS. Anxiety, irritability, and agitation as indicators of bipolar mania with depressive symptoms: a post hoc analysis of two clinical trials. Int J Bipolar Disord 2017;5:36. [PMID: 29105003 DOI: 10.1186/s40345-017-0103-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 247 |
Fisher A, Manicavasagar V, Sharpe L, Laidsaar-Powell R, Juraskova I. A Qualitative Exploration of Clinician Views and Experiences of Treatment Decision-Making in Bipolar II Disorder. Community Ment Health J 2017;53:958-71. [PMID: 28102459 DOI: 10.1007/s10597-016-0077-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 248 |
Meijboom RW, Grootens KP. Dispensability of Annual Laboratory Follow-Up After More than 2 Years of Valproic Acid Use: A Systematic Review. CNS Drugs 2017;31:939-57. [PMID: 29214384 DOI: 10.1007/s40263-017-0479-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 249 |
Kessing LV, Gerds TA, Knudsen NN, Jørgensen LF, Kristiansen SM, Voutchkova D, Ernstsen V, Schullehner J, Hansen B, Andersen PK, Ersbøll AK. Lithium in drinking water and the incidence of bipolar disorder: A nation-wide population-based study. Bipolar Disord 2017;19:563-7. [PMID: 28714553 DOI: 10.1111/bdi.12524] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 250 |
Grigg J, Worsley R, Thew C, Gurvich C, Thomas N, Kulkarni J. Antipsychotic-induced hyperprolactinemia: synthesis of world-wide guidelines and integrated recommendations for assessment, management and future research. Psychopharmacology (Berl) 2017;234:3279-97. [PMID: 28889207 DOI: 10.1007/s00213-017-4730-6] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 251 |
Samara MT, Goldberg Y, Levine SZ, Furukawa TA, Geddes JR, Cipriani A, Davis JM, Leucht S. Initial symptom severity of bipolar I disorder and the efficacy of olanzapine: a meta-analysis of individual participant data from five placebo-controlled studies. Lancet Psychiatry 2017;4:859-67. [PMID: 28939419 DOI: 10.1016/S2215-0366(17)30331-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 252 |
Alsady M, de Groot T, Kortenoeven MLA, Carmone C, Neijman K, Bekkenkamp-Grovenstein M, Engelke U, Wevers R, Baumgarten R, Korstanje R, Deen PMT. Lithium induces aerobic glycolysis and glutaminolysis in collecting duct principal cells. Am J Physiol Renal Physiol 2018;314:F230-9. [PMID: 29070571 DOI: 10.1152/ajprenal.00297.2017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 253 |
Golden JC, Goethe JW, Woolley SB. Complex psychotropic polypharmacy in bipolar disorder across varying mood polarities: A prospective cohort study of 2712 inpatients. J Affect Disord 2017;221:6-10. [PMID: 28628769 DOI: 10.1016/j.jad.2017.06.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 254 |
Mahableshwarkar AR, Calabrese JR, Macek TA, Budur K, Adefuye A, Dong X, Hanson E, Sachs GS. Efficacy and safety of sublingual ramelteon as an adjunctive therapy in the maintenance treatment of bipolar I disorder in adults: A phase 3, randomized controlled trial. J Affect Disord 2017;221:275-82. [PMID: 28662460 DOI: 10.1016/j.jad.2017.06.044] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 255 |
Li DJ, Tseng PT, Stubbs B, Chu CS, Chang HY, Vieta E, Fornaro M, Carvalho AF, Solmi M, Veronese N, Chen TY, Chen YW, Lin PY, Chow PC. Efficacy, safety and tolerability of aripiprazole in bipolar disorder: An updated systematic review and meta-analysis of randomized controlled trials. Prog Neuropsychopharmacol Biol Psychiatry 2017;79:289-301. [PMID: 28651936 DOI: 10.1016/j.pnpbp.2017.06.023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 256 |
Bobo WV. The Diagnosis and Management of Bipolar I and II Disorders: Clinical Practice Update. Mayo Clin Proc 2017;92:1532-51. [PMID: 28888714 DOI: 10.1016/j.mayocp.2017.06.022] [Cited by in Crossref: 33] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 257 |
Pan YJ, Yeh LL, Chan HY, Chang CK. Transformation of excess mortality in people with schizophrenia and bipolar disorder in Taiwan. Psychol Med 2017;47:2483-93. [PMID: 28443526 DOI: 10.1017/S0033291717001040] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 258 |
Pompili M, Verzura C, Trovini G, Buscajoni A, Falcone G, Naim S, Nardella A, Sorice S, Baldessarini RJ, Girardi P. Lurasidone: efficacy and safety in the treatment of psychotic and mood disorders. Expert Opin Drug Saf 2018;17:197-205. [PMID: 28902525 DOI: 10.1080/14740338.2017.1379989] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 259 |
Mohebi P, Fallahi Khoshknab M, Rahgoi A, Norouzi Tabrizi K, Khodaie Ardakani MR. Effect of the Community Re-entry Program on Medication Adherence in Patients with Bipolar Disorder Type I. ijrn 2017;3:58-65. [DOI: 10.21859/ijrn-03048] [Reference Citation Analysis]
|
| 260 |
Sharma V, Doobay M, Baczynski C. Bipolar postpartum depression: An update and recommendations. J Affect Disord 2017;219:105-11. [PMID: 28535448 DOI: 10.1016/j.jad.2017.05.014] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 261 |
Alyahya B, Friesen M, Nauche B, Laliberté M. Acute lamotrigine overdose: a systematic review of published adult and pediatric cases. Clinical Toxicology 2018;56:81-9. [DOI: 10.1080/15563650.2017.1370096] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 262 |
Valvassori SS, Borges CP, Varela RB, Bavaresco DV, Bianchini G, Mariot E, Arent CO, Resende WR, Budni J, Quevedo J. The different effects of lithium and tamoxifen on memory formation and the levels of neurotrophic factors in the brain of male and female rats. Brain Research Bulletin 2017;134:228-35. [DOI: 10.1016/j.brainresbull.2017.08.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 263 |
Su JA, Cheng BH, Huang YC, Lee CP, Yang YH, Lu ML, Hsu CY, Lee Y, McIntyre RS, Chin Lin T, Chin-Hung Chen V. Bipolar disorder and the risk of fracture: A nationwide population-based cohort study. J Affect Disord 2017;218:246-52. [PMID: 28477503 DOI: 10.1016/j.jad.2017.04.037] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 264 |
Hsieh MH, Chuang PY, Wu CS, Chang CJ, Chung PF, Tang CH. Bipolar patients treated with long-acting injectable risperidone in Taiwan: A 1-year mirror-image study using a national claims database. J Affect Disord 2017;218:327-34. [PMID: 28494390 DOI: 10.1016/j.jad.2017.04.074] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 265 |
Malhi GS, Gessler D, Outhred T. The use of lithium for the treatment of bipolar disorder: Recommendations from clinical practice guidelines. J Affect Disord 2017;217:266-80. [PMID: 28437764 DOI: 10.1016/j.jad.2017.03.052] [Cited by in Crossref: 93] [Cited by in F6Publishing: 92] [Article Influence: 15.5] [Reference Citation Analysis]
|
| 266 |
Wingård L, Bodén R, Brandt L, Tiihonen J, Tanskanen A, Kieler H, Andersen M, Reutfors J. Reducing the rehospitalization risk after a manic episode: A population based cohort study of lithium, valproate, olanzapine, quetiapine and aripiprazole in monotherapy and combinations. J Affect Disord 2017;217:16-23. [PMID: 28364619 DOI: 10.1016/j.jad.2017.03.054] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 267 |
Pelletier L, O'Donnell S, Dykxhoorn J, McRae L, Patten SB. Under-diagnosis of mood disorders in Canada. Epidemiol Psychiatr Sci 2017;26:414-23. [PMID: 27150498 DOI: 10.1017/S2045796016000329] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 268 |
Phelps JR, James J. Psychiatric consultation in the collaborative care model: The “bipolar sieve” effect. Medical Hypotheses 2017;105:10-6. [DOI: 10.1016/j.mehy.2017.06.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 269 |
Murru A, Torra M, Callari A, Pacchiarotti I, Romero S, Gonzalez de la Presa B, Varo C, Goikolea JM, Pérez-Sola V, Vieta E, Colom F. A study on the bioequivalence of lithium and valproate salivary and blood levels in the treatment of bipolar disorder. Eur Neuropsychopharmacol 2017;27:744-50. [PMID: 28666638 DOI: 10.1016/j.euroneuro.2017.06.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 270 |
Chen P, Dols A, Rej S, Sajatovic M. Update on the Epidemiology, Diagnosis, and Treatment of Mania in Older-Age Bipolar Disorder. Curr Psychiatry Rep 2017;19:46. [PMID: 28647815 DOI: 10.1007/s11920-017-0804-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 271 |
García-Portilla MP, Bobes J. Preventive recommendations on the use of valproic acid in pregnant or gestational women to be very present. Rev Psiquiatr Salud Ment 2017;10:129-33. [PMID: 28688547 DOI: 10.1016/j.rpsm.2017.06.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 272 |
Ahn SW, Baek JH, Yang SY, Kim Y, Cho Y, Choi Y, Lee K, Park T, Hong KS. Long-term response to mood stabilizer treatment and its clinical correlates in patients with bipolar disorders: a retrospective observational study. Int J Bipolar Disord 2017;5:24. [PMID: 28480482 DOI: 10.1186/s40345-017-0093-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 273 |
Pinna M, Manchia M, Puddu S, Minnai G, Tondo L, Salis P. Cutaneous adverse reaction during lithium treatment: a case report and updated systematic review with meta-analysis. Int J Bipolar Disord 2017;5:20. [PMID: 28405955 DOI: 10.1186/s40345-017-0091-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 274 |
Dehning J, Grunze H, Hausmann A. Bupropion Maintenance Treatment in Refractory Bipolar Depression: A Case Report. Clin Pract Epidemiol Ment Health 2017;13:43-8. [PMID: 28659991 DOI: 10.2174/1745017901713010043] [Reference Citation Analysis]
|
| 275 |
Wesseloo R, Wierdsma AI, van Kamp IL, Munk-Olsen T, Hoogendijk WJG, Kushner SA, Bergink V. Lithium dosing strategies during pregnancy and the postpartum period. Br J Psychiatry 2017;211:31-6. [PMID: 28673946 DOI: 10.1192/bjp.bp.116.192799] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 276 |
García-portilla MP, Bobes J. Preventive recommendations on the use of valproic acid in pregnant or gestational women to be very present. Revista de Psiquiatría y Salud Mental (English Edition) 2017;10:129-133. [DOI: 10.1016/j.rpsmen.2017.06.001] [Reference Citation Analysis]
|
| 277 |
Al-taweel DM, Alsuwaidan M. A medication assessment tool to evaluate prescribers’ adherence to evidence-based guidelines in bipolar disorder. Int J Clin Pharm 2017;39:897-905. [DOI: 10.1007/s11096-017-0498-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 278 |
Duffy A, Patten S, Goodday S, Weir A, Heffer N, Cipriani A. Efficacy and tolerability of lithium in treating acute mania in youth with bipolar disorder: protocol for a systematic review. Int J Bipolar Disord 2017;5:22. [PMID: 28447333 DOI: 10.1186/s40345-017-0092-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 279 |
Aguglia A, Di Stefano A, Maina G. A 10-year evaluation on adolescents with anxiety disorders: are they at risk of bipolarity? Int J Psychiatry Clin Pract 2017;21:125-30. [PMID: 27997262 DOI: 10.1080/13651501.2016.1268163] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 280 |
Budde M, Degner D, Brockmöller J, Schulze TG. Pharmacogenomic aspects of bipolar disorder: An update. Eur Neuropsychopharmacol 2017;27:599-609. [PMID: 28342679 DOI: 10.1016/j.euroneuro.2017.02.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 281 |
Hwang JY, Choi JW, Kang SG, Hwang SH, Kim SJ, Lee YJ. Comparison of the Effects of Quetiapine XR and Lithium Monotherapy on Actigraphy-Measured Circadian Parameters in Patients With Bipolar II Depression. J Clin Psychopharmacol 2017;37:351-4. [PMID: 28328790 DOI: 10.1097/JCP.0000000000000699] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 282 |
Paulzen M, Haen E, Stegmann B, Unterecker S, Hiemke C, Gründer G, Schoretsanitis G. Clinical response in a risperidone-medicated naturalistic sample: patients' characteristics and dose-dependent pharmacokinetic patterns. Eur Arch Psychiatry Clin Neurosci 2017;267:325-33. [PMID: 27695935 DOI: 10.1007/s00406-016-0736-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 283 |
Parker GB, Graham RK, Tavella G. Is there consensus across international evidence-based guidelines for the management of bipolar disorder? Acta Psychiatr Scand 2017;135:515-26. [PMID: 28260229 DOI: 10.1111/acps.12717] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 284 |
Szmulewicz AG, Angriman F, Samamé C, Ferraris A, Vigo D, Strejilevich SA. Dopaminergic agents in the treatment of bipolar depression: a systematic review and meta-analysis. Acta Psychiatr Scand 2017;135:527-38. [PMID: 28256707 DOI: 10.1111/acps.12712] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 285 |
Schaffer A, Weinstock LM, Sinyor M, Reis C, Goldstein BI, Yatham LN, Levitt AJ. Self-poisoning suicide deaths in people with bipolar disorder: characterizing a subgroup and identifying treatment patterns. Int J Bipolar Disord 2017;5:16. [PMID: 28332123 DOI: 10.1186/s40345-017-0081-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 286 |
Sani G, Perugi G, Tondo L. Treatment of Bipolar Disorder in a Lifetime Perspective: Is Lithium Still the Best Choice? Clin Drug Investig 2017;37:713-27. [DOI: 10.1007/s40261-017-0531-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 287 |
Buoli M, Grassi S, Ciappolino V, Serati M, Altamura AC. The Use of Zonisamide for the Treatment of Psychiatric Disorders: A Systematic Review. Clin Neuropharmacol 2017;40:85-92. [PMID: 28195838 DOI: 10.1097/WNF.0000000000000208] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 288 |
Tebeka S, Airagnes G, Limosin F. Antipsychotiques : quand et comment les prescrire ? La Revue de Médecine Interne 2017;38:328-336. [DOI: 10.1016/j.revmed.2016.12.007] [Reference Citation Analysis]
|
| 289 |
Chatterton ML, Stockings E, Berk M, Barendregt JJ, Carter R, Mihalopoulos C. Psychosocial therapies for the adjunctive treatment of bipolar disorder in adults: network meta-analysis. Br J Psychiatry 2017;210:333-41. [PMID: 28209591 DOI: 10.1192/bjp.bp.116.195321] [Cited by in Crossref: 49] [Cited by in F6Publishing: 60] [Article Influence: 8.2] [Reference Citation Analysis]
|
| 290 |
Özdemir A, Aksoy Poyraz C, Poyraz BÇ, Usta Sağlam NG, Enginkaya S, Tomruk N. Use of Lithium in Severe Acute Manic Episodes: Retrospective Prescription Practice From a Tertiary Inpatient Unit. J Psychiatr Pract 2017;23:167-72. [PMID: 28492454 DOI: 10.1097/PRA.0000000000000226] [Reference Citation Analysis]
|
| 291 |
Soczynska JK, Kennedy SH, Alsuwaidan M, Mansur RB, Li M, McAndrews MP, Brietzke E, Woldeyohannes HO, Taylor VH, McIntyre RS. A pilot, open-label, 8-week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression. Bipolar Disord 2017;19:198-213. [PMID: 28599348 DOI: 10.1111/bdi.12496] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 292 |
Fjukstad KK, Engum A, Lydersen S, Dieset I, Steen NE, Andreassen OA, Spigset O. Metabolic risk factors in schizophrenia and bipolar disorder: The effect of comedication with selective serotonin reuptake inhibitors and antipsychotics. Eur Psychiatry. 2018;48:71-78. [PMID: 29331603 DOI: 10.1016/j.eurpsy.2017.04.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 293 |
Maripuu M, Wikgren M, Karling P, Adolfsson R, Norrback KF. Hyper- and hypocortisolism in bipolar disorder - A beneficial influence of lithium on the HPA-axis? J Affect Disord 2017;213:161-7. [PMID: 28237543 DOI: 10.1016/j.jad.2017.02.026] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 294 |
Lindström L, Lindström E, Nilsson M, Höistad M. Maintenance therapy with second generation antipsychotics for bipolar disorder - A systematic review and meta-analysis. J Affect Disord 2017;213:138-50. [PMID: 28222360 DOI: 10.1016/j.jad.2017.02.012] [Cited by in Crossref: 76] [Cited by in F6Publishing: 98] [Article Influence: 12.7] [Reference Citation Analysis]
|
| 295 |
Rosso G, Solia F, Albert U, Maina G. Affective Recurrences in Bipolar Disorder After Switching From Lithium to Valproate or Vice Versa: A Series of 57 Cases. J Clin Psychopharmacol 2017;37:278-81. [PMID: 28129310 DOI: 10.1097/JCP.0000000000000660] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 296 |
da Silva EG, Pfaffenseller B, Walz J, Stertz L, Fries G, Rosa AR, Magalhães PV. Peripheral insulin-like growth factor 1 in bipolar disorder. Psychiatry Res 2017;250:30-4. [PMID: 28135645 DOI: 10.1016/j.psychres.2017.01.061] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 297 |
Quaranta S, Dupouey J, Colle R, Verstuyft C. Pharmacogénétique des médicaments antidépresseurs : état des connaissances et des pratiques – recommandations du Réseau national de pharmacogénétique (RNPGx). Therapies 2017;72:301-9. [DOI: 10.1016/j.therap.2016.09.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 298 |
Rosenblat JD, McIntyre RS. Treatment recommendations for DSM-5-defined mixed features. CNS Spectr 2017;22:147-54. [PMID: 27629159 DOI: 10.1017/S1092852916000432] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 299 |
Quaranta S, Dupouey J, Colle R, Verstuyft C. Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation – recommendations from the French National Network of Pharmacogenetics. Therapies 2017;72:311-8. [DOI: 10.1016/j.therap.2016.09.018] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 300 |
Stahl SM, Morrissette DA, Faedda G, Fava M, Goldberg JF, Keck PE, Lee Y, Malhi G, Marangoni C, McElroy SL, Ostacher M, Rosenblat JD, Solé E, Suppes T, Takeshima M, Thase ME, Vieta E, Young A, Zimmerman M, McIntyre RS. Guidelines for the recognition and management of mixed depression. CNS Spectr 2017;22:203-19. [PMID: 28421980 DOI: 10.1017/S1092852917000165] [Cited by in Crossref: 79] [Cited by in F6Publishing: 75] [Article Influence: 13.2] [Reference Citation Analysis]
|
| 301 |
Loscertales HR, Modamio P, Lastra CF, Mariño EL. Assessing the stability of lamotrigine dispersible/chewable tablets when stored in blister punch cards. Curr Med Res Opin 2017;33:949-53. [PMID: 28277872 DOI: 10.1080/03007995.2017.1297927] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 302 |
Pikalov A, Tsai J, Mao Y, Silva R, Cucchiaro J, Loebel A. Long-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment. Int J Bipolar Disord 2017;5:9. [PMID: 28168632 DOI: 10.1186/s40345-017-0075-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 303 |
Bond DJ, Torres IJ, Lee SS, Kozicky JM, Silveira LE, Dhanoa T, Lam RW, Yatham LN. Lower cognitive functioning as a predictor of weight gain in bipolar disorder: a 12-month study. Acta Psychiatr Scand 2017;135:239-49. [PMID: 27995622 DOI: 10.1111/acps.12674] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 304 |
Schulze L, Remington G, Giacobbe P, Kennedy SH, Blumberger DM, Daskalakis ZJ, Downar J. Effect of antipsychotic pharmacotherapy on clinical outcomes of intermittent theta-burst stimulation for refractory depression. J Psychopharmacol 2017;31:312-9. [PMID: 27852961 DOI: 10.1177/0269881116675516] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 305 |
Bond DJ, Silveira LE, MacMillan EL, Torres IJ, Lang DJ, Su W, Honer WG, Lam RW, Yatham LN. Diagnosis and body mass index effects on hippocampal volumes and neurochemistry in bipolar disorder. Transl Psychiatry 2017;7:e1071. [PMID: 28350397 DOI: 10.1038/tp.2017.42] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 306 |
Aubry RE, Scott L, Cassidy E. Lithium monitoring patterns in the United Kingdom and Ireland: Can shared care agreements play a role in improving monitoring quality? A systematic review. Ir J Psychol Med 2017;34:127-40. [PMID: 30115218 DOI: 10.1017/ipm.2017.2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 307 |
Husain MI, Chaudhry IB, Rahman RR, Hamirani MM, Mehmood N, Haddad PM, Hodsoll J, Young AH, Naeem F, Husain N. Pilot study of a culturally adapted psychoeducation (CaPE) intervention for bipolar disorder in Pakistan. Int J Bipolar Disord 2017;5:3. [PMID: 28155203 DOI: 10.1186/s40345-017-0074-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 308 |
De Filippis S, Cuomo I, Kotzalidis GD, Pucci D, Zingaretti P, Porrari R, Fini C, Motta P, Caloro M, Girardi P. Does the efficacy of asenapine in bipolar disorder increase in the presence of comorbidity with a substance use disorder? A naturalistic study. Ther Adv Psychopharmacol 2017;7:67-77. [PMID: 28255436 DOI: 10.1177/2045125316674698] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 309 |
Chu CS, Chou PH, Chen YH, Huang MW, Hsu MY, Lan TH, Lin CH. Association between antipsychotic drug use and cataracts in patients with bipolar disorder: A population-based, nested case-control study. J Affect Disord 2017;209:86-92. [PMID: 27889598 DOI: 10.1016/j.jad.2016.11.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 310 |
Baumann P, Spies M, Möller HJ, Kasper S, Bitter I, Laux G. A proposal for a psychopharmacology-pharmacotherapy catalogue of learning objectives and a curriculum in Europe. World J Biol Psychiatry 2017;18:29-38. [PMID: 26850137 DOI: 10.3109/15622975.2016.1149219] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 311 |
Malhi GS, Morris G, Hamilton A, Outhred T, Das P. Defining the role of SGAs in the long-term treatment of bipolar disorder. Bipolar Disord 2017;19:65-7. [PMID: 28346768 DOI: 10.1111/bdi.12472] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 312 |
Henter ID, de Sousa RT, Gold PW, Brunoni AR, Zarate CA Jr, Machado-Vieira R. Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression. Expert Rev Clin Pharmacol 2017;10:153-66. [PMID: 27781556 DOI: 10.1080/17512433.2017.1253472] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 313 |
Vinberg M, Mikkelsen RL, Kirkegaard T, Christensen EM, Kessing LV. Differences in clinical presentation between bipolar I and II disorders in the early stages of bipolar disorder: A naturalistic study. J Affect Disord 2017;208:521-7. [PMID: 27816324 DOI: 10.1016/j.jad.2016.10.031] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 314 |
Hu C, Torres IJ, Qian H, Wong H, Halli P, Dhanoa T, Ahn S, Wang G, Bond DJ, Lam RW, Yatham LN. Trajectories of body mass index change in first episode of mania: 3-year data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). J Affect Disord 2017;208:291-7. [PMID: 27794253 DOI: 10.1016/j.jad.2016.08.048] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 315 |
Fisher A, Manicavasagar V, Sharpe L, Laidsaar-Powell R, Juraskova I. A qualitative exploration of patient and family views and experiences of treatment decision-making in bipolar II disorder. J Ment Health. 2018;27:66-79. [PMID: 28084845 DOI: 10.1080/09638237.2016.1276533] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 316 |
Dose M. Akut- und Notfallsituationen bei minderbegabten Menschen. Die Psychiatrische Notfallmedizin 2017. [DOI: 10.1016/b978-3-437-22881-0.00026-5] [Reference Citation Analysis]
|
| 317 |
Malhi GS, Gessler D, Fritz K, Allwang C, Outhred T, Das P. Recommendations in International Clinical Practice Guidelines for Lithium Therapy of Bipolar Disorder. The Science and Practice of Lithium Therapy 2017. [DOI: 10.1007/978-3-319-45923-3_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 318 |
Alda M, McKinnon M, Blagdon R, Garnham J, MacLellan S, O'Donovan C, Hajek T, Nair C, Dursun S, MacQueen G. Methylene blue treatment for residual symptoms of bipolar disorder: randomised crossover study. Br J Psychiatry 2017;210:54-60. [PMID: 27284082 DOI: 10.1192/bjp.bp.115.173930] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 319 |
Literaturverzeichnis zu Voderholzer/Hohagen (Hrsg.): Therapie psychischer Erkrankungen, 13. Auflage. Therapie psychischer Erkrankungen 2017. [DOI: 10.1016/b978-3-437-24909-9.16001-3] [Reference Citation Analysis]
|
| 320 |
Bauer M, Severus E, Laux G. Bipolare affektive Störungen. Psychiatrie, Psychosomatik, Psychotherapie 2017. [DOI: 10.1007/978-3-662-49295-6_68] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 321 |
Albuquerque J, Deshauer D. Manic and Hypomanic States. Physician Mental Health and Well-Being 2017. [DOI: 10.1007/978-3-319-55583-6_7] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 322 |
Shah N, Grover S, Rao GP. Clinical Practice Guidelines for Management of Bipolar Disorder. Indian J Psychiatry 2017;59:S51-66. [PMID: 28216785 DOI: 10.4103/0019-5545.196974] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 323 |
Dayer A, Perroud N, Aubry J. Lithium Response Variability (Pharmacogenomics Studies). The Science and Practice of Lithium Therapy 2017. [DOI: 10.1007/978-3-319-45923-3_8] [Reference Citation Analysis]
|
| 324 |
Flores-ramos M, Leff P, Fernández-guasti A, Becerra Palars C. Is it important to consider the sex of the patient when using lithium or valproate to treat the bipolar disorder? Pharmacology Biochemistry and Behavior 2017;152:105-11. [DOI: 10.1016/j.pbb.2016.02.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 325 |
Cakir S, Yazıcı O, Post RM. Decreased responsiveness following lithium discontinuation in bipolar disorder: A naturalistic observation study. Psychiatry Res 2017;247:305-9. [PMID: 27974284 DOI: 10.1016/j.psychres.2016.11.046] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 326 |
Thomas KL, Doroudgar S. Lithium. Side Effects of Drugs Annual 2017. [DOI: 10.1016/bs.seda.2017.06.006] [Reference Citation Analysis]
|
| 327 |
Rej S. Lithium in Older Age Bipolar Disorder. Bipolar Disorder in Older Age Patients 2017. [DOI: 10.1007/978-3-319-48912-4_7] [Reference Citation Analysis]
|
| 328 |
An FR, Zhang L, Zhang QE, Ungvari GS, Ng CH, Chiu HFK, Wu PP, Jin X, Li L, Lok GKI, Xiang YT. Electroconvulsive therapy and its relationships with clinical characteristics and quality of life in Chinese psychiatric patients. Psychiatry Res 2016;246:246-9. [PMID: 27723522 DOI: 10.1016/j.psychres.2016.09.046] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 329 |
Passos IC, Kapczinski F. Should bipolar disorder treatment be modified depending on staging? Expert Rev Neurother 2017;17:93-5. [PMID: 27915494 DOI: 10.1080/14737175.2017.1268532] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 330 |
Gitlin M. Lithium side effects and toxicity: prevalence and management strategies. Int J Bipolar Disord 2016;4:27. [PMID: 27900734 DOI: 10.1186/s40345-016-0068-y] [Cited by in Crossref: 187] [Cited by in F6Publishing: 193] [Article Influence: 26.7] [Reference Citation Analysis]
|
| 331 |
Bai YM, Li CT, Tsai SJ, Tu PC, Chen MH, Su TP. Metabolic syndrome and adverse clinical outcomes in patients with bipolar disorder. BMC Psychiatry 2016;16:448. [PMID: 27978821 DOI: 10.1186/s12888-016-1143-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 332 |
Fountoulakis KN, Grunze H, Vieta E, Young A, Yatham L, Blier P, Kasper S, Moeller HJ. The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 3: The Clinical Guidelines. Int J Neuropsychopharmacol 2017;20:180-95. [PMID: 27941079 DOI: 10.1093/ijnp/pyw109] [Cited by in Crossref: 56] [Cited by in F6Publishing: 81] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 333 |
Thomson M, Sharma V. Therapeutics of postpartum depression. Expert Review of Neurotherapeutics 2017;17:495-507. [DOI: 10.1080/14737175.2017.1265888] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 334 |
Bosche B, Molcanyi M, Rej S, Doeppner TR, Obermann M, Müller DJ, Das A, Hescheler J, Macdonald RL, Noll T, Härtel FV. Low-Dose Lithium Stabilizes Human Endothelial Barrier by Decreasing MLC Phosphorylation and Universally Augments Cholinergic Vasorelaxation Capacity in a Direct Manner. Front Physiol 2016;7:593. [PMID: 27999548 DOI: 10.3389/fphys.2016.00593] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 335 |
Dols A, Kessing LV, Strejilevich SA, Rej S, Tsai SY, Gildengers AG, Almeida OP, Shulman KI, Sajatovic M; International Society for Bipolar Disorders Task Force for Older Adults with Bipolar Disorder. Do current national and international guidelines have specific recommendations for older adults with bipolar disorder? A brief report. Int J Geriatr Psychiatry 2016;31:1295-300. [PMID: 27442023 DOI: 10.1002/gps.4534] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 336 |
McGirr A, Vöhringer PA, Ghaemi SN, Lam RW, Yatham LN. Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials. Lancet Psychiatry 2016;3:1138-46. [PMID: 28100425 DOI: 10.1016/S2215-0366(16)30264-4] [Cited by in Crossref: 92] [Cited by in F6Publishing: 64] [Article Influence: 13.1] [Reference Citation Analysis]
|
| 337 |
Pérez-Castelló I, Mangas-Sanjuan V, González-García I, Gonzalez-Alvarez I, Bermejo M, Marco-Garbayo JL, Trocóniz IF. Population pharmacokinetic model of lithium and drug compliance assessment. Eur Neuropsychopharmacol 2016;26:1868-76. [PMID: 27865605 DOI: 10.1016/j.euroneuro.2016.11.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 338 |
Pagano HP, Zapata LB, Berry-bibee EN, Nanda K, Curtis KM. Safety of hormonal contraception and intrauterine devices among women with depressive and bipolar disorders: a systematic review. Contraception 2016;94:641-9. [DOI: 10.1016/j.contraception.2016.06.012] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 339 |
Schoretsanitis G, Haen E, Gründer G, Stegmann B, Schruers KR, Hiemke C, Lammertz SE, Paulzen M. Pharmacokinetic Drug-Drug Interactions of Mood Stabilizers and Risperidone in Patients Under Combined Treatment. J Clin Psychopharmacol 2016;36:554-61. [PMID: 27811552 DOI: 10.1097/JCP.0000000000000601] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 340 |
Malhi GS, Gershon S, Outhred T. Lithiumeter: Version 2.0. Bipolar Disord 2016;18:631-41. [PMID: 28063207 DOI: 10.1111/bdi.12455] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 341 |
Chan HW, Huang CY, Feng WJ, Yen YC. Clinical outcomes of long-acting injectable risperidone in patients with bipolar I disorder: A 1-year retrospective cohort study. J Affect Disord 2016;205:360-4. [PMID: 27568173 DOI: 10.1016/j.jad.2016.08.023] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 342 |
Hodgkin D, Merrick EL, O'Brien PL, McGuire TG, Lee S, Deckersbach T, Nierenberg AA. Testing for clinical inertia in medication treatment of bipolar disorder. J Affect Disord 2016;205:13-9. [PMID: 27391267 DOI: 10.1016/j.jad.2016.03.073] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 343 |
Fountoulakis KN, Yatham L, Grunze H, Vieta E, Young A, Blier P, Kasper S, Moeller HJ. The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm. Int J Neuropsychopharmacol 2017;20:121-79. [PMID: 27816941 DOI: 10.1093/ijnp/pyw100] [Cited by in Crossref: 23] [Cited by in F6Publishing: 44] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 344 |
Kelly T, Denmark L, Lieberman DZ. Elevated levels of circulating thyroid hormone do not cause the medical sequelae of hyperthyroidism. Prog Neuropsychopharmacol Biol Psychiatry 2016;71:1-6. [PMID: 27302764 DOI: 10.1016/j.pnpbp.2016.06.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 345 |
Geoffroy PA, Samalin L, Llorca PM, Curis E, Bellivier F. Influence of lithium on sleep and chronotypes in remitted patients with bipolar disorder. J Affect Disord 2016;204:32-9. [PMID: 27318597 DOI: 10.1016/j.jad.2016.06.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 346 |
Minichino A, Delle Chiaie R, Cruccu G, Piroso S, Di Stefano G, Francesconi M, Bersani FS, Biondi M, Truini A. Pain-processing abnormalities in bipolar I disorder, bipolar II disorder, and schizophrenia: A novel trait marker for psychosis proneness and functional outcome? Bipolar Disord 2016;18:591-601. [PMID: 27782355 DOI: 10.1111/bdi.12439] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 347 |
Morriss R, Lobban F, Riste L, Davies L, Holland F, Long R, Lykomitrou G, Peters S, Roberts C, Robinson H, Jones S; NIHR PARADES Psychoeducation Study Group. Clinical effectiveness and acceptability of structured group psychoeducation versus optimised unstructured peer support for patients with remitted bipolar disorder (PARADES): a pragmatic, multicentre, observer-blind, randomised controlled superiority trial. Lancet Psychiatry 2016;3:1029-38. [PMID: 27688021 DOI: 10.1016/S2215-0366(16)30302-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 49] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 348 |
Li K, Wei Q, Li G, He X, Liao Y, Gan Z. Time to lack of persistence with pharmacological treatment among patients with current depressive episodes: a natural study with 1-year follow-up. Patient Prefer Adherence 2016;10:2209-15. [PMID: 27822021 DOI: 10.2147/PPA.S109941] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 349 |
Sharma V, Sharma S. Peripartum management of bipolar disorder: what do the latest guidelines recommend? Expert Rev Neurother 2017;17:335-44. [PMID: 27769136 DOI: 10.1080/14737175.2017.1243470] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 350 |
Laforgue EJ, Bulteau S, Cholet J, Victorri-Vigneau C, Guitteny M, Mauduit N, Vanelle JM, Sauvaget A. [Concordance between hospital prescriptions and recommendations in the treatment of mania]. Therapie 2017;72:327-37. [PMID: 27726886 DOI: 10.1016/j.therap.2016.07.007] [Reference Citation Analysis]
|
| 351 |
Solmi M, Veronese N, Zaninotto L, van der Loos ML, Gao K, Schaffer A, Reis C, Normann C, Anghelescu IG, Correll CU. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials. CNS Spectr 2016;21:403-18. [PMID: 27686028 DOI: 10.1017/S1092852916000523] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 352 |
Pesavento JA, Kolli V, Garcia-Delgar B, Coffey BJ. Autoimmune Thyroiditis in an Adolescent Girl on Lithium. J Child Adolesc Psychopharmacol 2016;26:756-9. [PMID: 27732081 DOI: 10.1089/cap.2016.29116.bjc] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 353 |
Oldani L, Altamura AC, Abdelghani M, Young AH. Brain stimulation treatments in bipolar disorder: A review of the current literature. World J Biol Psychiatry 2016;17:482-94. [PMID: 25471324 DOI: 10.3109/15622975.2014.984630] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 354 |
van den Ameele S, van Diermen L, Staels W, Coppens V, Dumont G, Sabbe B, Morrens M. The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: A systematic review. J Affect Disord 2016;203:364-73. [PMID: 27344047 DOI: 10.1016/j.jad.2016.06.016] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 355 |
Kelly T. A hypothesis on the mechanism of action of high-dose thyroid in refractory mood disorders. Med Hypotheses 2016;97:16-21. [PMID: 27876122 DOI: 10.1016/j.mehy.2016.09.022] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 356 |
Kallestad H, Wullum E, Scott J, Stiles TC, Morken G. The long-term outcomes of an effectiveness trial of group versus individual psychoeducation for bipolar disorders. J Affect Disord 2016;202:32-8. [PMID: 27253214 DOI: 10.1016/j.jad.2016.05.043] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 357 |
Panza F, Lozupone M, Stella E, Miscio G, La Montagna M, Daniele A, di Mauro L, Bellomo A, Logroscino G, Greco A, Seripa D. The pharmacogenetic road to avoid adverse drug reactions and therapeutic failures in revolving door patients with psychiatric illnesses: focus on the CYP2D6 isoenzymes. Expert Review of Precision Medicine and Drug Development 2016;1:431-42. [DOI: 10.1080/23808993.2016.1232148] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 358 |
Levin JB, Krivenko A, Howland M, Schlachet R, Sajatovic M. Medication Adherence in Patients with Bipolar Disorder: A Comprehensive Review. CNS Drugs 2016;30:819-35. [PMID: 27435356 DOI: 10.1007/s40263-016-0368-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 63] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 359 |
Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P, Hasnain M, Jollant F, Levitt AJ, MacQueen GM, McInerney SJ, McIntosh D, Milev RV, Müller DJ, Parikh SV, Pearson NL, Ravindran AV, Uher R; CANMAT Depression Work Group. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments. Can J Psychiatry 2016;61:540-60. [PMID: 27486148 DOI: 10.1177/0706743716659417] [Cited by in Crossref: 557] [Cited by in F6Publishing: 541] [Article Influence: 79.6] [Reference Citation Analysis]
|
| 360 |
Tondo L, Baldessarini RJ. Suicidal Behavior in Mood Disorders: Response to Pharmacological Treatment. Curr Psychiatry Rep 2016;18:88. [PMID: 27542851 DOI: 10.1007/s11920-016-0715-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 51] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 361 |
Lam RW, McIntosh D, Wang J, Enns MW, Kolivakis T, Michalak EE, Sareen J, Song WY, Kennedy SH, MacQueen GM, Milev RV, Parikh SV, Ravindran AV; CANMAT Depression Work Group. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of Care. Can J Psychiatry 2016;61:510-23. [PMID: 27486151 DOI: 10.1177/0706743716659416] [Cited by in Crossref: 162] [Cited by in F6Publishing: 163] [Article Influence: 23.1] [Reference Citation Analysis]
|
| 362 |
Bauer MS, Miller CJ, Li M, Bajor LA, Lee A. A population-based study of the comparative effectiveness of second-generation antipsychotics vs older antimanic agents in bipolar disorder. Bipolar Disord 2016;18:481-9. [PMID: 27650468 DOI: 10.1111/bdi.12425] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 363 |
Woo YS, Bahk WM, Park YM, Chung S, Yoon BH, Won S, Lee JG, Lee HB, Kim W, Jeong JH, Lee K, Kim MD. Effects of switching to aripiprazole from current atypical antipsychotics on subsyndromal symptoms and tolerability in patients with bipolar disorder. Int Clin Psychopharmacol 2016;31:275-86. [PMID: 27487259 DOI: 10.1097/YIC.0000000000000136] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 364 |
Parikh SV, Quilty LC, Ravitz P, Rosenbluth M, Pavlova B, Grigoriadis S, Velyvis V, Kennedy SH, Lam RW, MacQueen GM, Milev RV, Ravindran AV, Uher R; CANMAT Depression Work Group. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological Treatments. Can J Psychiatry 2016;61:524-39. [PMID: 27486150 DOI: 10.1177/0706743716659418] [Cited by in Crossref: 198] [Cited by in F6Publishing: 142] [Article Influence: 28.3] [Reference Citation Analysis]
|
| 365 |
Milev RV, Giacobbe P, Kennedy SH, Blumberger DM, Daskalakis ZJ, Downar J, Modirrousta M, Patry S, Vila-Rodriguez F, Lam RW, MacQueen GM, Parikh SV, Ravindran AV; CANMAT Depression Work Group. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments. Can J Psychiatry 2016;61:561-75. [PMID: 27486154 DOI: 10.1177/0706743716660033] [Cited by in Crossref: 338] [Cited by in F6Publishing: 329] [Article Influence: 48.3] [Reference Citation Analysis]
|
| 366 |
Lam RW, Kennedy SH, Parikh SV, MacQueen GM, Milev RV, Ravindran AV; CANMAT Depression Work Group. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Introduction and Methods. Can J Psychiatry 2016;61:506-9. [PMID: 27486152 DOI: 10.1177/0706743716659061] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 367 |
Hayes JF, Marston L, Walters K, Geddes JR, King M, Osborn DP. Adverse Renal, Endocrine, Hepatic, and Metabolic Events during Maintenance Mood Stabilizer Treatment for Bipolar Disorder: A Population-Based Cohort Study. PLoS Med 2016;13:e1002058. [PMID: 27483368 DOI: 10.1371/journal.pmed.1002058] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 368 |
Jaeschke RR, Sowa-kućma M, Pańczyszyn-trzewik P, Misztak P, Styczeń K, Datka W. Lurasidone: The 2016 update on the pharmacology, efficacy and safety profile. Pharmacological Reports 2016;68:748-55. [DOI: 10.1016/j.pharep.2016.04.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 369 |
Ferrari AJ, Stockings E, Khoo JP, Erskine HE, Degenhardt L, Vos T, Whiteford HA. The prevalence and burden of bipolar disorder: findings from the Global Burden of Disease Study 2013. Bipolar Disord 2016;18:440-50. [PMID: 27566286 DOI: 10.1111/bdi.12423] [Cited by in Crossref: 331] [Cited by in F6Publishing: 341] [Article Influence: 47.3] [Reference Citation Analysis]
|
| 370 |
Yatham LN, Beaulieu S, Schaffer A, Kauer-Sant'Anna M, Kapczinski F, Lafer B, Sharma V, Parikh SV, Daigneault A, Qian H, Bond DJ, Silverstone PH, Walji N, Milev R, Baruch P, da Cunha A, Quevedo J, Dias R, Kunz M, Young LT, Lam RW, Wong H. Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial. Mol Psychiatry 2016;21:1050-6. [PMID: 26460229 DOI: 10.1038/mp.2015.158] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 371 |
Tondo L, Baldessarini RJ. Depression following mania. Mol Psychiatry 2016;21:990. [PMID: 27113995 DOI: 10.1038/mp.2016.63] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 372 |
Çakir S, Çağlar N. Electroconvulsive Therapy in the Treatment of Mood Disorders: One-Year Follow-up. Noro Psikiyatr Ars 2017;54:196-201. [PMID: 29033629 DOI: 10.5152/npa.2016.14845] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 373 |
Hui Poon S, Sim K, Baldessarini RJ. Pharmacological Approaches for Treatment-resistant Bipolar Disorder. Curr Neuropharmacol 2015;13:592-604. [PMID: 26467409 DOI: 10.2174/1570159x13666150630171954] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 374 |
Panza F, Lozupone M, Stella E, Lofano L, Gravina C, Urbano M, Daniele A, Bellomo A, Logroscino G, Greco A, Seripa D. Psychiatry meets pharmacogenetics for the treatment of revolving door patients with psychiatric disorders. Expert Review of Neurotherapeutics 2016;16:1357-69. [DOI: 10.1080/14737175.2016.1204913] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 375 |
Schoretsanitis G, Stegmann B, Hiemke C, Gründer G, Schruers KRJ, Walther S, Lammertz SE, Haen E, Paulzen M. Pharmacokinetic patterns of risperidone-associated adverse drug reactions. Eur J Clin Pharmacol 2016;72:1091-8. [DOI: 10.1007/s00228-016-2085-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 376 |
Cakir S, Tasdelen Durak R, Ozyildirim I, Ince E, Sar V. Childhood trauma and treatment outcome in bipolar disorder. J Trauma Dissociation 2016;17:397-409. [PMID: 26683845 DOI: 10.1080/15299732.2015.1132489] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 377 |
Rej S, Pira S, Marshe V, Do A, Elie D, Looper KJ, Herrmann N, Müller DJ. Molecular mechanisms in lithium-associated renal disease: a systematic review. Int Urol Nephrol 2016;48:1843-53. [DOI: 10.1007/s11255-016-1352-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 378 |
Verdoux H, Pambrun E, Cortaredona S, Coldefy M, Le Neindre C, Tournier M, Verger P. Geographical disparities in prescription practices of lithium and clozapine: a community-based study. Acta Psychiatr Scand 2016;133:470-80. [PMID: 26826542 DOI: 10.1111/acps.12554] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 379 |
Rej S, Schuurmans J, Elie D, Stek ML, Shulman K, Dols A. Attitudes towards pharmacotherapy in late-life bipolar disorder. Int Psychogeriatr 2016;28:945-50. [PMID: 26778416 DOI: 10.1017/S1041610215002380] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 380 |
Wu CS, Hsieh MH, Tang CH, Chang CJ. Comparative effectiveness of long-acting injectable risperidone vs. long-acting injectable first-generation antipsychotics in bipolar disorder. J Affect Disord 2016;197:189-95. [PMID: 26994437 DOI: 10.1016/j.jad.2016.03.043] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 381 |
Arıkan MK, Poyraz CA, Baş A, Sağlam NG, Batun GC, Gültekin G, Poyraz BÇ. Changing Trends in Treatment of Acute Mania: Experience of a Tertiary Centre Over a Decade. Psychiatr Q 2016;87:305-13. [PMID: 26220636 DOI: 10.1007/s11126-015-9388-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 382 |
Barbato A, Vallarino M, Rapisarda F, Lora A, Parabiaghi A, D'Avanzo B, Lesage A. Do people with bipolar disorders have access to psychosocial treatments? A survey in Italy. Int J Soc Psychiatry 2016;62:334-44. [PMID: 26896028 DOI: 10.1177/0020764016631368] [Cited by in Crossref: 6] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 383 |
Pfennig A, Conell J, Ritter P, Ritter D, Severus E, Meyer TD, Hautzinger M, Wolff J, Godemann F, Reif A, Bauer M. Leitliniengerechte psychiatrisch-psychotherapeutische Behandlung bei bipolaren Störungen: Welche Ressourcen werden dafür benötigt? Nervenarzt 2017;88:222-33. [DOI: 10.1007/s00115-016-0083-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 384 |
Samalin L, Vieta E, Okasha TA, Uddin MJ, Ahmadi Abhari SA, Nacef F, Mishyiev V, Aizenberg D, Ratner Y, Melas-Melt L, Sedeki I, Llorca PM. Management of bipolar disorder in the intercontinental region: an international, multicenter, non-interventional, cross-sectional study in real-life conditions. Sci Rep 2016;6:25920. [PMID: 27181262 DOI: 10.1038/srep25920] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 385 |
Heesch CB, Moore TA, Gutierrez CA, Lee S. Hospitalizations and emergency room visits after initiation of long-acting injectable antipsychotics. Ment Health Clin 2016;6:134-41. [PMID: 29955461 DOI: 10.9740/mhc.2016.05.134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 386 |
Elie D, Segal M, Low NC, Mucsi I, Holcroft C, Shulman K, Looper KJ, Rej S. Statins in the prevention of lithium-associated diabetes insipidus: preliminary findings. Kidney Int 2015;87:862. [PMID: 25826552 DOI: 10.1038/ki.2014.409] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 387 |
Karanti A, Kardell M, Lundberg U, Landén M. Changes in mood stabilizer prescription patterns in bipolar disorder. J Affect Disord 2016;195:50-6. [PMID: 26859073 DOI: 10.1016/j.jad.2016.01.043] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 388 |
Ketter TA, Sarma K, Silva R, Kroger H, Cucchiaro J, Loebel A. LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDY. Depress Anxiety 2016;33:424-34. [PMID: 26918425 DOI: 10.1002/da.22479] [Cited by in Crossref: 31] [Cited by in F6Publishing: 51] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 389 |
Samalin L, Murru A, Vieta E. Management of inter-episodic periods in patients with bipolar disorder. Expert Rev Neurother 2016;16:659-70. [PMID: 27058008 DOI: 10.1080/14737175.2016.1176530] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 390 |
Kishi T, Oya K, Iwata N. Long-Acting Injectable Antipsychotics for Prevention of Relapse in Bipolar Disorder: A Systematic Review and Meta-Analyses of Randomized Controlled Trials. Int J Neuropsychopharmacol 2016;19:pyw038. [PMID: 27207910 DOI: 10.1093/ijnp/pyw038] [Cited by in Crossref: 26] [Cited by in F6Publishing: 47] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 391 |
Grande I, Berk M, Birmaher B, Vieta E. Bipolar disorder. Lancet 2016;387:1561-72. [PMID: 26388529 DOI: 10.1016/S0140-6736(15)00241-X] [Cited by in Crossref: 860] [Cited by in F6Publishing: 618] [Article Influence: 122.9] [Reference Citation Analysis]
|
| 392 |
Yoshimi N, Futamura T, Kakumoto K, Salehi AM, Sellgren CM, Holmén-Larsson J, Jakobsson J, Pålsson E, Landén M, Hashimoto K. Blood metabolomics analysis identifies abnormalities in the citric acid cycle, urea cycle, and amino acid metabolism in bipolar disorder. BBA Clin 2016;5:151-8. [PMID: 27114925 DOI: 10.1016/j.bbacli.2016.03.008] [Cited by in Crossref: 61] [Cited by in F6Publishing: 50] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 393 |
Spina E, Pisani F, de Leon J. Clinically significant pharmacokinetic drug interactions of antiepileptic drugs with new antidepressants and new antipsychotics. Pharmacological Research 2016;106:72-86. [DOI: 10.1016/j.phrs.2016.02.014] [Cited by in Crossref: 62] [Cited by in F6Publishing: 67] [Article Influence: 8.9] [Reference Citation Analysis]
|
| 394 |
Nodwell J, Young LT. Reply. Acta Psychiatr Scand 2016;133:335-6. [PMID: 26714100 DOI: 10.1111/acps.12542] [Reference Citation Analysis]
|
| 395 |
Marras C, Herrmann N, Fischer HD, Fung K, Gruneir A, Rochon PA, Rej S, Vigod S, Seitz D, Shulman KI. Lithium Use in Older Adults is Associated with Increased Prescribing of Parkinson Medications. Am J Geriatr Psychiatry 2016;24:301-9. [PMID: 27037047 DOI: 10.1016/j.jagp.2015.11.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 396 |
Mezni A, Khazri A, Khazri O, Limam F, Cosette P, Aouani E. Neuroprotective Activity of Grape Seed and Skin Extract Against Lithium Exposure Using Proteomic Research. Mol Neurobiol 2017;54:2720-30. [DOI: 10.1007/s12035-016-9853-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 397 |
Ware K, Tillery E, Linder L. General pharmacokinetic/pharmacodynamic concepts of mood stabilizers in the treatment of bipolar disorder. Ment Health Clin 2016;6:54-61. [PMID: 29955448 DOI: 10.9740/mhc.2016.01.054] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 398 |
Li DJ, Tseng PT, Chen YW, Wu CK, Lin PY. Significant Treatment Effect of Bupropion in Patients With Bipolar Disorder but Similar Phase-Shifting Rate as Other Antidepressants: A Meta-Analysis Following the PRISMA Guidelines. Medicine (Baltimore) 2016;95:e3165. [PMID: 27043678 DOI: 10.1097/MD.0000000000003165] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 399 |
Pavlova B, Perroud N, Cordera P, Uher R, Dayer A, Aubry JM. Childhood maltreatment and comorbid anxiety in people with bipolar disorder. J Affect Disord 2016;192:22-7. [PMID: 26706828 DOI: 10.1016/j.jad.2015.12.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 400 |
Machado-Vieira R, Otaduy MC, Zanetti MV, De Sousa RT, Dias VV, Leite CC, Forlenza OV, Busatto GF, Soares JC, Gattaz WF. A Selective Association between Central and Peripheral Lithium Levels in Remitters in Bipolar Depression: A 3T-(7) Li Magnetic Resonance Spectroscopy Study. Acta Psychiatr Scand 2016;133:214-20. [PMID: 26513535 DOI: 10.1111/acps.12511] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 401 |
Kessing LV, Vradi E, Andersen PK. Nationwide and population-based prescription patterns in bipolar disorder. Bipolar Disord 2016;18:174-82. [PMID: 26890465 DOI: 10.1111/bdi.12371] [Cited by in Crossref: 72] [Cited by in F6Publishing: 71] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 402 |
Bond DJ, Andreazza AC, Hughes J, Dhanoa T, Torres IJ, Kozicky JM, Young LT, Lam RW, Yatham LN. Association of peripheral inflammation with body mass index and depressive relapse in bipolar disorder. Psychoneuroendocrinology 2016;65:76-83. [PMID: 26731572 DOI: 10.1016/j.psyneuen.2015.12.012] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 403 |
Miller S, Dennehy EB, Suppes T. The Prevalence and Diagnostic Validity of Short-Duration Hypomanic Episodes and Major Depressive Episodes. Curr Psychiatry Rep 2016;18:27. [PMID: 26830885 DOI: 10.1007/s11920-016-0669-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 404 |
Castro VM, Roberson AM, McCoy TH, Wiste A, Cagan A, Smoller JW, Rosenbaum JF, Ostacher M, Perlis RH. Stratifying Risk for Renal Insufficiency Among Lithium-Treated Patients: An Electronic Health Record Study. Neuropsychopharmacology 2016;41:1138-43. [PMID: 26294109 DOI: 10.1038/npp.2015.254] [Cited by in Crossref: 35] [Cited by in F6Publishing: 58] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 405 |
Beyer JL, Payne ME. Nutrition and Bipolar Depression. Psychiatr Clin North Am 2016;39:75-86. [PMID: 26876319 DOI: 10.1016/j.psc.2015.10.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 406 |
Buoli M, Caldiroli A, Altamura AC. Psychiatric Conditions in Parkinson Disease: A Comparison With Classical Psychiatric Disorders. J Geriatr Psychiatry Neurol 2016;29:72-91. [PMID: 26377851 DOI: 10.1177/0891988715606233] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 407 |
Yasemin G. Curly Hair Induced by Valproate in Bipolar Disorder. Clin Psychopharmacol Neurosci 2016;14:114. [PMID: 26792051 DOI: 10.9758/cpn.2016.14.1.114] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 408 |
Bauer MS, Krawczyk L, Miller CJ, Abel E, Osser DN, Franz A, Brandt C, Rooney M, Fleming J, Godleski L. Team-Based Telecare for Bipolar Disorder. Telemed J E Health 2016;22:855-64. [PMID: 26906927 DOI: 10.1089/tmj.2015.0255] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 409 |
Italiano D, Capuano A, Alibrandi A, Ferrara R, Cannata A, Trifirò G, Sultana J, Ferrajolo C, Tari M, Tari DU, Perrotta M, Pagliaro C, Rafaniello C, Spina E, Arcoraci V. Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011. Br J Clin Pharmacol 2015;79:1010-9. [PMID: 25556909 DOI: 10.1111/bcp.12577] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 410 |
Szmulewicz A, Samamé C, Caravotta P, Martino DJ, Igoa A, Hidalgo-Mazzei D, Colom F, Strejilevich SA. Behavioral and emotional adverse events of drugs frequently used in the treatment of bipolar disorders: clinical and theoretical implications. Int J Bipolar Disord 2016;4:6. [PMID: 26879750 DOI: 10.1186/s40345-016-0047-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 411 |
Chen PS, Chang HH, Huang CC, Lee CC, Lee SY, Chen SL, Huang SY, Yang YK, Lu RB. A longitudinal study of the association between the GNB3 C825T polymorphism and metabolic disturbance in bipolar II patients treated with valproate. Pharmacogenomics J 2017;17:155-61. [PMID: 26856249 DOI: 10.1038/tpj.2015.96] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 412 |
Kleimann A, Schrader V, Stübner S, Greil W, Kahl KG, Bleich S, Grohmann R, Frieling H, Toto S. Psychopharmacological treatment of 1650 in-patients with acute mania-data from the AMSP study. J Affect Disord 2016;191:164-71. [PMID: 26655125 DOI: 10.1016/j.jad.2015.11.037] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 413 |
Bond DJ, da Silveira LE, MacMillan EL, Torres IJ, Lang DJ, Su W, Honer WG, Lam RW, Yatham LN. Relationship between body mass index and hippocampal glutamate/glutamine in bipolar disorder. Br J Psychiatry 2016;208:146-52. [PMID: 26585092 DOI: 10.1192/bjp.bp.115.163360] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 414 |
Ketter TA, Miller S, Dell'Osso B, Wang PW. Treatment of bipolar disorder: Review of evidence regarding quetiapine and lithium. J Affect Disord 2016;191:256-73. [PMID: 26688495 DOI: 10.1016/j.jad.2015.11.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 415 |
Meduri M, Gregoraci G, Baglivo V, Balestrieri M, Isola M, Brambilla P. A meta-analysis of efficacy and safety of aripiprazole in adult and pediatric bipolar disorder in randomized controlled trials and observational studies. J Affect Disord 2016;191:187-208. [PMID: 26674213 DOI: 10.1016/j.jad.2015.11.033] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 416 |
Hayes JF, Marston L, Walters K, Geddes JR, King M, Osborn DP. Lithium vs. valproate vs. olanzapine vs. quetiapine as maintenance monotherapy for bipolar disorder: a population-based UK cohort study using electronic health records. World Psychiatry 2016;15:53-8. [PMID: 26833609 DOI: 10.1002/wps.20298] [Cited by in Crossref: 70] [Cited by in F6Publishing: 72] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 417 |
Valvassori SS, Dal-Pont GC, Steckert AV, Varela RB, Lopes-Borges J, Mariot E, Resende WR, Arent CO, Carvalho AF, Quevedo J. Sodium butyrate has an antimanic effect and protects the brain against oxidative stress in an animal model of mania induced by ouabain. Psychiatry Res 2016;235:154-9. [PMID: 26654753 DOI: 10.1016/j.psychres.2015.11.017] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 418 |
Medeiros GC, Senço SB, Lafer B, Almeida KM. Association between duration of untreated bipolar disorder and clinical outcome: data from a Brazilian sample. Braz J Psychiatry 2016;38:6-10. [PMID: 26785105 DOI: 10.1590/1516-4446-2015-1680] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 419 |
Prajapati AR, Wilson J, Maidment I. Efficacy and safety of second-generation antipsychotic long-acting injections (SGA LAIs) in maintenance treatment of bipolar disorder: protocol for a systematic review and meta-analysis. BMJ Open 2016;6:e010237. [DOI: 10.1136/bmjopen-2015-010237] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 420 |
Van Sant S. Psychopharmacological Treatment. Evidence-Based Practices in Behavioral Health 2016. [DOI: 10.1007/978-3-319-40537-7_7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 421 |
Datto C, Pottorf WJ, Feeley L, LaPorte S, Liss C. Bipolar II compared with bipolar I disorder: baseline characteristics and treatment response to quetiapine in a pooled analysis of five placebo-controlled clinical trials of acute bipolar depression. Ann Gen Psychiatry 2016;15:9. [PMID: 26973704 DOI: 10.1186/s12991-016-0096-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 422 |
Fabrazzo M, Tortorella A. Safety and Tolerability of Mood Stabilisers. Pharmacovigilance in Psychiatry 2016. [DOI: 10.1007/978-3-319-24741-0_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 423 |
Grunze H, Grunze A, Born C. Behandlung bipolarer Störungen. Polypharmazie in der Behandlung psychischer Erkrankungen 2016. [DOI: 10.1007/978-3-7091-1849-8_3] [Reference Citation Analysis]
|
| 424 |
Saito-tanji Y, Tsujimoto E, Taketani R, Yamamoto A, Ono H. Effectiveness of Simple Individual Psychoeducation for Bipolar II Disorder. Case Reports in Psychiatry 2016;2016:1-4. [DOI: 10.1155/2016/6062801] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 425 |
Bulteau S, Doligez N, Victorri-vigneau C, Laforgue E, Guitteny M, Sauvaget A, Vanelle J. Les antidépresseurs ont-ils encore un intérêt dans la dépression bipolaire ? Annales Médico-psychologiques, revue psychiatrique 2016;174:70-76. [DOI: 10.1016/j.amp.2015.12.010] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 426 |
Beyer JL, Krishnan KRR. Treatment of Bipolar Disorder in Special Populations. Bipolar Depression: Molecular Neurobiology, Clinical Diagnosis, and Pharmacotherapy 2016. [DOI: 10.1007/978-3-319-31689-5_13] [Reference Citation Analysis]
|
| 427 |
Dell'Osso L, Del Grande C, Gesi C, Carmassi C, Musetti L. A new look at an old drug: neuroprotective effects and therapeutic potentials of lithium salts. Neuropsychiatr Dis Treat 2016;12:1687-703. [PMID: 27468233 DOI: 10.2147/NDT.S106479] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 8.1] [Reference Citation Analysis]
|
| 428 |
Alosaimi FD, Alhabbad A, Abalhassan MF, Fallata EO, Alzain NM, Alassiry MZ, Haddad BA. Patterns of psychotropic medication use in inpatient and outpatient psychiatric settings in Saudi Arabia. Neuropsychiatr Dis Treat 2016;12:897-907. [PMID: 27143891 DOI: 10.2147/NDT.S100405] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 429 |
Song HR, Kwon YJ, Bahk WM, Woo YS, Lee HB, Lee J, Lee DB, Lee SY, Kim MD, Won S, Lee K, Sohn I, Lee JG, Shin YC, Chung S, Jang S, Jae YM, Yoon BH. Current prescription pattern of maintenance treatments for bipolar patients in Korea: A focus on the transition from acute treatments. Psychiatry Clin Neurosci 2016;70:42-50. [PMID: 26243698 DOI: 10.1111/pcn.12337] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 430 |
Molina JD, Durán M, López-muñoz F, Álamo C, Toledo-romero F. The Role of Antiepileptic Drugs in Bipolar Depression. Melatonin, Neuroprotective Agents and Antidepressant Therapy 2016. [DOI: 10.1007/978-81-322-2803-5_50] [Reference Citation Analysis]
|
| 431 |
Geddes JR, Gardiner A, Rendell J, Voysey M, Tunbridge E, Hinds C, Yu LM, Hainsworth J, Attenburrow MJ, Simon J, Goodwin GM, Harrison PJ; CEQUEL Investigators and Collaborators. Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial. Lancet Psychiatry 2016;3:31-9. [PMID: 26687300 DOI: 10.1016/S2215-0366(15)00450-2] [Cited by in Crossref: 73] [Cited by in F6Publishing: 50] [Article Influence: 10.4] [Reference Citation Analysis]
|
| 432 |
Maroney ME, Liu MT, Smith T, Thomas KL. Lithium. Side Effects of Drugs Annual 2016. [DOI: 10.1016/bs.seda.2016.07.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 433 |
Psychotic disorders in women. Comprehensive Women's Mental Health 2015. [DOI: 10.1017/cbo9781107045132.022] [Reference Citation Analysis]
|
| 434 |
Janicak PG, Cutler BR. Lithium Pharmacology. Encyclopedia of Inorganic and Bioinorganic Chemistry 2015. [DOI: 10.1002/9781119951438.eibc2346] [Reference Citation Analysis]
|
| 435 |
Heijnen WT, De Fruyt J, Wierdsma AI, Sienaert P, Birkenhäger TK. Efficacy of Tranylcypromine in Bipolar Depression: A Systematic Review. J Clin Psychopharmacol 2015;35:700-5. [PMID: 26479223 DOI: 10.1097/JCP.0000000000000409] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 436 |
Malhi GS, Bassett D, Boyce P, Bryant R, Fitzgerald PB, Fritz K, Hopwood M, Lyndon B, Mulder R, Murray G, Porter R, Singh AB. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry 2015;49:1087-206. [PMID: 26643054 DOI: 10.1177/0004867415617657] [Cited by in Crossref: 524] [Cited by in F6Publishing: 510] [Article Influence: 65.5] [Reference Citation Analysis]
|
| 437 |
Sharma V, Khan M, Sommerdyk C. Quetiapine in the Acute Treatment of Bipolar Postpartum Depression: A Chart Review. J Clin Psychopharmacol 2015;35:733-5. [PMID: 26444950 DOI: 10.1097/JCP.0000000000000415] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 438 |
Machado-Vieira R, Gattaz WF, Zanetti MV, De Sousa RT, Carvalho AF, Soeiro-de-Souza MG, Leite CC, Otaduy MC. A Longitudinal (6-week) 3T (1)H-MRS Study on the Effects of Lithium Treatment on Anterior Cingulate Cortex Metabolites in Bipolar Depression. Eur Neuropsychopharmacol 2015;25:2311-7. [PMID: 26428274 DOI: 10.1016/j.euroneuro.2015.08.023] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 439 |
Miller CJ, Li M, Penfold RB, Lee AF, Smith EG, Nordberg SS, Osser DN, Bajor L, Zhang F, Bauer MS. The Ascendancy of Second-Generation Antipsychotics as Frontline Antimanic Agents. J Clin Psychopharmacol 2015;35:645-53. [PMID: 26488678 DOI: 10.1097/JCP.0000000000000405] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 440 |
Vasudev K, Sharma P. Is Valproate Depressogenic in Patients Remitting from Acute Mania? Case Series. Case Rep Psychiatry 2015;2015:456830. [PMID: 26664794 DOI: 10.1155/2015/456830] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 441 |
Peng D, Jiang K. Comorbid bipolar disorder and obsessive-compulsive disorder. Shanghai Arch Psychiatry. 2015;27:246-248. [PMID: 26549961 DOI: 10.11919/j.issn.1002-0829.215009] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
|
| 442 |
Sajatovic M, Strejilevich SA, Gildengers AG, Dols A, Al Jurdi RK, Forester BP, Kessing LV, Beyer J, Manes F, Rej S, Rosa AR, Schouws SN, Tsai SY, Young RC, Shulman KI. A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force. Bipolar Disord 2015;17:689-704. [PMID: 26384588 DOI: 10.1111/bdi.12331] [Cited by in Crossref: 148] [Cited by in F6Publishing: 171] [Article Influence: 18.5] [Reference Citation Analysis]
|
| 443 |
Ahuja N, Cole A. Practical approach to management of catatonia. Future Neurology 2015;10:455-466. [DOI: 10.2217/fnl.15.39] [Reference Citation Analysis]
|
| 444 |
Schulz SC, Murray A, Silberschmidt A, Bond DJ. A Multidisciplinary First-Episode Psychosis Program. Psychiatric Annals 2015;45:561-8. [DOI: 10.3928/00485713-20151103-07] [Reference Citation Analysis]
|
| 445 |
Faurholt-Jepsen M, Ritz C, Frost M, Mikkelsen RL, Margrethe Christensen E, Bardram J, Vinberg M, Kessing LV. Mood instability in bipolar disorder type I versus type II-continuous daily electronic self-monitoring of illness activity using smartphones. J Affect Disord 2015;186:342-9. [PMID: 26277270 DOI: 10.1016/j.jad.2015.06.026] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 446 |
Ostinelli EG, Cavallotti S, Castelnovo A, Guanella E, Gambini O, D'Agostino A. Asenapine in the Treatment of Acute Mania: A Real-World Observational Study With 6 Months Follow-Up. J Clin Psychopharmacol 2015;35:553-8. [PMID: 26252438 DOI: 10.1097/JCP.0000000000000374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 447 |
Pichler EM, Hattwich G, Grunze H, Muehlbacher M. Safety and tolerability of anticonvulsant medication in bipolar disorder. Expert Opinion on Drug Safety 2015;14:1703-24. [DOI: 10.1517/14740338.2015.1088001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 448 |
Buoli M, Ciappolino V, Altamura AC. Paliperidone Palmitate Depot in the Long-term Treatment of Psychotic Bipolar Disorder: A Case Series. Clinical Neuropharmacology 2015;38:209-11. [DOI: 10.1097/wnf.0000000000000103] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 449 |
Vázquez GH, Holtzman JN, Tondo L, Baldessarini RJ. Efficacy and tolerability of treatments for bipolar depression. J Affect Disord 2015;183:258-62. [PMID: 26042634 DOI: 10.1016/j.jad.2015.05.016] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 450 |
Schaffer A, Isometsä ET, Tondo L, Moreno DH, Sinyor M, Kessing LV, Turecki G, Weizman A, Azorin JM, Ha K, Reis C, Cassidy F, Goldstein T, Rihmer Z, Beautrais A, Chou YH, Diazgranados N, Levitt AJ, Zarate CA Jr, Yatham L. Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder. Aust N Z J Psychiatry 2015;49:785-802. [PMID: 26185269 DOI: 10.1177/0004867415594427] [Cited by in Crossref: 88] [Cited by in F6Publishing: 111] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 451 |
Tada M, Uchida H, Mizushima J, Suzuki T, Mimura M, Nio S. Antidepressant dose and treatment response in bipolar depression: Reanalysis of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) data. J Psychiatr Res 2015;68:151-6. [PMID: 26228414 DOI: 10.1016/j.jpsychires.2015.06.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 452 |
Toffol E, Hätönen T, Tanskanen A, Lönnqvist J, Wahlbeck K, Joffe G, Tiihonen J, Haukka J, Partonen T. Lithium is associated with decrease in all-cause and suicide mortality in high-risk bipolar patients: A nationwide registry-based prospective cohort study. J Affect Disord 2015;183:159-65. [PMID: 26005778 DOI: 10.1016/j.jad.2015.04.055] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 453 |
Nicholas J, Larsen ME, Proudfoot J, Christensen H. Mobile Apps for Bipolar Disorder: A Systematic Review of Features and Content Quality. J Med Internet Res 2015;17:e198. [PMID: 26283290 DOI: 10.2196/jmir.4581] [Cited by in Crossref: 284] [Cited by in F6Publishing: 297] [Article Influence: 35.5] [Reference Citation Analysis]
|
| 454 |
Wang Z, Chen J, Zhang C, Gao K, Hong W, Xing M, Wu Z, Yuan C, Huang J, Peng D, Wang Y, Lu W, Yi Z, Yu X, Zhao J, Fang Y. Guidelines concordance of maintenance treatment in euthymic patients with bipolar disorder: Data from the national bipolar mania pathway survey (BIPAS) in mainland China. J Affect Disord 2015;182:101-5. [PMID: 25983305 DOI: 10.1016/j.jad.2015.04.028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 455 |
Chou YH, Chu PC, Wu SW, Lee JC, Lee YH, Sun IW, Chang CL, Huang CL, Liu IC, Tsai CF, Yen YC. A Systemic Review and Experts' Consensus for Long-acting Injectable Antipsychotics in Bipolar Disorder. Clin Psychopharmacol Neurosci 2015;13:121-8. [PMID: 26243837 DOI: 10.9758/cpn.2015.13.2.121] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 456 |
Valvassori SS, Tonin PT, Varela RB, Carvalho AF, Mariot E, Amboni RT, Bianchini G, Andersen ML, Quevedo J. Lithium modulates the production of peripheral and cerebral cytokines in an animal model of mania induced by dextroamphetamine. Bipolar Disord 2015;17:507-17. [PMID: 25929806 DOI: 10.1111/bdi.12299] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 457 |
Murru A, Popovic D, Pacchiarotti I, Hidalgo D, León-Caballero J, Vieta E. Management of adverse effects of mood stabilizers. Curr Psychiatry Rep 2015;17:603. [PMID: 26084665 DOI: 10.1007/s11920-015-0603-z] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 458 |
McCormick U, Murray B, McNew B. Diagnosis and treatment of patients with bipolar disorder: A review for advanced practice nurses. J Am Assoc Nurse Pract 2015;27:530-42. [PMID: 26172568 DOI: 10.1002/2327-6924.12275] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 459 |
Passos IC, Kapczinski NS, Quevedo J, Kauer-sant’anna M, Kapczinski F. Staging Models and Functional Outcomes in Bipolar Disorder: Clinical Implications. Curr Treat Options Psych 2015;2:205-17. [DOI: 10.1007/s40501-015-0046-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 460 |
van der Voort TY, van Meijel B, Hoogendoorn AW, Goossens PJ, Beekman AT, Kupka RW. Collaborative care for patients with bipolar disorder: Effects on functioning and quality of life. J Affect Disord 2015;179:14-22. [PMID: 25841077 DOI: 10.1016/j.jad.2015.03.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 461 |
Galling B, Garcia MA, Osuchukwu U, Hagi K, Correll CU. Safety and tolerability of antipsychotic-mood stabilizer co-treatment in the management of acute bipolar disorder: results from a systematic review and exploratory meta-analysis. Expert Opinion on Drug Safety 2015;14:1181-99. [DOI: 10.1517/14740338.2015.1053457] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 462 |
Alda M. Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics. Mol Psychiatry 2015;20:661-70. [PMID: 25687772 DOI: 10.1038/mp.2015.4] [Cited by in Crossref: 205] [Cited by in F6Publishing: 208] [Article Influence: 25.6] [Reference Citation Analysis]
|
| 463 |
Chakrabarty T, Kozicky JM, Torres IJ, Lam RW, Yatham LN. Verbal memory impairment in new onset bipolar disorder: Relationship with frontal and medial temporal morphology. World J Biol Psychiatry 2015;16:249-60. [PMID: 25708742 DOI: 10.3109/15622975.2014.1000373] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 464 |
Daggenvoorde T, Geerling B, Goossens PJ. A qualitative study of nursing care for hospitalized patients with acute mania. Arch Psychiatr Nurs 2015;29:186-91. [PMID: 26001719 DOI: 10.1016/j.apnu.2015.02.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 465 |
Luciano M, Del Vecchio V, Sampogna G, De Rosa C, Fiorillo A. Including family members in psychoeducation for bipolar disorder: is it worth it? Bipolar Disord 2015;17:458-9. [PMID: 25940653 DOI: 10.1111/bdi.12298] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 466 |
Lally J, MacCabe JH. Antipsychotic medication in schizophrenia: a review. Br Med Bull 2015;114:169-79. [PMID: 25957394 DOI: 10.1093/bmb/ldv017] [Cited by in Crossref: 277] [Cited by in F6Publishing: 263] [Article Influence: 34.6] [Reference Citation Analysis]
|
| 467 |
Forte A, Baldessarini RJ, Tondo L, Vázquez GH, Pompili M, Girardi P. Long-term morbidity in bipolar-I, bipolar-II, and unipolar major depressive disorders. J Affect Disord 2015;178:71-8. [PMID: 25797049 DOI: 10.1016/j.jad.2015.02.011] [Cited by in Crossref: 100] [Cited by in F6Publishing: 102] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 468 |
Eiring Ø, Nylenna M, Nytrøen K. Patient-Important Outcomes in the Long-Term Treatment of Bipolar Disorder: A Mixed-Methods Approach Investigating Relative Preferences and a Proposed Taxonomy. Patient 2016;9:91-102. [DOI: 10.1007/s40271-015-0128-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 469 |
Kelly T. An examination of myth: a favorable cardiovascular risk-benefit analysis of high-dose thyroid for affective disorders. J Affect Disord 2015;177:49-58. [PMID: 25745835 DOI: 10.1016/j.jad.2015.01.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 470 |
Vigod SN, Gomes T, Wilton AS, Taylor VH, Ray JG. Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study. BMJ 2015;350:h2298. [PMID: 25972273 DOI: 10.1136/bmj.h2298] [Cited by in Crossref: 95] [Cited by in F6Publishing: 95] [Article Influence: 11.9] [Reference Citation Analysis]
|
| 471 |
Rocha MV, Nery-Fernandes F, Guimarães JL, Quarantini Lde C, de Oliveira IR, Ladeia-Rocha GG, Jackowski AP, de Araujo Neto C, Miranda-Scippa Â. Normal Metabolic Levels in Prefrontal Cortex in Euthymic Bipolar I Patients with and without Suicide Attempts. Neural Plast 2015;2015:165180. [PMID: 26075096 DOI: 10.1155/2015/165180] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 472 |
Goi PD, Bücker J, Vianna-sulzbach M, Rosa AR, Grande I, Chendo I, Sodré LA, Kauer-sant'anna M, Silveira L, Kunz M, Ceresér KM, Gama CS, Massuda R. Pharmacological treatment and staging in bipolar disorder: evidence from clinical practice. Rev Bras Psiquiatr 2015;37:121-5. [DOI: 10.1590/1516-4446-2014-1554] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 473 |
Uchida H, Suzuki T. Cardiac Sudden Death in Psychiatric Patients. Can J Psychiatry 2015;60:203-5. [PMID: 26174522 DOI: 10.1177/070674371506000501] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 474 |
Gemmill AW, Milgrom J, Highet N. Conclusion. Identifying Perinatal Depression and Anxiety 2015. [DOI: 10.1002/9781118509722.ch16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 475 |
Razzouk D, Kayo M, Sousa A, Gregorio G, Cogo-Moreira H, Cardoso AA, Mari Jde J. The impact of antipsychotic polytherapy costs in the public health care in Sao Paulo, Brazil. PLoS One 2015;10:e0124791. [PMID: 25853709 DOI: 10.1371/journal.pone.0124791] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 476 |
Gignac A, McGirr A, Lam RW, Yatham LN. Course and outcome following a first episode of mania: four-year prospective data from the Systematic Treatment Optimization Program (STOP-EM). J Affect Disord 2015;175:411-7. [PMID: 25678174 DOI: 10.1016/j.jad.2015.01.032] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 477 |
Delattre IK, Van de Walle P, Van Campenhout C, Neels H, Verstraete AG, Wallemacq P. How appropriate is therapeutic drug monitoring for lithium? Data from the Belgian external quality assessment scheme. Clin Biochem 2015;48:617-21. [PMID: 25818475 DOI: 10.1016/j.clinbiochem.2015.03.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 478 |
Pereira Junior Bde S, Tortella G, Lafer B, Nunes P, Benseñor IM, Lotufo PA, Machado-Vieira R, Brunoni AR. The bipolar depression electrical treatment trial (BETTER): design, rationale, and objectives of a randomized, sham-controlled trial and data from the pilot study phase. Neural Plast 2015;2015:684025. [PMID: 25878904 DOI: 10.1155/2015/684025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 479 |
Li H, Hong W, Zhang C, Wu Z, Wang Z, Yuan C, Li Z, Huang J, Lin Z, Fang Y. IL-23 and TGF-β1 levels as potential predictive biomarkers in treatment of bipolar I disorder with acute manic episode. J Affect Disord 2015;174:361-6. [PMID: 25545602 DOI: 10.1016/j.jad.2014.12.033] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 480 |
Inoue T, Inagaki Y, Kimura T, Shirakawa O. Prevalence and predictors of bipolar disorders in patients with a major depressive episode: the Japanese epidemiological trial with latest measure of bipolar disorder (JET-LMBP). J Affect Disord 2015;174:535-41. [PMID: 25556671 DOI: 10.1016/j.jad.2014.12.023] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 481 |
Kittel-Schneider S, Wobrock T, Scherk H, Schneider-Axmann T, Trost S, Zilles D, Wolf C, Schmitt A, Malchow B, Hasan A, Backens M, Reith W, Falkai P, Gruber O, Reif A. Influence of DGKH variants on amygdala volume in patients with bipolar affective disorder and schizophrenia. Eur Arch Psychiatry Clin Neurosci 2015;265:127-36. [PMID: 24958494 DOI: 10.1007/s00406-014-0513-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 482 |
Sanford M, Dhillon S. Lurasidone: a review of its use in adult patients with bipolar I depression. CNS Drugs 2015;29:253-63. [PMID: 25698146 DOI: 10.1007/s40263-015-0234-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 483 |
Karthick S, Kattimani S, Rajkumar RP, Bharadwaj B, Sarkar S. Long term course of bipolar I disorder in India: Using retrospective life chart method. Journal of Affective Disorders 2015;173:255-260. [DOI: 10.1016/j.jad.2014.10.056] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 484 |
Mcdonald KC, Bulloch AG, Duffy A, Bresee L, Williams JV, Lavorato DH, Patten SB. Prevalence of Bipolar I and II Disorder in Canada. Can J Psychiatry 2015;60:151-6. [PMID: 25886691 DOI: 10.1177/070674371506000310] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 485 |
Parikh SV, Hawke LD, Velyvis V, Zaretsky A, Beaulieu S, Patelis-Siotis I, MacQueen G, Young LT, Yatham LN, Cervantes P. Combined treatment: impact of optimal psychotherapy and medication in bipolar disorder. Bipolar Disord 2015;17:86-96. [PMID: 25046246 DOI: 10.1111/bdi.12233] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 486 |
Muralidharan K, Kozicky JM, Bücker J, Silveira LE, Torres IJ, Yatham LN. Are cognitive deficits similar in remitted early bipolar I disorder patients treated with lithium or valproate? Data from the STOP-EM study. Eur Neuropsychopharmacol 2015;25:223-30. [PMID: 25261261 DOI: 10.1016/j.euroneuro.2014.09.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 487 |
Carlborg A, Thuresson M, Ferntoft L, Bodegard J. Characteristics of bipolar disorder patients treated with immediate- and extended-release quetiapine in a real clinical setting: a longitudinal, cohort study of 1761 patients. Ther Adv Psychopharmacol 2015;5:13-21. [PMID: 25653826 DOI: 10.1177/2045125314560740] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 488 |
Nolen WA. More robust evidence for the efficacy of lithium in the long-term treatment of bipolar disorder: should lithium (again) be recommended as the single preferred first-line treatment? Int J Bipolar Disord 2015;3:1. [PMID: 25642404 DOI: 10.1186/s40345-014-0017-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 489 |
Carvalho AF, Quevedo J, McIntyre RS, Soeiro-de-Souza MG, Fountoulakis KN, Berk M, Hyphantis TN, Vieta E. Treatment implications of predominant polarity and the polarity index: a comprehensive review. Int J Neuropsychopharmacol 2014;18:pyu079. [PMID: 25522415 DOI: 10.1093/ijnp/pyu079] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 490 |
Soeiro-DE-Souza MG, Dias VV, Missio G, Balanzá-Martinez V, Valiengo L, Carvalho AF, Moreno RA. Role of quetiapine beyond its clinical efficacy in bipolar disorder: From neuroprotection to the treatment of psychiatric disorders (Review). Exp Ther Med 2015;9:643-52. [PMID: 25667608 DOI: 10.3892/etm.2015.2213] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 491 |
Jeong JH, Lee JG, Kim MD, Sohn I, Shim SH, Wang HR, Woo YS, Jon DI, Seo JS, Shin YC, Min KJ, Yoon BH, Bahk WM. Korean Medication Algorithm for Bipolar Disorder 2014: comparisons with other treatment guidelines. Neuropsychiatr Dis Treat 2015;11:1561-71. [PMID: 26170669 DOI: 10.2147/NDT.S86552] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 492 |
Malempati RN. Aripiprazole adjunct treatment in bipolar I or II disorder, depressed state: a 2-year clinical study. J Nerv Ment Dis 2015;203:58-64. [PMID: 25536100 DOI: 10.1097/NMD.0000000000000234] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 493 |
Di Sciascio G, Riva MA. Aripiprazole: from pharmacological profile to clinical use. Neuropsychiatr Dis Treat 2015;11:2635-47. [PMID: 26508859 DOI: 10.2147/NDT.S88117] [Cited by in Crossref: 13] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 494 |
Teixeira AL, de Sousa RT, Zanetti MV, Brunoni AR, Busatto GF, Zarate CA Jr, Gattaz WF, Machado-Vieira R. Increased plasma levels of soluble TNF receptors 1 and 2 in bipolar depression and impact of lithium treatment. Hum Psychopharmacol 2015;30:52-6. [PMID: 25572309 DOI: 10.1002/hup.2450] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 495 |
Kato M, Kimura T, Kimura T, Hara T. Safety and effectiveness of controlled-release paroxetine in routine clinical practice: results of a postmarketing surveillance study of patients with depression. Neuropsychiatr Dis Treat 2015;11:435-52. [PMID: 25759586 DOI: 10.2147/NDT.S77542] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 496 |
Albert U, De Cori D, Aguglia A, Barbaro F, Lanfranco F, Bogetto F, Maina G. Effects of maintenance lithium treatment on serum parathyroid hormone and calcium levels: a retrospective longitudinal naturalistic study. Neuropsychiatr Dis Treat 2015;11:1785-91. [PMID: 26229473 DOI: 10.2147/NDT.S86103] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 497 |
Attenburrow MJ, Smith K. Valproate? Lithium comes first. BJPsych advances 2015;21:3-4. [DOI: 10.1192/apt.21.1.3] [Reference Citation Analysis]
|
| 498 |
Scheidemantel T, Korobkova I, Rej S, Sajatovic M. Asenapine for bipolar disorder. Neuropsychiatr Dis Treat 2015;11:3007-17. [PMID: 26674884 DOI: 10.2147/NDT.S78043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 499 |
Fountoulakis KN. Treatment Guidelines. Bipolar Disorder 2015. [DOI: 10.1007/978-3-642-37216-2_18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 500 |
Bauer M, Severus E, Laux G. Bipolare affektive Störungen. Psychiatrie, Psychosomatik, Psychotherapie 2015. [DOI: 10.1007/978-3-642-45028-0_68-1] [Reference Citation Analysis]
|
| 501 |
Dell'Osso B, Albert U, Atti AR, Carmassi C, Carrà G, Cosci F, Del Vecchio V, Di Nicola M, Ferrari S, Goracci A, Iasevoli F, Luciano M, Martinotti G, Nanni MG, Nivoli A, Pinna F, Poloni N, Pompili M, Sampogna G, Tarricone I, Tosato S, Volpe U, Fiorillo A. Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice. Neuropsychiatr Dis Treat 2015;11:1885-909. [PMID: 26257524 DOI: 10.2147/NDT.S83130] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 502 |
Squassina A, Manchia M, Mitropoulou C, Patrinos GP. An Introduction to Pharmacogenomics and Personalized Medicine. PanVascular Medicine 2015. [DOI: 10.1007/978-3-642-37078-6_226] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 503 |
Woo YS, Lee JG, Jeong JH, Kim MD, Sohn I, Shim SH, Jon DI, Seo JS, Shin YC, Min KJ, Yoon BH, Bahk WM. Korean Medication Algorithm Project for Bipolar Disorder: third revision. Neuropsychiatr Dis Treat 2015;11:493-506. [PMID: 25750530 DOI: 10.2147/NDT.S77838] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 504 |
Wang Z, Li Z, Gao K, Fang Y. Association between brain-derived neurotrophic factor genetic polymorphism Val66Met and susceptibility to bipolar disorder: a meta-analysis. BMC Psychiatry 2014;14:366. [PMID: 25539739 DOI: 10.1186/s12888-014-0366-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 505 |
Epstein RA, Moore KM, Bobo WV. Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges. Drug Healthc Patient Saf 2015;7:7-29. [PMID: 25565896 DOI: 10.2147/DHPS.S50556] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 506 |
Rej S, Elie D, Mucsi I, Looper KJ, Segal M. Chronic Kidney Disease in Lithium-Treated Older Adults: A Review of Epidemiology, Mechanisms, and Implications for the Treatment of Late-Life Mood Disorders. Drugs Aging 2015;32:31-42. [DOI: 10.1007/s40266-014-0234-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 507 |
Carvalho AF, Berk M, Hyphantis TN, McIntyre RS. The integrative management of treatment-resistant depression: a comprehensive review and perspectives. Psychother Psychosom 2014;83:70-88. [PMID: 24458008 DOI: 10.1159/000357500] [Cited by in Crossref: 72] [Cited by in F6Publishing: 74] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 508 |
Silveira LE, Kozicky JM, Muralidharan K, Bücker J, Torres IJ, Bond DJ, Kapczinski F, Kauer-Sant'Anna M, Lam RW, Yatham LN. Neurocognitive functioning in overweight and obese patients with bipolar disorder: data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). Can J Psychiatry 2014;59:639-48. [PMID: 25702364 DOI: 10.1177/070674371405901205] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 509 |
Kemp DE. Managing the side effects associated with commonly used treatments for bipolar depression. J Affect Disord 2014;169 Suppl 1:S34-44. [PMID: 25533913 DOI: 10.1016/S0165-0327(14)70007-2] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 510 |
Hirschfeld RM. Differential diagnosis of bipolar disorder and major depressive disorder. J Affect Disord 2014;169 Suppl 1:S12-6. [PMID: 25533909 DOI: 10.1016/S0165-0327(14)70004-7] [Cited by in Crossref: 114] [Cited by in F6Publishing: 116] [Article Influence: 12.7] [Reference Citation Analysis]
|
| 511 |
Miller CJ, Li M, Penfold RB, Lee AF, Smith EG, Osser DN, Bajor L, Bauer MS. Patterns of initiation of second generation antipsychotics for bipolar disorder: a month-by-month analysis of provider behavior. BMC Psychiatry 2014;14:339. [PMID: 25433807 DOI: 10.1186/s12888-014-0339-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 512 |
Volkert J, Zierhut KC, Schiele MA, Wenzel M, Kopf J, Kittel-Schneider S, Reif A. Predominant polarity in bipolar disorder and validation of the polarity index in a German sample. BMC Psychiatry 2014;14:322. [PMID: 25412678 DOI: 10.1186/s12888-014-0322-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 513 |
Park KJ, Shon S, Lee H, Joo Y, Youngstrom EA, Kim H. Antidepressant-Emergent Mood Switch in Korean Adolescents With Mood Disorder. Clinical Neuropharmacology 2014;37:177-85. [DOI: 10.1097/wnf.0000000000000055] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 514 |
Kutzelnigg A, Kopeinig M, Chen CK, Fábián A, Pujol-Luna MG, Shin YC, Treuer T, D'yachkova Y, Deix C, Kasper S, Doby D. Compliance as a stable function in the treatment course of bipolar disorder in patients stabilized on olanzapine: results from a 24-month observational study. Int J Bipolar Disord 2014;2:13. [PMID: 25360398 DOI: 10.1186/s40345-014-0013-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 515 |
Rej S, Beaulieu S, Segal M, Low NCP, Mucsi I, Holcroft C, Shulman K, Looper KJ. Lithium Dosing and Serum Concentrations Across the Age Spectrum: From Early Adulthood to the Tenth Decade of Life. Drugs Aging 2014;31:911-6. [DOI: 10.1007/s40266-014-0221-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 516 |
McInerney SJ, Kennedy SH. Review of evidence for use of antidepressants in bipolar depression. Prim Care Companion CNS Disord 2014;16. [PMID: 25667812 DOI: 10.4088/PCC.14r01653] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 517 |
Degli Esposti L, Sangiorgi D, Mencacci C, Spina E, Pasina C, Alacqua M, la Tour F. Pharmaco-utilisation and related costs of drugs used to treat schizophrenia and bipolar disorder in Italy: the IBIS study. BMC Psychiatry 2014;14:282. [PMID: 25312446 DOI: 10.1186/s12888-014-0282-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 518 |
Vetter J, Bohleber L, Böker H. Psycho- und soziotherapeutische Interventionen bei bipolaren affektiven Störungen: Review. Zeitschrift für Psychiatrie, Psychologie und Psychotherapie 2014;62:265-272. [DOI: 10.1024/1661-4747/a000206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 519 |
Swann AC. Non-pharmacological and pharmacological treatments act on the same brain. World Psychiatry 2014;13:262-4. [PMID: 25273299 DOI: 10.1002/wps.20166] [Reference Citation Analysis]
|
| 520 |
Mackala SA, Torres IJ, Kozicky J, Michalak EE, Yatham LN. Cognitive performance and quality of life early in the course of bipolar disorder. J Affect Disord 2014;168:119-24. [PMID: 25043323 DOI: 10.1016/j.jad.2014.06.045] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 521 |
Buoli M, Caldiroli A, Caletti E, Zugno E, Altamura AC. The impact of mood episodes and duration of illness on cognition in bipolar disorder. Compr Psychiatry 2014;55:1561-6. [PMID: 25011691 DOI: 10.1016/j.comppsych.2014.06.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 522 |
Miura T, Noma H, Furukawa TA, Mitsuyasu H, Tanaka S, Stockton S, Salanti G, Motomura K, Shimano-Katsuki S, Leucht S, Cipriani A, Geddes JR, Kanba S. Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis. Lancet Psychiatry 2014;1:351-9. [PMID: 26360999 DOI: 10.1016/S2215-0366(14)70314-1] [Cited by in Crossref: 234] [Cited by in F6Publishing: 180] [Article Influence: 26.0] [Reference Citation Analysis]
|
| 523 |
Schuepbach D, Seifritz E. Pharmakotherapie der bipolaren Störungen und der Manie. Zeitschrift für Psychiatrie, Psychologie und Psychotherapie 2014;62:243-254. [DOI: 10.1024/1661-4747/a000204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 524 |
Barbero JD, Garcia-Parés G, Llorens M, Tost M, Cobo J, Palao D, Labad J. Thyroglobulin antibodies and risk of readmission at one year in subjects with bipolar disorder. Psychiatry Res 2014;219:109-13. [PMID: 24913831 DOI: 10.1016/j.psychres.2014.05.028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 525 |
Zhang Y, Yang H, Yang S, Liang W, Dai P, Wang C, Zhang Y. Antidepressants for bipolar disorder: A meta-analysis of randomized, double-blind, controlled trials. Neural Regen Res 2013;8:2962-74. [PMID: 25206617 DOI: 10.3969/j.issn.1673-5374.2013.31.009] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
|
| 526 |
Barbosa IG, Bauer ME, Machado-Vieira R, Teixeira AL. Cytokines in bipolar disorder: paving the way for neuroprogression. Neural Plast 2014;2014:360481. [PMID: 25313338 DOI: 10.1155/2014/360481] [Cited by in Crossref: 101] [Cited by in F6Publishing: 104] [Article Influence: 11.2] [Reference Citation Analysis]
|
| 527 |
Janney CA, Bauer MS, Kilbourne AM. Self-management and bipolar disorder--a clinician's guide to the literature 2011-2014. Curr Psychiatry Rep 2014;16:485. [PMID: 25123130 DOI: 10.1007/s11920-014-0485-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 528 |
Mohammad O, Osser DN. The psychopharmacology algorithm project at the Harvard South Shore Program: an algorithm for acute mania. Harv Rev Psychiatry 2014;22:274-94. [PMID: 25188733 DOI: 10.1097/HRP.0000000000000018] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 529 |
Kim SW, Berk L, Kulkarni J, Dodd S, de Castella A, Fitzgerald PB, Amminger GP, Berk M. Impact of comorbid anxiety disorders and obsessive-compulsive disorder on 24-month clinical outcomes of bipolar I disorder. J Affect Disord 2014;166:243-8. [PMID: 25012437 DOI: 10.1016/j.jad.2014.05.017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 530 |
Kelly T. A favorable risk-benefit analysis of high dose thyroid for treatment of bipolar disorders with regard to osteoporosis. J Affect Disord 2014;166:353-8. [PMID: 24981132 DOI: 10.1016/j.jad.2014.04.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 531 |
Kessing LV, Vradi E, Andersen PK. Starting lithium prophylaxis early v. late in bipolar disorder. Br J Psychiatry 2014;205:214-20. [PMID: 25012681 DOI: 10.1192/bjp.bp.113.142802] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 532 |
Curran G, Ravindran A. Lithium for bipolar disorder: a review of the recent literature. Expert Review of Neurotherapeutics 2014;14:1079-98. [DOI: 10.1586/14737175.2014.947965] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 533 |
Samalin L, Tremey A, Llorca P. Quetiapine extended release for the treatment of bipolar disorder. Expert Review of Neurotherapeutics 2014;14:987-1005. [DOI: 10.1586/14737175.2014.946407] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 534 |
Dell'Osso B, Cremaschi L, Palazzo MC, Spagnolin G, Cattaneo A, Grancini B, Maggi M, Altamura AC. Use of asenapine as add-on therapy in the treatment of bipolar disorder: a comprehensive review and case series. Expert Opin Drug Saf 2014;13:1199-208. [PMID: 25084462 DOI: 10.1517/14740338.2014.938047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 535 |
Vázquez GH. The impact of psychopharmacology on contemporary clinical psychiatry. Can J Psychiatry 2014;59:412-6. [PMID: 25161065 DOI: 10.1177/070674371405900803] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 536 |
Wang JL, Shamah SM, Sun AX, Waldman ID, Haggarty SJ, Perlis RH. Label-free, live optical imaging of reprogrammed bipolar disorder patient-derived cells reveals a functional correlate of lithium responsiveness. Transl Psychiatry 2014;4:e428. [PMID: 25158003 DOI: 10.1038/tp.2014.72] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 537 |
Machado-Vieira R, Zanetti MV, DE Sousa RT, Soeiro-DE-Souza MG, Moreno RA, Busatto GF, Gattaz WF. Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study. Exp Ther Med 2014;8:1205-8. [PMID: 25187825 DOI: 10.3892/etm.2014.1864] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 538 |
de Sousa RT, Machado-Vieira R, Zarate CA Jr, Manji HK. Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder. Expert Opin Ther Targets 2014;18:1131-47. [PMID: 25056514 DOI: 10.1517/14728222.2014.940893] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 539 |
Bond DJ, Ha TH, Lang DJ, Su W, Torres IJ, Honer WG, Lam RW, Yatham LN. Body mass index-related regional gray and white matter volume reductions in first-episode mania patients. Biol Psychiatry 2014;76:138-45. [PMID: 24120119 DOI: 10.1016/j.biopsych.2013.08.030] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 540 |
Wang M, Tong JH, Huang DS, Zhu G, Liang GM, Du H. Efficacy of olanzapine monotherapy for treatment of bipolar I depression: a randomized, double-blind, placebo controlled study. Psychopharmacology (Berl) 2014;231:2811-8. [PMID: 24481570 DOI: 10.1007/s00213-014-3453-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 541 |
Soeiro-de-Souza MG, Teixeira AL, Mateo EC, Zanetti MV, Rodrigues FG, de Paula VJ, Bezerra JF, Moreno RA, Gattaz WF, Machado-Vieira R. Leukocyte telomerase activity and antidepressant efficacy in bipolar disorder. Eur Neuropsychopharmacol 2014;24:1139-43. [PMID: 24731723 DOI: 10.1016/j.euroneuro.2014.03.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 542 |
Grunze H, Azorin JM. Clinical decision making in the treatment of mixed states. World J Biol Psychiatry 2014;15:355-68. [PMID: 24824425 DOI: 10.3109/15622975.2014.908238] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 543 |
Rej S, AlAqeel B, Segal M, Low NC, Mucsi I, Holcroft C, Looper K. Is environmental temperature related to renal symptoms, serum lithium levels, and other laboratory test results in current lithium users? Hum Psychopharmacol 2014;29:392-6. [PMID: 25163443 DOI: 10.1002/hup.2413] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 544 |
Faria AD, de Mattos Souza LD, de Azevedo Cardoso T, Pinheiro KA, Pinheiro RT, da Silva RA, Jansen K. The influence of psychoeducation on regulating biological rhythm in a sample of patients with bipolar II disorder: a randomized clinical trial. Psychol Res Behav Manag 2014;7:167-74. [PMID: 25061340 DOI: 10.2147/PRBM.S52352] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 545 |
Suttajit S, Srisurapanont M, Maneeton N, Maneeton B. Quetiapine for acute bipolar depression: a systematic review and meta-analysis. Drug Des Devel Ther 2014;8:827-38. [PMID: 25028535 DOI: 10.2147/DDDT.S63779] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 546 |
Wang Z, Gao K, Hong W, Xing M, Wu Z, Chen J, Zhang C, Yuan C, Huang J, Peng D, Wang Y, Lu W, Yi Z, Yu X, Zhao J, Fang Y. Pharmacotherapy for acute mania and disconcordance with treatment guidelines: bipolar mania pathway survey (BIPAS) in mainland China. BMC Psychiatry 2014;14:167. [PMID: 24903426 DOI: 10.1186/1471-244X-14-167] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 547 |
Romo-Nava F, Alvarez-Icaza González D, Fresán-Orellana A, Saracco Alvarez R, Becerra-Palars C, Moreno J, Ontiveros Uribe MP, Berlanga C, Heinze G, Buijs RM. Melatonin attenuates antipsychotic metabolic effects: an eight-week randomized, double-blind, parallel-group, placebo-controlled clinical trial. Bipolar Disord 2014;16:410-21. [PMID: 24636483 DOI: 10.1111/bdi.12196] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 548 |
Grande I, Magalhães PV, Chendo I, Stertz L, Panizutti B, Colpo GD, Rosa AR, Gama CS, Kapczinski F, Vieta E. Staging bipolar disorder: clinical, biochemical, and functional correlates. Acta Psychiatr Scand 2014;129:437-44. [PMID: 24628576 DOI: 10.1111/acps.12268] [Cited by in Crossref: 81] [Cited by in F6Publishing: 79] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 549 |
Rej S, Segal M, Low NC, Mucsi I, Holcroft C, Shulman K, Looper K. The McGill Geriatric Lithium-Induced Diabetes Insipidus Clinical Study (McGLIDICS). Can J Psychiatry 2014;59:327-34. [PMID: 25007407 DOI: 10.1177/070674371405900606] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 550 |
Coplan JD, Gopinath S, Abdallah CG, Berry BR. A neurobiological hypothesis of treatment-resistant depression - mechanisms for selective serotonin reuptake inhibitor non-efficacy. Front Behav Neurosci. 2014;8:189. [PMID: 24904340 DOI: 10.3389/fnbeh.2014.00189] [Cited by in Crossref: 47] [Cited by in F6Publishing: 57] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 551 |
Pan PY, Lee MS, Lo MC, Yang EL, Yeh CB. Olanzapine is superior to lamotrigine in the prevention of bipolar depression: a naturalistic observational study. BMC Psychiatry 2014;14:145. [PMID: 24885966 DOI: 10.1186/1471-244X-14-145] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 552 |
Rakofsky JJ, Dunlop BW. Review of nutritional supplements for the treatment of bipolar depression. Depress Anxiety 2014;31:379-90. [PMID: 24353094 DOI: 10.1002/da.22220] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 553 |
Samalin L, Llorca P. Avis critique sur la place du lithium dans les recommandations professionnelles sur la prise en charge du trouble bipolaire. Annales Médico-psychologiques, revue psychiatrique 2014;172:177-181. [DOI: 10.1016/j.amp.2014.02.007] [Reference Citation Analysis]
|
| 554 |
Álamo C, López-muñoz F, García-garcía P. The effectiveness of lurasidone as an adjunct to lithium or divalproex in the treatment of bipolar disorder. Expert Review of Neurotherapeutics 2014;14:593-605. [DOI: 10.1586/14737175.2014.915741] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 555 |
Wang Z, Gao K, Hong W, Xing M, Wu Z, Chen J, Zhang C, Yuan C, Huang J, Peng D, Wang Y, Lu W, Yi Z, Yu X, Zhao J, Fang Y. Guidelines disconcordance in acute bipolar depression: data from the national Bipolar Mania Pathway Survey (BIPAS) in mainland China. PLoS One 2014;9:e96096. [PMID: 24763748 DOI: 10.1371/journal.pone.0096096] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 556 |
Soeiro-de-souza MG, Gold PW, Brunoni AR, de Sousa RT, Zanetti MV, Carvalho AF, Gattaz WF, Machado-vieira R, Teixeira AL. Lithium Decreases Plasma Adiponectin Levels in Bipolar Depression. Neuroscience Letters 2014;564:111-4. [DOI: 10.1016/j.neulet.2014.02.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 557 |
Vázquez GH, Baldessarini RJ, Tondo L. Co-occurrence of anxiety and bipolar disorders: clinical and therapeutic overview. Depress Anxiety 2014;31:196-206. [PMID: 24610817 DOI: 10.1002/da.22248] [Cited by in Crossref: 62] [Cited by in F6Publishing: 68] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 558 |
de Sousa RT, Zarate CA Jr, Zanetti MV, Costa AC, Talib LL, Gattaz WF, Machado-Vieira R. Oxidative stress in early stage Bipolar Disorder and the association with response to lithium. J Psychiatr Res 2014;50:36-41. [PMID: 24332923 DOI: 10.1016/j.jpsychires.2013.11.011] [Cited by in Crossref: 114] [Cited by in F6Publishing: 113] [Article Influence: 12.7] [Reference Citation Analysis]
|
| 559 |
Marlinge E, Bellivier F, Houenou J. White matter alterations in bipolar disorder: potential for drug discovery and development. Bipolar Disord 2014;16:97-112. [PMID: 24571279 DOI: 10.1111/bdi.12135] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 560 |
Severino G, Squassina A, Costa M, Pisanu C, Calza S, Alda M, Del Zompo M, Manchia M. Pharmacogenomics of bipolar disorder. Pharmacogenomics 2013;14:655-74. [PMID: 23570469 DOI: 10.2217/pgs.13.51] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 561 |
Tondo L, Vázquez GH, Baldessarini RJ. Options for pharmacological treatment of refractory bipolar depression. Curr Psychiatry Rep 2014;16:431. [PMID: 24425269 DOI: 10.1007/s11920-013-0431-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 562 |
Bücker J, Popuri S, Muralidharan K, Kozicky JM, Baitz HA, Honer WG, Torres IJ, Yatham LN. Sex differences in cognitive functioning in patients with bipolar disorder who recently recovered from a first episode of mania: data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). J Affect Disord 2014;155:162-8. [PMID: 24238868 DOI: 10.1016/j.jad.2013.10.044] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 563 |
Keedwell PA, Young AH. Emerging drugs for bipolar depression: an update. Expert Opinion on Emerging Drugs 2013;19:25-36. [DOI: 10.1517/14728214.2014.872628] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 564 |
de Sousa RT, Uno M, Zanetti MV, Shinjo SM, Busatto GF, Gattaz WF, Marie SK, Machado-Vieira R. Leukocyte mitochondrial DNA copy number in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2014;48:32-5. [PMID: 24036318 DOI: 10.1016/j.pnpbp.2013.09.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 565 |
Bayes A, Parker G, Fletcher K. Clinical differentiation of bipolar II disorder from borderline personality disorder. Curr Opin Psychiatry 2014;27:14-20. [PMID: 24270482 DOI: 10.1097/YCO.0000000000000021] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 566 |
Swartz HA, Swanson J. Psychotherapy for Bipolar Disorder in Adults: A Review of the Evidence. Focus (Am Psychiatr Publ). 2014;12:251-266. [PMID: 26279641 DOI: 10.1176/appi.focus.12.3.251] [Cited by in Crossref: 22] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 567 |
Sayyaparaju KK, Grunze H, Fountoulakis KN. When to start aripiprazole therapy in patients with bipolar mania. Neuropsychiatr Dis Treat 2014;10:459-70. [PMID: 24648740 DOI: 10.2147/NDT.S40066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 568 |
Hertz DL, Ellingrod VL, Mcinnis MG. Bipolar Disorder in the Cancer Patient. Psychopharmacology in Oncology and Palliative Care 2014. [DOI: 10.1007/978-3-642-40134-3_11] [Reference Citation Analysis]
|
| 569 |
El-mallakh RS. Lithium. Side Effects of Drugs Annual 2014. [DOI: 10.1016/b978-0-444-63407-8.00003-4] [Reference Citation Analysis]
|
| 570 |
Bourin M, Thibaut F. Can Antipsychotic Agents be Considered as Real Antimanic Treatments? Front Psychiatry 2014;5:60. [PMID: 24904443 DOI: 10.3389/fpsyt.2014.00060] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 571 |
Squassina A, Manchia M, Mitropoulou C, Patrinos GP. Pharmacogenomics and Personalized Medicine: Bridging Genetic Knowledge and Clinical Practice. PanVascular Medicine 2014. [DOI: 10.1007/978-3-642-37393-0_226-1] [Reference Citation Analysis]
|
| 572 |
Llorca PM, Abbar M, Courtet P, Guillaume S, Lancrenon S, Samalin L. Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness. BMC Psychiatry 2013;13:340. [PMID: 24359031 DOI: 10.1186/1471-244X-13-340] [Cited by in Crossref: 108] [Cited by in F6Publishing: 121] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 573 |
Azorin J, Belzeaux R, Cermolacce M, Kaladjian A, Corréard N, Dassa D, Dubois M, Maurel M, Micoulaud Franchi J, Pringuey D, Fakra E. Recommandations sur le traitement des épisodes mixtes dans les guidelines actuels. L'Encéphale 2013;39:185-7. [DOI: 10.1016/s0013-7006(13)70120-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 574 |
Kim SH, Yu HS, Park HG, Ahn YM, Kim YS, Lee YH, Ha K, Shin SY. Egr1 regulates lithium-induced transcription of the Period 2 (PER2) gene. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2013;1832:1969-79. [DOI: 10.1016/j.bbadis.2013.06.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 575 |
Pope CJ, Sharma V, Mazmanian D. Recognition, diagnosis and treatment of postpartum bipolar depression. Expert Review of Neurotherapeutics 2014;14:19-28. [DOI: 10.1586/14737175.2014.846219] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 576 |
Albert U, De Cori D, Aguglia A, Barbaro F, Lanfranco F, Bogetto F, Maina G. Lithium-associated hyperparathyroidism and hypercalcaemia: a case-control cross-sectional study. J Affect Disord 2013;151:786-90. [PMID: 23870428 DOI: 10.1016/j.jad.2013.06.046] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 577 |
Sharma V. Mixed depression in the postpartum period: diagnostic and treatment issues. J Psychiatry Neurosci 2013;38:E30-1. [PMID: 24148848 DOI: 10.1503/jpn.130150] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 578 |
Köster M, Grohmann R, Engel RR, Nitsche MA, Rüther E, Degner D. Seizures during antidepressant treatment in psychiatric inpatients--results from the transnational pharmacovigilance project "Arzneimittelsicherheit in der Psychiatrie" (AMSP) 1993-2008. Psychopharmacology (Berl) 2013;230:191-201. [PMID: 24068157 DOI: 10.1007/s00213-013-3281-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 579 |
Ehret MJ, Baker W, O'Neill H. BDNF Val66Met polymorphism and lithium response: a meta-analysis. Per Med 2013;10:777-84. [PMID: 29776284 DOI: 10.2217/pme.13.74] [Reference Citation Analysis]
|
| 580 |
Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, Post RM, Berk M, Goodwin GM, Sachs GS, Tondo L, Findling RL, Youngstrom EA, Tohen M, Undurraga J, González-Pinto A, Goldberg JF, Yildiz A, Altshuler LL, Calabrese JR, Mitchell PB, Thase ME, Koukopoulos A, Colom F, Frye MA, Malhi GS, Fountoulakis KN, Vázquez G, Perlis RH, Ketter TA, Cassidy F, Akiskal H, Azorin JM, Valentí M, Mazzei DH, Lafer B, Kato T, Mazzarini L, Martínez-Aran A, Parker G, Souery D, Ozerdem A, McElroy SL, Girardi P, Bauer M, Yatham LN, Zarate CA, Nierenberg AA, Birmaher B, Kanba S, El-Mallakh RS, Serretti A, Rihmer Z, Young AH, Kotzalidis GD, MacQueen GM, Bowden CL, Ghaemi SN, Lopez-Jaramillo C, Rybakowski J, Ha K, Perugi G, Kasper S, Amsterdam JD, Hirschfeld RM, Kapczinski F, Vieta E. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry 2013;170:1249-62. [PMID: 24030475 DOI: 10.1176/appi.ajp.2013.13020185] [Cited by in Crossref: 457] [Cited by in F6Publishing: 489] [Article Influence: 45.7] [Reference Citation Analysis]
|
| 581 |
Köhler S, Bauer M, Bschor T. Pharmakologische Behandlung der bipolaren Depression: Evidenz aus klinischen Leitlinien und Behandlungsempfehlungen. Nervenarzt 2014;85:1075-83. [DOI: 10.1007/s00115-013-3919-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 582 |
Takeshima M, Oka T. Association between the so-called "activation syndrome" and bipolar II disorder, a related disorder, and bipolar suggestive features in outpatients with depression. J Affect Disord 2013;151:196-202. [PMID: 23790740 DOI: 10.1016/j.jad.2013.05.077] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 583 |
Fletcher K, Parker G, Manicavasagar V. Behavioral Activation System (BAS) differences in bipolar I and II disorder. J Affect Disord 2013;151:121-8. [PMID: 23810478 DOI: 10.1016/j.jad.2013.05.061] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 584 |
Masson M. Texte 24. Certains antiépileptiques stabilisent l’humeur. 24 textes fondateurs de la psychiatrie 2013. [DOI: 10.3917/arco.asson.2013.01.0357] [Reference Citation Analysis]
|
| 585 |
Buoli M, Dobrea C, Caldiroli A, Cremaschi L, Altamura AC. Augmentative asenapine in a recurrent manic catatonic patient with partial response to clozapine. Case Rep Psychiatry 2013;2013:503601. [PMID: 24171130 DOI: 10.1155/2013/503601] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 586 |
Vázquez GH, Tondo L, Undurraga J, Baldessarini RJ. Overview of antidepressant treatment of bipolar depression. Int J Neuropsychopharmacol 2013;16:1673-85. [PMID: 23428003 DOI: 10.1017/S1461145713000023] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 587 |
Berghöfer A, Alda M, Adli M, Baethge C, Bauer M, Bschor T, Grof P, Müller-Oerlinghausen B, Rybakowski JK, Suwalska A, Pfennig A. Stability of lithium treatment in bipolar disorder - long-term follow-up of 346 patients. Int J Bipolar Disord 2013;1:11. [PMID: 25505678 DOI: 10.1186/2194-7511-1-11] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 588 |
Young AH, Calabrese JR, Gustafsson U, Berk M, McElroy SL, Thase ME, Suppes T, Earley W. Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies. Int J Bipolar Disord 2013;1:10. [PMID: 25505677 DOI: 10.1186/2194-7511-1-10] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 589 |
Grof P, Müller-oerlinghausen B. S3-Leitlinien zu bipolaren Störungen sind zeitgerechte und wichtige Instrumente für die klinische Praxis. Kontra. Nervenarzt 2013;84:876-878. [DOI: 10.1007/s00115-013-3797-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 590 |
Vieta E, Valentí M. Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis. CNS Drugs 2013;27:515-29. [PMID: 23749421 DOI: 10.1007/s40263-013-0073-y] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 591 |
Turner TL. The use of antipsychotics in maintenance treatment of bipolar disorder. Mental Health Clinician 2013;2:412-415. [DOI: 10.9740/mhc.n155513] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 592 |
Vieta E, Valentí M. Mixed states in DSM-5: implications for clinical care, education, and research. J Affect Disord 2013;148:28-36. [PMID: 23561484 DOI: 10.1016/j.jad.2013.03.007] [Cited by in Crossref: 94] [Cited by in F6Publishing: 96] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 593 |
Geddes JR, Miklowitz DJ. Treatment of bipolar disorder. Lancet 2013;381:1672-82. [PMID: 23663953 DOI: 10.1016/S0140-6736(13)60857-0] [Cited by in Crossref: 496] [Cited by in F6Publishing: 512] [Article Influence: 49.6] [Reference Citation Analysis]
|
| 594 |
Schaffer A, Parikh SV, Kennedy SH, Milev R, Frey BN, Goldstein BI, Beaulieu S, Alda M, O'Donovan C, MacQueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Bond DJ, Lam RW, Yatham LN. Response to commentaries on the Canadian Network for Mood and Anxiety Treatments/International Society for Bipolar Disorders 2013 updated bipolar disorder guidelines. Bipolar Disord 2013;15:338-9. [PMID: 23521579 DOI: 10.1111/bdi.12055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 595 |
Young AH, Altamura AC, González-Pinto AM, Millet B, Wiedemann K. Use of asenapine in clinical practice for the management of bipolar mania. J Psychopharmacol 2013;27:3-13. [PMID: 23535350 DOI: 10.1177/1359786813482534] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 596 |
Malhi GS. Have the CANMAT bipolar guidelines transmogrified from do matter to can matter? Bipolar Disord 2013;15:54-7. [PMID: 23339675 DOI: 10.1111/bdi.12033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 597 |
Swann AC. CANMAT Guidelines commentary: where does the evidence come from, and how can we use it for our patients? Bipolar Disord 2013;15:45-9. [PMID: 23339673 DOI: 10.1111/bdi.12037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 598 |
Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, O'Donovan C, Macqueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Milev R, Bond DJ, Frey BN, Goldstein BI. The evolution of CANMAT Bipolar Disorder Guidelines: past, present, and future. Bipolar Disord 2013;15:58-60. [PMID: 23339676 DOI: 10.1111/bdi.12038] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 599 |
Ostacher MJ. Raising the bar for the evidence in evidence-based guidelines. Bipolar Disord 2013;15:50-3. [PMID: 23339674 DOI: 10.1111/bdi.12032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 600 |
Bourin M, Thibaut F. How assess drugs in the treatment of acute bipolar mania? Front Pharmacol 2013;4:4. [PMID: 23372551 DOI: 10.3389/fphar.2013.00004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 601 |
Woo YS, Wang HR, Bahk WM. Lurasidone as a potential therapy for bipolar disorder. Neuropsychiatr Dis Treat 2013;9:1521-9. [PMID: 24143101 DOI: 10.2147/NDT.S51910] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 602 |
Yu X, Correll CU, Xiang YT, Xu Y, Huang J, Yang F, Wang G, Si T, Kane JM, Masand P. Efficacy of Atypical Antipsychotics in the Management of Acute Agitation and Aggression in Hospitalized Patients with Schizophrenia or Bipolar Disorder: Results from a Systematic Review. Shanghai Arch Psychiatry 2016;28:241-52. [PMID: 28638198 DOI: 10.11919/j.issn.1002-0829.216072] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
|
